ChangeUID	ChangeUID (old file)	IndexString	IndexString (old file)	Score	Coverage	Coverage (old file)	ACount	ACount (old file)	CCount	CCount (old file)	GCount	GCount (old file)	TCount	TCount (old file)	MutCount	MutCount (old file)	SumQualityScore	SumQualityScore (old file)	MinQualityScore	MinQualityScore (old file)	MaxQualityScore	MaxQualityScore (old file)	AverageQualityScore	AverageQualityScore (old file)	Forward	Forward (old file)	Reverse	Reverse (old file)	DistinctCoverage	DistinctCoverage (old file)	DistinctTags	DistinctTags (old file)	DistinctPairs	DistinctPairs (old file)	MutPct	MutPct (old file)	MutType	MutType (old file)	Chrom	Chrom (old file)	Start	Start (old file)	End	End (old file)	BaseFrom	BaseFrom (old file)	BaseTo	BaseTo (old file)	LookupKey	LookupKey (old file)	ENSG	ENSG (old file)	GeneName	GeneName (old file)	Transcript	Transcript (old file)	TxBaseFrom	TxBaseTo	TxBaseTo (old file)	AminoStart	AminoStart (old file)	AminoEnd	AminoEnd (old file)	AAFrom	AAFrom (old file)	AATo	AATo (old file)	Consequence	Consequence (old file)	Exon Rank	Exon Rank (old file)	Transcript GeneName	Transcript GeneName (old file)	HUGO GeneName	HUGO GeneName (old file)	Description	Description (old file)	Deleted	Deleted (old file)	SNP	SNP (old file)	NormalMutCount	NormalMutCount (old file)	NormalRawCoverage	NormalRawCoverage (old file)	NormalPhredCoverage	NormalPhredCoverage (old file)	NormalEffectiveCoverage	NormalEffectiveCoverage (old file)	NormalDistinctRawCoverage	NormalDistinctRawCoverage (old file)	NormalDistinctPhredCoverage	NormalDistinctPhredCoverage (old file)	NormalDistinctEffectiveCoverage	NormalDistinctEffectiveCoverage (old file)	GermlineNormMutPct	GermlineNormMutPct (old file)	Germline?	Germline? (old file)	TotalNormalMutCount	TotalNormalMutCount (old file)	NormalDistinctMutPairs	NormalDistinctMutPairs (old file)	ExcludeConsequence?	ExcludeConsequence? (old file)	Silent?	Silent? (old file)	NormMutPct	NormMutPct (old file)	CosmicGene	CosmicGene (old file)	CosmicTx	CosmicTx (old file)	CosmicAAChange	CosmicAAChange (old file)	CosmicEffect	CosmicEffect (old file)	CosmicID	CosmicID (old file)	DistMutPairsEORA	DistMutPairsEORA (old file)	DistMutPairsEORB	DistMutPairsEORB (old file)	NormalDistMutPairsEORA	NormalDistMutPairsEORA (old file)	NormalDistMutPairsEORB	NormalDistMutPairsEORB (old file)	DistMutPairsEORA+B	DistMutPairsEORA+B (old file)	EORMutPct	EORMutPct (old file)	NormalEORMutPct	NormalEORMutPct (old file)	Ignore	Ignore (old file)	IgnoreB	IgnoreB (old file)	AddlInfo	AddlInfo (old file)	LookupKeyB	LookupKeyB (old file)	AAChange	AAChange (old file)	ReportedMutation	ReportedMutation (old file)	ReportedConsequence	ReportedConsequence (old file)	PGDX Transcript	PGDX Transcript (old file)	PGDX CDS Length	PGDX CDS Length (old file)	PGDX Protein Length	PGDX Protein Length (old file)	LiftOver ID	LiftOver ID (old file)	Liftover hg18 Position	Liftover hg18 Position (old file)	LiftOver hg19 position	LiftOver hg19 position (old file)	sameLocation_Lookup	sameLocation_Lookup (old file)	Changes_SameLocation	Changes_SameLocation (old file)	Changes_Adjacent	Changes_Adjacent (old file)	polyN:ChangeUID	polyN:ChangeUID (old file)	PolyN_Dust	PolyN_Dust (old file)	Sample Name	Sample Name (old file)	CDD: #Gene	CDD: #Gene (old file)	CDD: Key	CDD: Key (old file)	CDD: Size Check	CDD: Size Check (old file)	CDD: Position of Mutation Within a Protein Domain	CDD: Position of Mutation Within a Protein Domain (old file)	CDD: Position of Mutation Near to a Protein Domain	CDD: Position of Mutation Near to a Protein Domain (old file)	COSMIC: Key	COSMIC: Key (old file)	COSMIC: Samples reported with the exact genomic change	COSMIC: Samples reported with the exact genomic change (old file)	COSMIC: Samples reported with a change in the same AA (Missense)	COSMIC: Samples reported with a change in the same AA (Missense) (old file)	COSMIC: Samples reported with a nearby change	COSMIC: Samples reported with a nearby change (old file)	COSMIC: Samples reported with any mutation in this gene	COSMIC: Samples reported with any mutation in this gene (old file)	COSMIC: Number of Exact Hits	COSMIC: Number of Exact Hits (old file)	PGDX Clinical: Gene_symbol	PGDX Clinical: Gene_symbol (old file)	PGDX Clinical: Gene_name	PGDX Clinical: Gene_name (old file)	PGDX Clinical: Gene_summary	PGDX Clinical: Gene_summary (old file)	PGDX Clinical: Gene_aliases	PGDX Clinical: Gene_aliases (old file)	PGDX Clinical: Pathway	PGDX Clinical: Pathway (old file)	PGDX Clinical: Prognostic text	PGDX Clinical: Prognostic text (old file)	PGDX Clinical: Prognostic ref	PGDX Clinical: Prognostic ref (old file)	PGDX Clinical: Prognostic fig	PGDX Clinical: Prognostic fig (old file)	PGDX Clinical: Prognostic fig legend	PGDX Clinical: Prognostic fig legend (old file)	PGDX Clinical: Prognostic fig ref	PGDX Clinical: Prognostic fig ref (old file)	PGDX Clinical: Predictive/Therapeutic text	PGDX Clinical: Predictive/Therapeutic text (old file)	PGDX Clinical: Predictive/Therapeutic ref	PGDX Clinical: Predictive/Therapeutic ref (old file)	PGDX Clinical: Predictive/Therapeutic fig	PGDX Clinical: Predictive/Therapeutic fig (old file)	PGDX Clinical: Predictive/Therapeutic fig legend	PGDX Clinical: Predictive/Therapeutic fig legend (old file)	PGDX Clinical: Predictive/Therapeutic fig ref	PGDX Clinical: Predictive/Therapeutic fig ref (old file)	PGDX: Gene Lookup	PGDX: Gene Lookup (old file)	PGDX: Biologically significant gene	PGDX: Biologically significant gene (old file)	PGDX: Clinically significant gene	PGDX: Clinically significant gene (old file)	PGDX: Chip Gene	PGDX: Chip Gene (old file)	CHASM: MUTID	CHASM: MUTID (old file)	CHASM: MUT	CHASM: MUT (old file)	CHASM: CHASM BRCA	CHASM: PValue BRCA	CHASM: BHFDR BRCA	VEST: MUTID	VEST: MUTID (old file)	VEST: MUT	VEST: MUT (old file)	VEST: VEST	VEST: VEST (old file)	VEST: PValue	VEST: PValue (old file)	VEST: BHFDR	VEST: BHFDR (old file)	PANTHER: Gene Symbol	PANTHER: Gene Symbol (old file)	PANTHER: Gene Identifier	PANTHER: Gene Identifier (old file)	PANTHER: Protein ID	PANTHER: Protein ID (old file)	PANTHER: SF ID	PANTHER: SF ID (old file)	PANTHER: Family Name	PANTHER: Family Name (old file)	PANTHER: Subfamily Name	PANTHER: Subfamily Name (old file)	PANTHER: Molecular function	PANTHER: Molecular function (old file)	PANTHER: Biological process	PANTHER: Biological process (old file)	PANTHER: Cellular components	PANTHER: Cellular components (old file)	PANTHER: Protein class	PANTHER: Protein class (old file)	PANTHER: Pathway	PANTHER: Pathway (old file)	OMIM_gene_symbol	OMIM_gene_symbol (old file)	OMIM_status	OMIM_status (old file)	OMIM_method	OMIM_method (old file)	OMIM_diseases	OMIM_diseases (old file)	OMIM_mim	OMIM_mim (old file)	VEP: ChangeUID	VEP: ChangeUID (old file)	VEP: Position	VEP: Position (old file)	VEP: Gene	VEP: Gene (old file)	VEP: Transcript	VEP: Transcript (old file)	VEP: Consequence	VEP: Consequence (old file)	VEP: cDNA Position	VEP: cDNA Position (old file)	VEP: CDS Position	VEP: CDS Position (old file)	VEP: Protein Position	VEP: Protein Position (old file)	VEP: Strand	VEP: Strand (old file)	VEP: AAChange	VEP: AAChange (old file)	VEP: Codon Change	VEP: Codon Change (old file)	VEP: HGVS Codon Change	VEP: HGVS Codon Change (old file)	VEP: HGVS AAChange	VEP: HGVS AAChange (old file)	snpEff360: ChangeUID	snpEff360: ChangeUID (old file)	snpEff360: GeneID	snpEff360: GeneID (old file)	snpEff360: GeneName	snpEff360: GeneName (old file)	snpEff360: Transcript	snpEff360: Transcript (old file)	snpEff360: CodonFrom	snpEff360: CodonFrom (old file)	snpEff360: CodonTo	snpEff360: CodonTo (old file)	snpEff360: codonStart	snpEff360: codonStart (old file)	snpEff360: codonEnd	snpEff360: codonEnd (old file)	snpEff360: AAFrom	snpEff360: AAFrom (old file)	snpEff360: AATo	snpEff360: AATo (old file)	snpEff360: Consequence	snpEff360: Consequence (old file)	snpEff360: Score	snpEff360: Score (old file)	dbSNP: Sample	dbSNP: Sample (old file)	dbSNP: Other dbSNP hits	dbSNP: Other dbSNP hits (old file)	dbSNP: SNPLookup	dbSNP: SNPLookup (old file)	dbSNP: Chrom	dbSNP: Chrom (old file)	dbSNP: Start	dbSNP: Start (old file)	dbSNP: End	dbSNP: End (old file)	dbSNP: Name	dbSNP: Name (old file)	dbSNP: Strand	dbSNP: Strand (old file)	dbSNP: refUCSC	dbSNP: refUCSC (old file)	dbSNP: Observed	dbSNP: Observed (old file)	dbSNP: Class	dbSNP: Class (old file)	dbSNP: Valid	dbSNP: Valid (old file)	dbSNP: AvHet	dbSNP: AvHet (old file)	dbSNP: AvHetSE	dbSNP: AvHetSE (old file)	dbSNP: Func	dbSNP: Func (old file)	dbSNP: Weight	dbSNP: Weight (old file)	dbSNP: Exceptions	dbSNP: Exceptions (old file)	dbSNP: Submitters	dbSNP: Submitters (old file)	dbSNP: AlleleFreqCount	dbSNP: AlleleFreqCount (old file)	dbSNP: Alleles	dbSNP: Alleles (old file)	dbSNP: AlleleNs	dbSNP: AlleleNs (old file)	dbSNP: AlleleFreqs	dbSNP: AlleleFreqs (old file)	dbSNP: Bitfields	dbSNP: Bitfields (old file)	dbSNP: isCommon	dbSNP: isCommon (old file)	dbSNP: isFlagged	dbSNP: isFlagged (old file)	dbSNP: isMultiple	dbSNP: isMultiple (old file)	ESP: Chrom	ESP: Chrom (old file)	ESP: Start	ESP: Start (old file)	ESP: End	ESP: End (old file)	ESP: ESPKey	ESP: ESPKey (old file)	ESP: dbsnp hit	ESP: dbsnp hit (old file)	ESP: European Allele Count	ESP: European Allele Count (old file)	ESP: African Allele Count	ESP: African Allele Count (old file)	ESP: Total Allele	ESP: Total Allele (old file)	ESP: MAF	ESP: MAF (old file)	ESP: Observed	ESP: Observed (old file)	ESP: European Genotype Count	ESP: European Genotype Count (old file)	ESP: African Genotype Count	ESP: African Genotype Count (old file)	ESP: Total Genotype Count	ESP: Total Genotype Count (old file)	ESP: Average Sample Depth	ESP: Average Sample Depth (old file)	ESP: GeneList	ESP: GeneList (old file)	ESP: scorePhastCons	ESP: scorePhastCons (old file)	ESP: consScoreGERP	ESP: consScoreGERP (old file)	ESP: chimpAllele	ESP: chimpAllele (old file)	ESP: ClinicalAssociation	ESP: ClinicalAssociation (old file)	ESP: EXOME_CHIP	ESP: EXOME_CHIP (old file)	ESP: GWAS_PUBMED	ESP: GWAS_PUBMED (old file)	ESP: Accession	ESP: Accession (old file)	ESP: functionGVS	ESP: functionGVS (old file)	ESP: aminoAcidChange	ESP: aminoAcidChange (old file)	ESP: proteinPosition	ESP: proteinPosition (old file)	ESP: cDNAPosition	ESP: cDNAPosition (old file)	ESP: granthamScore	ESP: granthamScore (old file)	ESP: polyPhen	ESP: polyPhen (old file)	AutoBLATHuman	AutoBLATHuman (old file)	Seq window	Seq window (old file)	BLAT sequence	BLAT sequence (old file)	BLAT URL	BLAT URL (old file)	PGDX Norm: Count	PGDX Norm: Count (old file)	PGDX Norm: rs	PGDX Norm: rs (old file)	Report: Sample Name	Report: Sample Name (old file)	Report: Alternate ID	Report: Alternate ID (old file)	Report: Tumor Type	Report: Tumor Type (old file)	Report: GeneName	Report: GeneName (old file)	Report: Description	Report: Description (old file)	Report: Transcript	Report: Transcript (old file)	Report: LookupKey	Report: LookupKey (old file)	Report: CodonChange	Report: CodonChange (old file)	Report: AAChange	Report: AAChange (old file)	Report: Exon Rank	Report: Exon Rank (old file)	Report: ReportedMutation	Report: ReportedMutation (old file)	Report: ReportedConsequence	Report: ReportedConsequence (old file)	Report: Seq window	Report: Seq window (old file)	Report: SupermutantMutPct	Report: SupermutantMutPct (old file)	Report: 95% Confidence Interval for % Mutant Reads	Report: 95% Confidence Interval for % Mutant Reads (old file)	Report: SupermutantCov	Report: SupermutantCov (old file)	Report: SupermutantCount	Report: SupermutantCount (old file)	Report: Mutant Molecules per mL	Report: Mutant Molecules per mL (old file)	Report: ENSG	Report: ENSG (old file)	Report: Pathway Analysis (GO Molecular Function)	Report: Pathway Analysis (GO Molecular Function) (old file)	Report: Pathway Analysis (GO Biological Process)	Report: Pathway Analysis (GO Biological Process) (old file)	Report: Pathway Analysis (Additional Information)	Report: Pathway Analysis (Additional Information) (old file)	Report: Samples with the Identical Somatic Mutation	Report: Samples with the Identical Somatic Mutation (old file)	Report: Somatic Mutations in the Same Amino Acid Residue	Report: Somatic Mutations in the Same Amino Acid Residue (old file)	Report: Somatic Mutations in Nearby Amino Acid Residues	Report: Somatic Mutations in Nearby Amino Acid Residues (old file)	Report: Gene Somatically Mutated in the Following Cancers	Report: Gene Somatically Mutated in the Following Cancers (old file)	Report: Position of Mutation Within a Protein Domain	Report: Position of Mutation Within a Protein Domain (old file)	Report: Position of Mutation Near to a Protein Domain	Report: Position of Mutation Near to a Protein Domain (old file)	Report: CHASM Score	Report: CHASM Score (old file)	Report: PValue	Report: PValue (old file)	Report: BHFDR	Report: BHFDR (old file)	Report: refUCSC	Report: refUCSC (old file)	Report: Observed	Report: Observed (old file)	Report: Class	Report: Class (old file)	Report: Valid	Report: Valid (old file)	Report: AvHet	Report: AvHet (old file)	Report: AvHetSE	Report: AvHetSE (old file)	Report: Func	Report: Func (old file)	Report: Weight	Report: Weight (old file)	Report: Exceptions	Report: Exceptions (old file)	Report: Submitters	Report: Submitters (old file)	Report: AlleleFreqCount	Report: AlleleFreqCount (old file)	Report: Alleles	Report: Alleles (old file)	Report: AlleleNs	Report: AlleleNs (old file)	Report: AlleleFreqs	Report: AlleleFreqs (old file)	Report: VEST	Report: VEST (old file)	Report: VEST(PValue)	Report: VEST(PValue) (old file)	Report: VEST(BHFDR)	Report: VEST(BHFDR) (old file)	Report: OMIM Diseases	Report: OMIM Diseases (old file)	Report: MIM#	Report: MIM# (old file)	Report: PGDX: Chip Gene	Report: PGDX: Chip Gene (old file)	CleanDistinctPairs	CleanDistinctPairs (old file)	CleanMutPct	CleanMutPct (old file)	OverlapsTumor	OverlapsTumor (old file)	OverlapsNormal	OverlapsNormal (old file)	IndelCount	IndelCount (old file)	NumAlleles	NumAlleles (old file)	NumIndelAlleles	NumIndelAlleles (old file)	Supermutant	Supermutant (old file)	SupermutantAvg	SupermutantAvg (old file)	SupermutantPct	SupermutantPct (old file)	SupermutantCov	SupermutantCov (old file)	CycleDist	CycleDist (old file)	Read1Dist	Read1Dist (old file)	Read2Dist	Read2Dist (old file)	MutReadDist	MutReadDist (old file)	ProperPairs	ProperPairs (old file)	ProperPairsPct	ProperPairsPct (old file)	MMTumor	MMTumor (old file)	LQTumor	LQTumor (old file)	MMAvg	MMAvg (old file)	MutMMAvg	MutMMAvg (old file)	LQAvg	LQAvg (old file)	MutLQAvg	MutLQAvg (old file)	MaskedPairs	MaskedPairs (old file)	MaskedMutPct	MaskedMutPct (old file)	PolyN	PolyN (old file)	PolyNN	PolyNN (old file)	PolyNNN	PolyNNN (old file)	PolyMut	PolyMut (old file)	Dust	Dust (old file)	RptMask	RptMask (old file)	MutCountCov	MutCountCov (old file)	SNP_Allele_Fraction_Normal	SNP_Allele_Fraction_Normal (old file)	SNP_Allele_Fraction_Tumor	SNP_Allele_Fraction_Tumor (old file)	Ref_Allele_Fraction_Tumor	Ref_Allele_Fraction_Tumor (old file)	Observed_MAF	Observed_MAF (old file)	Calculated_MAF_Amplification	Calculated_MAF_Amplification (old file)	dbSNP:ChangeUID	dbSNP:ChangeUID (old file)	ESPKEY	ESPKEY (old file)	ESP:ESPLookupID	ESP:ESPLookupID (old file)	PGDX Norm: ChangeUID	PGDX Norm: ChangeUID (old file)	CI ChangeUID	CI ChangeUID (old file)	95% Confidence Interval	95% Confidence Interval (old file)	CUID	CUID (old file)	HematopoiesisAssociations	HematopoiesisAssociations (old file)	SMChangeUID	SMChangeUID (old file)	SMExcludeCUID	SMExcludeCUID (old file)	IChangeUID	IChangeUID (old file)	OlapIndels	OlapIndels (old file)	ExcludeIndel	ExcludeIndel (old file)	HChangeUID	HChangeUID (old file)	HotList	HotList (old file)	CHChangeUID	CHChangeUID (old file)	CosmicHotSpot	CosmicHotSpot (old file)	Row	Row (old file)	Row	Row (old file)	Total	Total (old file)	Strand Bias Percentage (minimum strand)	Strand Bias Percentage (minimum strand) (old file)	Strand Bias p-value	Strand Bias p-value (old file)	BaseFrom/BaseTo	BaseFrom/BaseTo (old file)	Strand Bias Percentage Result	Strand Bias Percentage Result (old file)	Strand Bias p-value Result	Strand Bias p-value Result (old file)	Strand Bias Mutation Type	Strand Bias Mutation Type (old file)	OverallStrandBiasResult	OverallStrandBiasResult (old file)	Tum RMS MAPQ	Norm RMS MAPQ	Tum NERDist Mean	Tum NERDist SD	Tum Mut RMS MAPQ	GC count	AT count	RMD Score	Normal Bqual Mean	Fisher Left	Fisher Right	Fisher Two-tail	Var Type	Var Length	RepeatMasker	RepeatMaskerDistance	GC_Percent	BWA Tum Var Quality	BWA Tum Distinct Cov	BWA Tum Distinct Pairs	BWA Tum MAF	BWA Strand Bias Z	BWA Strand Bias 50CI_L	BWA Strand Bias 50CI_H	BWA Tum Mean Base Quality	BWA Tum NERDist Mean	BWA Tum NERDist SD	BWA Tum RMS MAPQ	BWA Tum Mut RMS MAPQ	BWA Tum Mean Num Mismatches	BWA Tum Mut Mean Num Mismatches	BWA Mut MAPQ Difference	BWA Supermut Count	BWA Supermut Avg	BWA Supermut MAF	BWA Supermut Cov	BT2 Tum Var Quality	BT2 Tum Distinct Cov	BT2 Tum Distinct Pairs	BT2 Tum MAF	BT2 Strand Bias Z	BT2 Strand Bias 50CI_L	BT2 Strand Bias 50CI_H	BT2 Tum Mean Base Quality	BT2 Tum NERDist Mean	BT2 Tum NERDist SD	BT2 Tum RMS MAPQ	BT2 Tum Mut RMS MAPQ	BT2 Tum Mean Num Mismatches	BT2 Tum Mut Mean Num Mismatches	BT2 Mut MAPQ Difference	BT2 Supermut Count	BT2 Supermut Avg	BT2 Supermut MAF	BT2 Supermut Cov	DUST	ensg_id	ensg_id2	GeneInfo_Transcript	ExAC: AC	ExAC: AF	ExAC: AN	ExAC: AN_Adj	ExAC: BaseQRankSum	ExAC: ClippingRankSum	ExAC: DP	ExAC: FS	ExAC: GQ_MEAN	ExAC: GQ_STDDEV	ExAC: MQ	ExAC: MQ0	ExAC: MQRankSum	ExAC: NCC	ExAC: QD	ExAC: ReadPosRankSum	ExAC: VQSLOD	ExAC: culprit	ExAC: DOUBLETON_DIST	ExAC: K1_RUN	ExAC: K2_RUN	ExAC: K3_RUN
chr2.fa:16082945-16082945_T_A	chr2.fa:16082945-16082945_T_A			0.478	8806	42950	7	9	0	2			3784	4935	14	48	558	1995	39	16			39.8571	36.272728	0	1	7	12	3791	8189	7	13	7	13	0.00184648	0.001587			chr2.fa	chr2									chr2.fa:16082945-16082945_T_A	chr2.fa_16082945-16082945_T_A							agT															COLUMN NOT FOUND	MYCN	COLUMN NOT FOUND	MYCN													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr2_16082945-16082945_T_A	COLUMN NOT FOUND	253S>R	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS1687.1		1395		465																			COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND																v-myc myelocytomatosis viral related oncogene, neuroblastoma derived	"v-myc myelocytomatosis viral related oncogene, neuroblastoma derived"									Science. 1984 Jun 8;224(4653):1121-4, J Clin Oncol. 2009 Apr 1;27(10):1627-36	"Science. 1984 Jun 8;224(4653):1121-4, J Clin Oncol. 2009 Apr 1;27(10):1627-36"																													0.696	0.6033	NA																																		MYCN		confirmed		REa, A, Fd		Feingold syndrome		164280																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	CTCAGNACCTC	COLUMN NOT FOUND	ccgcgcccaggcggccgccAGACCAGCGGCGGCGACCACAAGGCCCTCAGTACCTCCGGAGAGGACACCCTGAGCGATTCAGGTAAAGACCGAACTCGGGT	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='ccgcgcccaggcggccgccAGACCAGCGGCGGCGACCACAAGGCCCTCAGTACCTCCGGAGAGGACACCCTGAGCGATTCAGGTAAAGACCGAACTCGGGT'&Submit=submit","Run BLAT")																	chr2.fa:16082945-16082945_T_A	chr2_16082945-16082945_T_A							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	CTCAGNACCTC	0.00184648	0.001617	0.00136662694305663	0.00111994176217274	3791	4946	7	8																			COLUMN NOT FOUND	-	COLUMN NOT FOUND	-	0.696	0.712	0.6033	0.5719	NA	0.60																																			-	Feingold syndrome	-	164280					0	0.000000											7	8	2	5.250000	0.00184648	0.001617	3791	4946	83	90					COLUMN NOT FOUND	83	83	13	7	1.000000	1	3905	38	0	0	0.000000	0	1.600000	1.42857	0.000000	0	-1.000000	-1	0	0	0.000000			0	1					1	0			0	0.001118	0	0.000000	0.00184647850171459	0.00109930377427629	0.998153521498285	0.998900696225724	0.00184647850171459	0.00109930377427629	270.785714285714	454.833333333333											0.00136662694305663	0.00111994176217274																											7	13	0	0.08	0.0078	0.0017							COLUMN NOT FOUND	BIAS			0.00158983	60	0	25.5714	15.0879	60	0	69	32	-32	0	1	SBS	0	0	-32	0.683168	82.8805	3791	7	0.00184648	2.64575	0	0.127469	39.8571	0.255714	0.150879	60	60	0	1.42857	0	7	2	0.00184648	3791	82.8805	4246	7	0.00164861	2.64575	0	0.127469	39.8571	0.255714	0.150879	41.988	42	0	1.42857	-0.012	7	2	0.00164861	4246	0	ENSG00000134323	ENSG00000134323	CCDS1687.1																						
chr4.fa:55598166-55598166_T_A	chr4.fa:55598166-55598166_T_A			0.395	2942	21585	5	10	0	1			1416	2267	10	49	386	1922	35	16			38.6	37.686275			5	11	1421	6338	5	11	5	11	0.00351865	0.001736			chr4.fa	chr4									chr4.fa:55598166-55598166_T_A	chr4.fa_55598166-55598166_T_A							-															COLUMN NOT FOUND	KIT	COLUMN NOT FOUND	KIT													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr4_55598166-55598166_T_A	COLUMN NOT FOUND	2361+2T>A	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Splice site donor		CCDS3496.1		2931		977																			COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND																		This gene encodes the human homolog of the proto-oncogene c-kit. This protein is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). 	"This gene encodes the human homolog of the proto-oncogene c-kit. This protein is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). "															Tumors containing kit mutations may be sensitive to Imatinib, Sunitinib and Vatalanib and inhibition of the heat shock protein HSP10 by IPI-504	"Tumors containing kit mutations may be sensitive to Imatinib, Sunitinib and Vatalanib and inhibition of the heat shock protein HSP10 by IPI-504"	N Engl J Med. 2005 Aug 18;353(7):701-11, Sarcoma. 2010;2010:458156, N Engl J Med. 2002 Aug 15;347(7):472-80, J Clin Oncol. 2011 Jul 20;29(21):2904-9, Br J Cancer. 2011 May 24;104(11):1686-90, Mol Cancer Ther. 2011 Oct;10(10):1897-908.	"N Engl J Med. 2005 Aug 18;353(7):701-11, Sarcoma. 2010;2010:458156, N Engl J Med. 2002 Aug 15;347(7):472-80, J Clin Oncol. 2011 Jul 20;29(21):2904-9, Br J Cancer. 2011 May 24;104(11):1686-90, Mol Cancer Ther. 2011 Oct;10(10):1897-908."			Effect of KIT mutations on Imatinib response in GIST patients##Reduction in tumor volume in mice carrying KIT mutations on treatment with Imatinib, Sunitinib and IPI-504	"Effect of KIT mutations on Imatinib response in GIST patients##Reduction in tumor volume in mice carrying KIT mutations on treatment with Imatinib, Sunitinib and IPI-504"																																																			KIT		confirmed		REa, A, H, Ch, H, REn		Piebaldism;Gastrointestinal stromal tumor, familial;Mast cell disease;Leukemia, acute myeloid;Germ cell tumors		172800;606764;154800;601626;273300																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	GAATGNAAGTG	COLUMN NOT FOUND	CTTTTCTTACCAGGTGGCAAAGGGCATGGCTTTCCTCGCCTCCAAGAATGTAAGTGGGAGTGATTCTCTAAAGAGTTTTGTGttttgtttttttgattttt	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='CTTTTCTTACCAGGTGGCAAAGGGCATGGCTTTCCTCGCCTCCAAGAATGTAAGTGGGAGTGATTCTCTAAAGAGTTTTGTGttttgtttttttgattttt'&Submit=submit","Run BLAT")																	chr4.fa:55598166-55598166_T_A	chr4_55598166-55598166_T_A							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Splice site donor	COLUMN NOT FOUND	GAATGNAAGTG	0.00351865	0.002194	0.00307880074736269	0.0019209666093566	1421	2279																					COLUMN NOT FOUND	-	COLUMN NOT FOUND	-																																									-	Piebaldism;Gastrointestinal stromal tumor, familial;Mast cell disease;Leukemia, acute myeloid;Germ cell tumors	-	172800;606764;154800;601626;273300					0	0.000000					0	1			0	2			2	5.600000	0.00351865	0.002194	1421	2279	30	98					COLUMN NOT FOUND	31	31	11	5	1.000000	1	44511	20	0	0	0.000000	0	1.392157	1.6	0.000000	0	-1.000000	-1	0	0	0.000000			0	1			1	2	2	39	39	0	0	0.002270	0	0.000000	0.00351864883884588	0.00157803376992268	0.996481351161154	0.998421966230077	0.00351864883884588	0.00157803376992268	142.1	316.85											0.00307880074736269	0.0019209666093566																											5	11			0.0312	5e-04							COLUMN NOT FOUND	BIAS			0.00339905	60	0	13.2	11.7074	60	0	40	61	-32	0	1	SBS	0	0	-32	0.39604	69.1619	1421	5	0.00351865	2.23607	0	0.150823	38.6	0.132	0.117074	60	60	0	1.6	0	5	2	0.00351865	1421	69.1619	1567	5	0.00319081	2.23607	0	0.150823	38.6	0.132	0.117074	41.9673	41.6077	0	1.6	0.3596	5	2	0.00319081	1567	39	ENSG00000157404	ENSG00000157404	CCDS3496.1																						
chr4.fa:55604673-55604673_G_A	chr4.fa:55604673-55604673_G_A			0.832	11032	53855	18	45			4674	5609	0	1	46	289	1828	11568	38	16			39.7391	38.304634	14	43	9	24	4692	8350	22	59	18	56	0.00383632	0.006707			chr4.fa	chr4									chr4.fa:55604673-55604673_G_A	chr4.fa_55604673-55604673_G_A							Ggc															COLUMN NOT FOUND	KIT	COLUMN NOT FOUND	KIT													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr4_55604673-55604673_G_A	COLUMN NOT FOUND	961G>S	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS3496.1		2931		977																			COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND																		This gene encodes the human homolog of the proto-oncogene c-kit. This protein is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). 	"This gene encodes the human homolog of the proto-oncogene c-kit. This protein is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). "															Tumors containing kit mutations may be sensitive to Imatinib, Sunitinib and Vatalanib and inhibition of the heat shock protein HSP10 by IPI-504	"Tumors containing kit mutations may be sensitive to Imatinib, Sunitinib and Vatalanib and inhibition of the heat shock protein HSP10 by IPI-504"	N Engl J Med. 2005 Aug 18;353(7):701-11, Sarcoma. 2010;2010:458156, N Engl J Med. 2002 Aug 15;347(7):472-80, J Clin Oncol. 2011 Jul 20;29(21):2904-9, Br J Cancer. 2011 May 24;104(11):1686-90, Mol Cancer Ther. 2011 Oct;10(10):1897-908.	"N Engl J Med. 2005 Aug 18;353(7):701-11, Sarcoma. 2010;2010:458156, N Engl J Med. 2002 Aug 15;347(7):472-80, J Clin Oncol. 2011 Jul 20;29(21):2904-9, Br J Cancer. 2011 May 24;104(11):1686-90, Mol Cancer Ther. 2011 Oct;10(10):1897-908."			Effect of KIT mutations on Imatinib response in GIST patients##Reduction in tumor volume in mice carrying KIT mutations on treatment with Imatinib, Sunitinib and IPI-504	"Effect of KIT mutations on Imatinib response in GIST patients##Reduction in tumor volume in mice carrying KIT mutations on treatment with Imatinib, Sunitinib and IPI-504"															0.290	0.0068	NA																																		KIT		confirmed		REa, A, H, Ch, H, REn		Piebaldism;Gastrointestinal stromal tumor, familial;Mast cell disease;Leukemia, acute myeloid;Germ cell tumors		172800;606764;154800;601626;273300																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	CTGTCNGCAGC	COLUMN NOT FOUND	CCAACCGACAGAAGCCCGTGGTAGACCATTCTGTGCGGATCAATTCTGTCGGCAGCACCGCTTCCTCCTCCCAGCCTCTGCTTGTGCACGACGATGTCTGA	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='CCAACCGACAGAAGCCCGTGGTAGACCATTCTGTGCGGATCAATTCTGTCGGCAGCACCGCTTCCTCCTCCCAGCCTCTGCTTGTGCACGACGATGTCTGA'&Submit=submit","Run BLAT")																	chr4.fa:55604673-55604673_G_A	chr4_55604673-55604673_G_A							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	CTGTCNGCAGC	0.00383632	0.003714	0.0017688852997851	0.00158535025260616	4692	5655	18	21																			COLUMN NOT FOUND	-	COLUMN NOT FOUND	-	0.290	0.268	0.0068	0.0141	NA	0.05																																			-	Piebaldism;Gastrointestinal stromal tumor, familial;Mast cell disease;Leukemia, acute myeloid;Germ cell tumors	-	172800;606764;154800;601626;273300					0	0.000000											18	21	2.55556	8.904762	0.00383632	0.003714	4692	5655			138	143	122	148	COLUMN NOT FOUND	83	83	55	18	0.982143	1	4747	52	0	0	0.000000	0	1.069536	1	0.000000	0	-1.000000	-1	0	0	0.000000	0	2	2	1	1	2	2	0					0	0.005366	0	0.000000	0.00383631713554987	0.0053898670499461	0.99616368286445	0.994610132950054	0.00383631713554987	0.0053898670499461	130.333333333333	92.7666666666667											0.0017688852997851	0.00158535025260616																											23	67	0.39	0.36	0.2024	0.0136					NOBIAS	BIAS	COLUMN NOT FOUND	BIAS		NOBIAS
	0.00416969	60	0	23.2414	14.7793	60	0	59	42	-101	0	1	SBS	0	0	-101	0.584158	117.009	4692	18	0.00383632	0.922313	0.311814	0.470795	39.7391	0.232414	0.147793	60	60	0	1	0	18	2.55556	0.00383632	4692	117.009	4896	18	0.00367647	0.922313	0.311814	0.470795	39.7391	0.232414	0.147793	41.9863	42	0	1	-0.0137	18	2.55556	0.00367647	4896	0	ENSG00000157404	ENSG00000157404	CCDS3496.1	1	8.236e-06	121412	121382	-4.400e-02	0.251	5726432	0.000	114.76	19.73	59.77	0	-5.180e-01	0	11.97	-3.850e-01	0.720	FS	.	G:1	GG:0	GGC:0
chr6.fa:152265472-152265472_T_A	chr6.fa:152265472-152265472_T_A			0.34	10498	45835	7	11	0	5			4420	5361	14	51	558	2117	39	16			39.8571	37.140350	0	1	7	15	4427	8051	7	16	7	15	0.00158121	0.001863			chr6.fa	chr6									chr6.fa:152265472-152265472_T_A	chr6.fa_152265472-152265472_T_A							Tcc															COLUMN NOT FOUND	ESR1	COLUMN NOT FOUND	ESR1													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr6_152265472-152265472_T_A	COLUMN NOT FOUND	309S>T	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS5234.1		1788		596																			COLUMN NOT FOUND	ESR1	COLUMN NOT FOUND	chr6.fa:152265472-152265472_T_A	COLUMN NOT FOUND	match	COLUMN NOT FOUND	-	COLUMN NOT FOUND	 Ligand binding domain of Estrogen receptor, which are activated by the hormone 17beta-estradiol (estrogen) (310-547)																																																							0.560	0.2530	NA																																		ESR1		confirmed		REa, A		Estrogen resistance;HDL response to hormonereplacement, augmented;Migraine, susceptibility to;Atherosclerosis, susceptibility to;Myocardial infarction,susceptibility to;Breast cancer		615363;;157300;;608446;114480																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	CCTTGNCCCTG	COLUMN NOT FOUND	GGCCAAGCCCGCTCATGATCAAACGCTCTAAGAAGAACAGCCTGGCCTTGTCCCTGACGGCCGACCAGATGGTCAGTGCCTTGTTGGATGCTGAGCCCCCG	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='GGCCAAGCCCGCTCATGATCAAACGCTCTAAGAAGAACAGCCTGGCCTTGTCCCTGACGGCCGACCAGATGGTCAGTGCCTTGTTGGATGCTGAGCCCCCG'&Submit=submit","Run BLAT")																	chr6.fa:152265472-152265472_T_A	chr6_152265472-152265472_T_A							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	CCTTGNCCCTG	0.00158121	0.001302	0.0011704475127275	0.000963789475424171	4427	5377																					COLUMN NOT FOUND	-	COLUMN NOT FOUND	 Ligand binding domain of Estrogen receptor, which are activated by the hormone 17beta-estradiol (estrogen) (310-547)	0.560	0.570	0.2530	0.2709	NA	0.40																																			-	Estrogen resistance;HDL response to hormonereplacement, augmented;Migraine, susceptibility to;Atherosclerosis, susceptibility to;Myocardial infarction,susceptibility to;Breast cancer	-	615363;;157300;;608446;114480					0	0.000000							2	3	0	1			2	5.428571	0.00158121	0.001302	4427	5377	26	95					COLUMN NOT FOUND	26	26	14	7	0.933333	1	34663	6550	0	0	0.000000	0	1.140351	1	0.000000	0	-1.000000	-1	1	0	0.066667			0	1			1	0					0	0.001113	0	0.000000	0.0015812062344703	0.00136713895103157	0.99841879376553	0.998632861048968	0.0015812062344703	0.00136713895103157	316.214285714286	365.727272727273											0.0011704475127275	0.000963789475424171																											7	16	0	0.06	0.0078	3e-04							COLUMN NOT FOUND	BIAS			0.00133359	60	0	17.4286	8.67968	60	0	61	40	-101	0	1	SBS	0	0	-101	0.60396	82.8805	4427	7	0.00158121	2.64575	0	0.127469	39.8571	0.174286	0.0867968	60	60	0	1	0	7	2	0.00158121	4427	82.8805	4631	7	0.00151155	2.64575	0	0.127469	39.8571	0.174286	0.0867968	41.9865	42	0	1	-0.0135	7	2	0.00151155	4631	0	ENSG00000091831	ENSG00000091831	CCDS5234.1																						
chr9.fa:98209537-98209537_C_T	chr9.fa:98209537-98209537_C_T			0.944	10594	74611	0	8	2151	4045	0	1	2392	4253	5550	38020	220532	1500563	27	2			39.7212	38.956436	1240	3071	1521	3670	4526	10427	1018	1788	2392	5953	0.528502	0.570922			chr9.fa	chr9									chr9.fa:98209537-98209537_C_T	chr9.fa_98209537-98209537_C_T							aGc															COLUMN NOT FOUND	PTCH1	COLUMN NOT FOUND	PTCH1													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr9_98209537-98209537_C_T	COLUMN NOT FOUND	1334S>N	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS6714.1		4344		1448																			COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND																		This gene encodes a member of the patched gene family. The encoded protein is the receptor for sonic hedgehog, a secreted molecule implicated in the formation of embryonic structures and in tumorigenesis, as well as the desert hedgehog and indian hedgehog proteins. 	"This gene encodes a member of the patched gene family. The encoded protein is the receptor for sonic hedgehog, a secreted molecule implicated in the formation of embryonic structures and in tumorigenesis, as well as the desert hedgehog and indian hedgehog proteins. "															The hedgehog pathway inhibitor, GDC-0449 has been shown to be effective against medulloblastoma cancer with a somatic PTCH1 mutation.	"The hedgehog pathway inhibitor, GDC-0449 has been shown to be effective against medulloblastoma cancer with a somatic PTCH1 mutation."																					0.564	0.2627	NA																																		PTCH1		confirmed		R, Fd, D		Basal cell nevus syndrome;Basal cell carcinoma,somatic;Holoprosencephaly-7		109400;605462;610828																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	TATTGNTAGGG	COLUMN NOT FOUND	TCCGAGGGTTGTGAGAACGGGCCCCGCGAGGGCCCCAGCGGGCCCTATTGCTAGGGCCAGAATGCCCTTCAGTAGAAATTTCAAAAGCGTCTCTGCGCGGT	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='TCCGAGGGTTGTGAGAACGGGCCCCGCGAGGGCCCCAGCGGGCCCTATTGCTAGGGCCAGAATGCCCTTCAGTAGAAATTTCAAAAGCGTCTCTGCGCGGT'&Submit=submit","Run BLAT")																	chr9.fa:98209537-98209537_C_T	chr9_98209537-98209537_C_T							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	TATTGNTAGGG	0.522782	0.378958	0.0145245742837414	0.0104325357457013	4543	8307	2375	3148																			COLUMN NOT FOUND	-	COLUMN NOT FOUND	-	0.564	0.670	0.2627	0.4672	NA	0.60																																			-	Basal cell nevus syndrome;Basal cell carcinoma,somatic;Holoprosencephaly-7	-	109400;605462;610828					0	0.000000							2	3	0	2	2375	3148	2.32253	7.996506	0.522782	0.378958	4543	8307			226	546	230	421	COLUMN NOT FOUND	91	91	5941	2392	0.997984	1	3820	30	0	0	0.000000	0	1.070718	1.00612	0.000000	0	-1.000000	-1	88	19	0.014782	0.00794314	0	0	1					1	0			0	0.509576	0	0.000000	0.528501988510826	0.408235745824534	0.471498011489174	0.591764254175466	0.471498011489174	0.408235745824534	1.06044985941893	1.22478250646602											0.0145245742837414	0.0104325357457013																											2761	6741	0.45	0.46									COLUMN NOT FOUND	BIAS		NOBIAS
	0.523881	60	0	25.0188	14.1252	60	0	62	39	-101	0	1	SBS	0	0	-101	0.613861	309.043	4526	2392	0.528502	4.97761	0.442217	0.456008	39.7212	0.250188	0.141252	60	60	0	1.00612	0	2375	2.32253	0.522782	4543	315.49	5378	2818	0.523987	7.6121	0.421949	0.434656	39.7136	0.246548	0.141869	41.9868	41.9765	0	1.00784	0.0103	2818	2.26189	0.523987	5378	0	ENSG00000185920	ENSG00000185920	CCDS6714.1	4	3.335e-05	119952	115454	-2.098e+00	4.000e-03	2962673	2.457	89.21	33.22	59.53	0	0.809	1401	12.75	-9.500e-02	1.78	MQ	.	C:0	CT:0	CTA:0
chr17.fa:7577568-7577568_C_T	chr17.fa:7577568-7577568_C_T			0.811	7850	43865	0	1	2941	4275			11	24	26	171	1034	6807	39	16			39.7692	38.241573	3	27	10	24	2952	7978	13	43	11	41	0.00372629	0.005139			chr17.fa	chr17									chr17.fa:7577568-7577568_C_T	chr17.fa_7577568-7577568_C_T							tGt															COLUMN NOT FOUND	TP53	COLUMN NOT FOUND	TP53													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr17_7577568-7577568_C_T	COLUMN NOT FOUND	238C>Y	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS11118.1		1182		394																			COLUMN NOT FOUND	TP53	COLUMN NOT FOUND	chr17.fa:7577568-7577568_C_T	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 P53 DNA-binding domain (109-288)	COLUMN NOT FOUND	-																	This gene encodes tumor protein p53, which responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where it's believed to contribute to transformation and malignancy. p53 is a DNA-binding protein containing transcription activation, DNA-binding, and oligomerization domains. It is postulated to bind to a p53-binding site and activate expression of downstream genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. 	"This gene encodes tumor protein p53, which responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where it's believed to contribute to transformation and malignancy. p53 is a DNA-binding protein containing transcription activation, DNA-binding, and oligomerization domains. It is postulated to bind to a p53-binding site and activate expression of downstream genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. "											TP53 mutation status is correlated with survival in breast cancer.  Patients without mutation in TP53 and a positive PR status (blue), without mutation in TP53 and negative PR status (red), with mutation in TP53 and positive PR status (green) and with TP53 mutation and negative PR status (black)## Radically resected NSCLC patients with TP53 mutations, especially those in exon 5, have a worse prognosis	"TP53 mutation status is correlated with survival in breast cancer.  Patients without mutation in TP53 and a positive PR status (blue), without mutation in TP53 and negative PR status (red), with mutation in TP53 and positive PR status (green) and with TP53 mutation and negative PR status (black)## Radically resected NSCLC patients with TP53 mutations, especially those in exon 5, have a worse prognosis"																									0.036	0.0000	NA																																		TP53		confirmed		REa, A, D		Colorectal cancer;Li-Fraumeni syndrome;Hepatocellular carcinoma;Osteosarcoma;Choroid plexus papilloma;Nasopharyngeal carcinoma;Pancreatic cancer;Adrenal cortical carcinoma;Breast cancer;Basal cell carcinoma 7;Glioma susceptibility 1		114500;151623;114550;259500;260500;607107;260350;202300;114480;614740;137800																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	TGTTANACATG	COLUMN NOT FOUND	TGATGGTGAGGATGGGCCTCCGGTTCATGCCGCCCATGCAGGAACTGTTACACATGTAGTTGTAGTGGATGGTGGTACAGTCAGAGCCAACCTAGGAGATA	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='TGATGGTGAGGATGGGCCTCCGGTTCATGCCGCCCATGCAGGAACTGTTACACATGTAGTTGTAGTGGATGGTGGTACAGTCAGAGCCAACCTAGGAGATA'&Submit=submit","Run BLAT")																	chr17.fa:7577568-7577568_C_T	chr17_7577568-7577568_C_T							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	TGTTANACATG	0.00372629	0.003721	0.00219798840192922	0.00181986054878386	2952	4300	11	16																			COLUMN NOT FOUND	 P53 DNA-binding domain (109-288)	COLUMN NOT FOUND	-	0.036	0.040			NA	0.05																																			-	Colorectal cancer;Li-Fraumeni syndrome;Hepatocellular carcinoma;Osteosarcoma;Choroid plexus papilloma;Nasopharyngeal carcinoma;Pancreatic cancer;Adrenal cortical carcinoma;Breast cancer;Basal cell carcinoma 7;Glioma susceptibility 1	-	114500;151623;114550;259500;260500;607107;260350;202300;114480;614740;137800					0	0.000000											11	16	2.36364	7.500000	0.00372629	0.003721	2952	4300	74	92	107	292	127	153	COLUMN NOT FOUND	86	64	41	11	1.000000	1	3960	12	0	0	0.000000	0	1.073034	1	0.000000	0	-1.000000	-1	0	0	0.000000			0	2	2	1	1	0					0	0.003898	0	0.000000	0.00372628726287263	0.00300864986837157	0.996273712737127	0.996991350131628	0.00372628726287263	0.00300864986837157	134.181818181818	166.1875											0.00219798840192922	0.00181986054878386																											13	51	0.23	0.47	0.0461	0.3899					BIAS	NOBIAS	COLUMN NOT FOUND	BIAS		NOBIAS
	0.0033121	60	0	21.4615	12.9466	60	0	53	48	-101	0	1	SBS	0	0	-101	0.524752	98.8227	2952	11	0.00372629	1.78587	0.129084	0.332454	39.7692	0.214615	0.129466	60	60	0	1	0	11	2.36364	0.00372629	2952	101.865	3274	12	0.00366524	1.97949	0.11693	0.311641	39.7143	0.21	0.125726	41.9913	42	0	1	-0.0087	12	2.33333	0.00366524	3274	0	ENSG00000141510	ENSG00000141510	CCDS11118.1	3	2.471e-05	121412	121356	-2.471e+00	1.12	1821254	3.059	69.22	17.14	59.41	0	-1.990e-01	0	3.36	-5.400e-02	-2.378e+00	QD	0.0185251180833	C:0	CA:1	CAC:0
chr17.fa:7578271-7578271_T_G	chr17.fa:7578271-7578271_T_G			0.787	10234	55240	0	4	0	6	17	41	4567	5965	44	243	1744	9631	36	16			39.6364	38.370518	11	31	11	43	4584	8967	22	71	17	61	0.00370855	0.006803			chr17.fa	chr17									chr17.fa:7578271-7578271_T_G	chr17.fa_7578271-7578271_T_G							cAt															COLUMN NOT FOUND	TP53	COLUMN NOT FOUND	TP53													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr17_7578271-7578271_T_G	COLUMN NOT FOUND	193H>P	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS11118.1		1182		394																			COLUMN NOT FOUND	TP53	COLUMN NOT FOUND	chr17.fa:7578271-7578271_T_G	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 P53 DNA-binding domain (109-288)	COLUMN NOT FOUND	-																	This gene encodes tumor protein p53, which responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where it's believed to contribute to transformation and malignancy. p53 is a DNA-binding protein containing transcription activation, DNA-binding, and oligomerization domains. It is postulated to bind to a p53-binding site and activate expression of downstream genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. 	"This gene encodes tumor protein p53, which responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where it's believed to contribute to transformation and malignancy. p53 is a DNA-binding protein containing transcription activation, DNA-binding, and oligomerization domains. It is postulated to bind to a p53-binding site and activate expression of downstream genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. "											TP53 mutation status is correlated with survival in breast cancer.  Patients without mutation in TP53 and a positive PR status (blue), without mutation in TP53 and negative PR status (red), with mutation in TP53 and positive PR status (green) and with TP53 mutation and negative PR status (black)## Radically resected NSCLC patients with TP53 mutations, especially those in exon 5, have a worse prognosis	"TP53 mutation status is correlated with survival in breast cancer.  Patients without mutation in TP53 and a positive PR status (blue), without mutation in TP53 and negative PR status (red), with mutation in TP53 and positive PR status (green) and with TP53 mutation and negative PR status (black)## Radically resected NSCLC patients with TP53 mutations, especially those in exon 5, have a worse prognosis"																									0.174	0.0002	NA																																		TP53		confirmed		REa, A, D		Colorectal cancer;Li-Fraumeni syndrome;Hepatocellular carcinoma;Osteosarcoma;Choroid plexus papilloma;Nasopharyngeal carcinoma;Pancreatic cancer;Adrenal cortical carcinoma;Breast cancer;Basal cell carcinoma 7;Glioma susceptibility 1		114500;151623;114550;259500;260500;607107;260350;202300;114480;614740;137800																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	TAAGANGCTGA	COLUMN NOT FOUND	TTCTGTCATCCAAATACTCCACACGCAAATTTCCTTCCACTCGGATAAGATGCTGAGGAGGGGCCAGACCTAAGAGCAATCAGTGAGGAATCAGAGGCCTG	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='TTCTGTCATCCAAATACTCCACACGCAAATTTCCTTCCACTCGGATAAGATGCTGAGGAGGGGCCAGACCTAAGAGCAATCAGTGAGGAATCAGAGGCCTG'&Submit=submit","Run BLAT")																	chr17.fa:7578271-7578271_T_G	chr17_7578271-7578271_T_G							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	TAAGANGCTGA	0.00370855	0.003989	0.00175966146875967	0.00159262604552313	4584	6017	17	24																			COLUMN NOT FOUND	 P53 DNA-binding domain (109-288)	COLUMN NOT FOUND	-	0.174	0.200	0.0002	0.0034	NA	0.05																																			-	Colorectal cancer;Li-Fraumeni syndrome;Hepatocellular carcinoma;Osteosarcoma;Choroid plexus papilloma;Nasopharyngeal carcinoma;Pancreatic cancer;Adrenal cortical carcinoma;Breast cancer;Basal cell carcinoma 7;Glioma susceptibility 1	-	114500;151623;114550;259500;260500;607107;260350;202300;114480;614740;137800					0	0.000000					0	1	2	4	0	1	17	24	2.58824	6.291667	0.00370855	0.003989	4584	6017	93	97	139	209	183	300	COLUMN NOT FOUND	87	87	61	17	1.000000	1	5872	48	0	0	0.000000	0	1.063745	1	0.000000	0	-1.000000	-1	1	1	0.016393	0.0588235	0	0	1					1	0			0	0.004399	0	0.000000	0.00370855148342059	0.00457742547728034	0.996291448516579	0.99542257452272	0.00370855148342059	0.00457742547728034	134.823529411765	109.231707317073											0.00175966146875967	0.00159262604552313																											22	74	0.5	0.42	0.5841	0.1003							COLUMN NOT FOUND	BIAS		NOBIAS
	0.00429939	60	0	26.7308	15.962	60	0	50	51	-101	0	1	SBS	0	0	-101	0.49505	114.564	4584	17	0.00370855	0	0.418205	0.581795	39.6364	0.267308	0.15962	60	60	0	1	0	17	2.58824	0.00370855	4584	122.691	5120	21	0.00410156	0.352506	0.387944	0.535132	39.6923	0.269062	0.169449	41.9825	41.4307	0	1.07692	0.5518	21	2.47619	0.00410156	5120	0	ENSG00000141510	ENSG00000141510	CCDS11118.1																						
chr17.fa:7578528-7578528_A_C	chr17.fa:7578528-7578528_A_C			0.909	12730	76439	5351	6704	190	390	0	5	0	8	458	2976	18104	117621	34	16			39.5284	38.538990	104	276	125	344	5537	10190	198	439	190	540	0.0343146	0.052993			chr17.fa	chr17									chr17.fa:7578528-7578528_A_C	chr17.fa_7578528-7578528_A_C							ttT															COLUMN NOT FOUND	TP53	COLUMN NOT FOUND	TP53													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr17_7578528-7578528_A_C	COLUMN NOT FOUND	134F>L	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS11118.1		1182		394																			COLUMN NOT FOUND	TP53	COLUMN NOT FOUND	chr17.fa:7578528-7578528_A_C	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 P53 DNA-binding domain (109-288)	COLUMN NOT FOUND	-																	This gene encodes tumor protein p53, which responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where it's believed to contribute to transformation and malignancy. p53 is a DNA-binding protein containing transcription activation, DNA-binding, and oligomerization domains. It is postulated to bind to a p53-binding site and activate expression of downstream genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. 	"This gene encodes tumor protein p53, which responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where it's believed to contribute to transformation and malignancy. p53 is a DNA-binding protein containing transcription activation, DNA-binding, and oligomerization domains. It is postulated to bind to a p53-binding site and activate expression of downstream genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. "											TP53 mutation status is correlated with survival in breast cancer.  Patients without mutation in TP53 and a positive PR status (blue), without mutation in TP53 and negative PR status (red), with mutation in TP53 and positive PR status (green) and with TP53 mutation and negative PR status (black)## Radically resected NSCLC patients with TP53 mutations, especially those in exon 5, have a worse prognosis	"TP53 mutation status is correlated with survival in breast cancer.  Patients without mutation in TP53 and a positive PR status (blue), without mutation in TP53 and negative PR status (red), with mutation in TP53 and positive PR status (green) and with TP53 mutation and negative PR status (black)## Radically resected NSCLC patients with TP53 mutations, especially those in exon 5, have a worse prognosis"																									0.318	0.0103	NA																																		TP53		confirmed		REa, A, D		Colorectal cancer;Li-Fraumeni syndrome;Hepatocellular carcinoma;Osteosarcoma;Choroid plexus papilloma;Nasopharyngeal carcinoma;Pancreatic cancer;Adrenal cortical carcinoma;Breast cancer;Basal cell carcinoma 7;Glioma susceptibility 1		114500;151623;114550;259500;260500;607107;260350;202300;114480;614740;137800																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	TGGCANAACAT	COLUMN NOT FOUND	GGTGTGGAATCAACCCACAGCTGCACAGGGCAGGTCTTGGCCAGTTGGCAAAACATCTTGTTGAGGGCAGGGGAGTACTGTAGGAAGAGGAAGGAGACAGA	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='GGTGTGGAATCAACCCACAGCTGCACAGGGCAGGTCTTGGCCAGTTGGCAAAACATCTTGTTGAGGGCAGGGGAGTACTGTAGGAAGAGGAAGGAGACAGA'&Submit=submit","Run BLAT")																	chr17.fa:7578528-7578528_A_C	chr17_7578528-7578528_A_C							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	TGGCANAACAT	0.0335679	0.032081	0.00474252966155645	0.00409691238519769	5541	7107	186	228																			COLUMN NOT FOUND	 P53 DNA-binding domain (109-288)	COLUMN NOT FOUND	-	0.318	0.254	0.0103	0.0109	NA	0.05																																			-	Colorectal cancer;Li-Fraumeni syndrome;Hepatocellular carcinoma;Osteosarcoma;Choroid plexus papilloma;Nasopharyngeal carcinoma;Pancreatic cancer;Adrenal cortical carcinoma;Breast cancer;Basal cell carcinoma 7;Glioma susceptibility 1	-	114500;151623;114550;259500;260500;607107;260350;202300;114480;614740;137800					0	0.000000							2	4			186	228	2.41935	7.811403	0.0335679	0.032081	5541	7107	98	99	181	436	171	202	COLUMN NOT FOUND	91	91	539	190	0.998148	1	7241	88	0	0	0.000000	0	1.073067	1.0131	0.000000	0	-1.000000	-1	3	0	0.005556	0	4	4	2	2	1	1	0					0	0.038933	0	0.000000	0.0343146108000722	0.0383217058072123	0.965685389199928	0.961678294192788	0.0343146108000722	0.0383217058072123	14.5710526315789	13.0474358974359											0.00474252966155645	0.00409691238519769																											229	620			0.0931	0.0035					NOBIAS	BIAS	COLUMN NOT FOUND	BIAS		NOBIAS
	0.035978	60	0	25.6178	14.2256	60	0	55	46	-101	0	1	SBS	0	0	-101	0.544554	207.614	5537	190	0.0343146	1.26404	0.429682	0.478615	39.5284	0.256178	0.142256	60	60	0	1.0131	0	186	2.41935	0.0335679	5541	211.383	5994	209	0.0348682	2.09857	0.404091	0.450747	39.5323	0.246454	0.142202	41.9813	41.9429	0	1.01613	0.0384	209	2.37321	0.0348682	5994	0	ENSG00000141510	ENSG00000141510	CCDS11118.1																						
Changes Gained (In new file but not in old):
ChangeUID	IndexString	Score	Coverage	ACount	CCount	GCount	TCount	MutCount	SumQualityScore	MinQualityScore	MaxQualityScore	AverageQualityScore	Forward	Reverse	DistinctCoverage	DistinctTags	DistinctPairs	MutPct	MutType	Chrom	Start	End	BaseFrom	BaseTo	LookupKey	ENSG	GeneName	Transcript	TxBaseFrom	TxBaseTo	AminoStart	AminoEnd	AAFrom	AATo	Consequence	Exon Rank	Transcript GeneName	HUGO GeneName	Description	Deleted	SNP	NormalMutCount	NormalRawCoverage	NormalPhredCoverage	NormalEffectiveCoverage	NormalDistinctRawCoverage	NormalDistinctPhredCoverage	NormalDistinctEffectiveCoverage	GermlineNormMutPct	Germline?	TotalNormalMutCount	NormalDistinctMutPairs	ExcludeConsequence?	Silent?	NormMutPct	CosmicGene	CosmicTx	CosmicAAChange	CosmicEffect	CosmicID	DistMutPairsEORA	DistMutPairsEORB	NormalDistMutPairsEORA	NormalDistMutPairsEORB	DistMutPairsEORA+B	EORMutPct	NormalEORMutPct	Ignore	IgnoreB	AddlInfo	LookupKeyB	AAChange	ReportedMutation	ReportedConsequence	PGDX Transcript	PGDX CDS Length	PGDX Protein Length	LiftOver ID	Liftover hg18 Position	LiftOver hg19 position	sameLocation_Lookup	Changes_SameLocation	Changes_Adjacent	polyN:ChangeUID	PolyN_Dust	Sample Name	CDD: #Gene	CDD: Key	CDD: Size Check	CDD: Position of Mutation Within a Protein Domain	CDD: Position of Mutation Near to a Protein Domain	COSMIC: Key	COSMIC: Samples reported with the exact genomic change	COSMIC: Samples reported with a change in the same AA (Missense)	COSMIC: Samples reported with a nearby change	COSMIC: Samples reported with any mutation in this gene	COSMIC: Number of Exact Hits	PGDX Clinical: Gene_symbol	PGDX Clinical: Gene_name	PGDX Clinical: Gene_summary	PGDX Clinical: Gene_aliases	PGDX Clinical: Pathway	PGDX Clinical: Prognostic text	PGDX Clinical: Prognostic ref	PGDX Clinical: Prognostic fig	PGDX Clinical: Prognostic fig legend	PGDX Clinical: Prognostic fig ref	PGDX Clinical: Predictive/Therapeutic text	PGDX Clinical: Predictive/Therapeutic ref	PGDX Clinical: Predictive/Therapeutic fig	PGDX Clinical: Predictive/Therapeutic fig legend	PGDX Clinical: Predictive/Therapeutic fig ref	PGDX: Gene Lookup	PGDX: Biologically significant gene	PGDX: Clinically significant gene	PGDX: Chip Gene	CHASM: MUTID	CHASM: MUT	CHASM: CHASM BRCA	CHASM: PValue BRCA	CHASM: BHFDR BRCA	VEST: MUTID	VEST: MUT	VEST: VEST	VEST: PValue	VEST: BHFDR	PANTHER: Gene Symbol	PANTHER: Gene Identifier	PANTHER: Protein ID	PANTHER: SF ID	PANTHER: Family Name	PANTHER: Subfamily Name	PANTHER: Molecular function	PANTHER: Biological process	PANTHER: Cellular components	PANTHER: Protein class	PANTHER: Pathway	OMIM_gene_symbol	OMIM_status	OMIM_method	OMIM_diseases	OMIM_mim	VEP: ChangeUID	VEP: Position	VEP: Gene	VEP: Transcript	VEP: Consequence	VEP: cDNA Position	VEP: CDS Position	VEP: Protein Position	VEP: Strand	VEP: AAChange	VEP: Codon Change	VEP: HGVS Codon Change	VEP: HGVS AAChange	snpEff360: ChangeUID	snpEff360: GeneID	snpEff360: GeneName	snpEff360: Transcript	snpEff360: CodonFrom	snpEff360: CodonTo	snpEff360: codonStart	snpEff360: codonEnd	snpEff360: AAFrom	snpEff360: AATo	snpEff360: Consequence	snpEff360: Score	dbSNP: Sample	dbSNP: Other dbSNP hits	dbSNP: SNPLookup	dbSNP: Chrom	dbSNP: Start	dbSNP: End	dbSNP: Name	dbSNP: Strand	dbSNP: refUCSC	dbSNP: Observed	dbSNP: Class	dbSNP: Valid	dbSNP: AvHet	dbSNP: AvHetSE	dbSNP: Func	dbSNP: Weight	dbSNP: Exceptions	dbSNP: Submitters	dbSNP: AlleleFreqCount	dbSNP: Alleles	dbSNP: AlleleNs	dbSNP: AlleleFreqs	dbSNP: Bitfields	dbSNP: isCommon	dbSNP: isFlagged	dbSNP: isMultiple	ESP: Chrom	ESP: Start	ESP: End	ESP: ESPKey	ESP: dbsnp hit	ESP: European Allele Count	ESP: African Allele Count	ESP: Total Allele	ESP: MAF	ESP: Observed	ESP: European Genotype Count	ESP: African Genotype Count	ESP: Total Genotype Count	ESP: Average Sample Depth	ESP: GeneList	ESP: scorePhastCons	ESP: consScoreGERP	ESP: chimpAllele	ESP: ClinicalAssociation	ESP: EXOME_CHIP	ESP: GWAS_PUBMED	ESP: Accession	ESP: functionGVS	ESP: aminoAcidChange	ESP: proteinPosition	ESP: cDNAPosition	ESP: granthamScore	ESP: polyPhen	AutoBLATHuman	Seq window	BLAT sequence	BLAT URL	PGDX Norm: Count	PGDX Norm: rs	Report: Sample Name	Report: Alternate ID	Report: Tumor Type	Report: GeneName	Report: Description	Report: Transcript	Report: LookupKey	Report: CodonChange	Report: AAChange	Report: Exon Rank	Report: ReportedMutation	Report: ReportedConsequence	Report: Seq window	Report: SupermutantMutPct	Report: 95% Confidence Interval for % Mutant Reads	Report: SupermutantCov	Report: SupermutantCount	Report: Mutant Molecules per mL	Report: ENSG	Report: Pathway Analysis (GO Molecular Function)	Report: Pathway Analysis (GO Biological Process)	Report: Pathway Analysis (Additional Information)	Report: Samples with the Identical Somatic Mutation	Report: Somatic Mutations in the Same Amino Acid Residue	Report: Somatic Mutations in Nearby Amino Acid Residues	Report: Gene Somatically Mutated in the Following Cancers	Report: Position of Mutation Within a Protein Domain	Report: Position of Mutation Near to a Protein Domain	Report: CHASM Score	Report: PValue	Report: BHFDR	Report: refUCSC	Report: Observed	Report: Class	Report: Valid	Report: AvHet	Report: AvHetSE	Report: Func	Report: Weight	Report: Exceptions	Report: Submitters	Report: AlleleFreqCount	Report: Alleles	Report: AlleleNs	Report: AlleleFreqs	Report: VEST	Report: VEST(PValue)	Report: VEST(BHFDR)	Report: OMIM Diseases	Report: MIM#	Report: PGDX: Chip Gene	CleanDistinctPairs	CleanMutPct	OverlapsTumor	OverlapsNormal	IndelCount	NumAlleles	NumIndelAlleles	Supermutant	SupermutantAvg	SupermutantPct	SupermutantCov	CycleDist	Read1Dist	Read2Dist	MutReadDist	ProperPairs	ProperPairsPct	MMTumor	LQTumor	MMAvg	MutMMAvg	LQAvg	MutLQAvg	MaskedPairs	MaskedMutPct	PolyN	PolyNN	PolyNNN	PolyMut	Dust	RptMask	MutCountCov	SNP_Allele_Fraction_Normal	SNP_Allele_Fraction_Tumor	Ref_Allele_Fraction_Tumor	Observed_MAF	Calculated_MAF_Amplification	dbSNP:ChangeUID	ESPKEY	ESP:ESPLookupID	PGDX Norm: ChangeUID	CI ChangeUID	95% Confidence Interval	CUID	HematopoiesisAssociations	SMChangeUID	SMExcludeCUID	IChangeUID	OlapIndels	ExcludeIndel	HChangeUID	HotList	CHChangeUID	CosmicHotSpot	Row	Row	Total	Strand Bias Percentage (minimum strand)	Strand Bias p-value	BaseFrom/BaseTo	Strand Bias Percentage Result	Strand Bias p-value Result	Strand Bias Mutation Type	OverallStrandBiasResult	Tum RMS MAPQ	Norm RMS MAPQ	Tum NERDist Mean	Tum NERDist SD	Tum Mut RMS MAPQ	GC count	AT count	RMD Score	Normal Bqual Mean	Fisher Left	Fisher Right	Fisher Two-tail	Var Type	Var Length	RepeatMasker	RepeatMaskerDistance	GC_Percent	BWA Tum Var Quality	BWA Tum Distinct Cov	BWA Tum Distinct Pairs	BWA Tum MAF	BWA Strand Bias Z	BWA Strand Bias 50CI_L	BWA Strand Bias 50CI_H	BWA Tum Mean Base Quality	BWA Tum NERDist Mean	BWA Tum NERDist SD	BWA Tum RMS MAPQ	BWA Tum Mut RMS MAPQ	BWA Tum Mean Num Mismatches	BWA Tum Mut Mean Num Mismatches	BWA Mut MAPQ Difference	BWA Supermut Count	BWA Supermut Avg	BWA Supermut MAF	BWA Supermut Cov	BT2 Tum Var Quality	BT2 Tum Distinct Cov	BT2 Tum Distinct Pairs	BT2 Tum MAF	BT2 Strand Bias Z	BT2 Strand Bias 50CI_L	BT2 Strand Bias 50CI_H	BT2 Tum Mean Base Quality	BT2 Tum NERDist Mean	BT2 Tum NERDist SD	BT2 Tum RMS MAPQ	BT2 Tum Mut RMS MAPQ	BT2 Tum Mean Num Mismatches	BT2 Tum Mut Mean Num Mismatches	BT2 Mut MAPQ Difference	BT2 Supermut Count	BT2 Supermut Avg	BT2 Supermut MAF	BT2 Supermut Cov	DUST	ensg_id	ensg_id2	GeneInfo_Transcript	ExAC: AC	ExAC: AF	ExAC: AN	ExAC: AN_Adj	ExAC: BaseQRankSum	ExAC: ClippingRankSum	ExAC: DP	ExAC: FS	ExAC: GQ_MEAN	ExAC: GQ_STDDEV	ExAC: MQ	ExAC: MQ0	ExAC: MQRankSum	ExAC: NCC	ExAC: QD	ExAC: ReadPosRankSum	ExAC: VQSLOD	ExAC: culprit	ExAC: DOUBLETON_DIST	ExAC: K1_RUN	ExAC: K2_RUN	ExAC: K3_RUN
chr10.fa:89623901-89623901_G_C	0	0.802	4134	0	1961	0	0	4130	163502	14	40	39.5506	1319	741	1962	715	1961	0.99949	Homo-SBS	chr10.fa	89623901	89623901	G	C	chr10.fa:89623901-89623901_G_C	ENSG00000171862	PTEN	CCDS31238.1	-				-		upstream_gene_variant	13	COLUMN NOT FOUND	COLUMN NOT FOUND	phosphatase and tensin homolog	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr10.fa:89623901-89623901_G_C	chr10:89613881-89613881	chr10:89623901-89623901	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr10.fa:89623901-89623901_G_C				endometrium (845 cases),central_nervous_system (560 cases),large_intestine (337 cases),haematopoietic_and_lymphoid_tissue (131 cases),skin (101 cases),breast (99 cases),lung (75 cases),prostate (59 cases),kidney (45 cases),ovary (44 cases),stomach (42 cases),thyroid (28 cases),liver (24 cases),upper_aerodigestive_tract (18 cases),cervix (13 cases),oesophagus (12 cases),soft_tissue (11 cases),urinary_tract (11 cases),vulva (9 cases),pancreas (9 cases),NS (8 cases),biliary_tract (5 cases),eye (4 cases),salivary_gland (3 cases),bone (2 cases),genital_tract (2 cases),meninges (2 cases),autonomic_ganglia (1 cases)		PTEN	phosphatase and tensin homolog	The protein encoded this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. 	10q23del;BZS;DEC;GLM2;MGC11227;MHAM;MMAC1;PTEN1;TEP1	Phosphatidylinositol signaling	Loss of PTEN is associated with worse prognosis in salivary gland cancer.  Homozygous PTEN deletion or mutation correlates with shorter survival in GBM patients.  Reduced PTEN expression leads to a worse prognosis in GIST patients.  PTEN mutations are associated with reduced survival in pediatric T-ALL patients	Br J Cancer. 2012 Feb 14;106(4):719-26, Neuropathology. 2011 Aug;31(4):376-83, Anticancer Res. 2010 Mar;30(3):981-5, J Huazhong Univ Sci Technolog Med Sci. 2010 Apr;30(2):165-9, Leukemia. 2010 Jan;24(1):239-42	S:\Sample reports\Automated Report Info\Figures for gene slide subset\PTEN_Prognostic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\PTEN_Prognostic2##S:\Sample reports\Automated Report Info\Figures for gene slide subset\PTEN_Prognostic3	Survival of salivary gland patients with tumors positive and negative for PTEN expression## PTEN deletion is associated with reduced survival in GBM patients##PTEN mutation and survival of pediatric T-ALL patients	Br J Cancer. 2012 Feb 14;106(4):719-26##Neuropathology. 2011 Aug;31(4):376-83##Leukemia. 2010 Jan;24(1):239-42	The combination of PTEN loss, low CEN7 copy number and PIK3CA gain is associated with poor response to gefitinib in NSCLC.  Activation of the PI3K pathway through loss of PTEN (or mutation of PIK3CA) may lead to resistance to lapatinib and trastuzumab in breast cancer. Loss of PTEN may confer sensitivity to PARP inhibitors in endometrial cancer and only colorectal cell lines with high PTEN expression are sensitive to 5-FU and oxiplatin treatment in vitro.  Over-expression of PTEN results in increased radioresistance in head and neck cancer.  Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in CRC	Br J Cancer. 2011 Dec 6;105(12):1920-6, BMC Cancer. 2011 Jun 15;11:11:248, Nat Rev Clin Oncol. 2011 May;8(5):302-6, Eur J Surg Oncol. 2011 Feb;37(2):140-7, Br J Cancer. 2010 Jun 8;102(12):1778-85, Br J Cancer. 2010 Mar 2;102(5):940	S:\Sample reports\Automated Report Info\Figures for gene slide subset\PTEN_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\PTEN_Therapeutic2	Survival in NSCLC patients with PTEN loss when treated with gefitinib##Overall response rate and clinical benefit rate in breast cancer patients treated with lapatinib according to PI3K pathway activation	Br J Cancer. 2011 Dec 6;105(12):1920-6## BMC Cancer. 2011 Jun 15;11:11:248	PTEN	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	PTEN	HUMAN|ENSEMBL=ENSG00000171862|UniProtKB=P60484		PTHR12305:SF14	PHOSPHATASE WITH HOMOLOGY TO TENSIN	PTEN	hydrolase activity#GO:0016787;hydrolase activity, acting on ester bonds#GO:0016788;catalytic activity#GO:0003824;phosphoprotein phosphatase activity#GO:0004721;phosphoric monoester hydrolase activity#GO:0016791	apoptosis#GO:0006915;lipid metabolic process#GO:0006629;induction of apoptosis#GO:0006917;immune system process#GO:0002376;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell cycle#GO:0007049;cell communication#GO:0007154;cell adhesion#GO:0007155;cellular process#GO:0009987;protein metabolic process#GO:0019538;phospholipid metabolic process#GO:0006644;protein modification process#GO:0006464;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein phosphatase#PC00195;phosphatase#PC00181;hydrolase#PC00121	p53 pathway#P00059>PTEN#G01579;p53 pathway feedback loops 2#P04398>PTEN#G04714;Insulin/IGF pathway-protein kinase B signaling cascade#P00033>PTEN#G04675;Insulin/IGF pathway-protein kinase B signaling cascade#P00033>PTEN#P00905;Inflammation mediated by chemokine and cytokine signaling pathway#P00031>PTEN#P00849;p53 pathway#P00059>PTEN#P01480;Hypoxia response via HIF activation#P00030>PTEN#P00824;PI3 kinase pathway#P00048>PTEN#P01189;p53 pathway feedback loops 2#P04398>PTEN#P04658						chr10.fa:89623901-89623901_G_C	10:89623901	ENSG00000171862	CCDS31238.1	upstream_gene_variant	-		-	1	-	-	-326G>C	N/A													PGDX9323P2_PS_Seq2_BWA		rs2943772_G_C	chr10	89623900	89623901	rs2943772	-	G	C/G	single	by-cluster,by-hapmap	0	0	near-gene-5,untranslated-5	1	SingleAlleleFreq	BCM-HGSC-SUB,BL,BUSHMAN,COMPLETE_GENOMICS,CSHL-HAPMAP,ENSEMBL,HUMANGENOME_JCVI,PJP,SC_JCM,SSMP,	1	G,	9.000000,																																		COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	41	rs2943772	PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	PTEN	phosphatase and tensin homolog	CCDS31238.1	chr10.fa:89623901-89623901_G_C	-326G>C	N/A	13	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	1	N/A	1961	1961	COLUMN NOT FOUND	ENSG00000171862	hydrolase activity#GO:0016787;hydrolase activity, acting on ester bonds#GO:0016788;catalytic activity#GO:0003824;phosphoprotein phosphatase activity#GO:0004721;phosphoric monoester hydrolase activity#GO:0016791	apoptosis#GO:0006915;lipid metabolic process#GO:0006629;induction of apoptosis#GO:0006917;immune system process#GO:0002376;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell cycle#GO:0007049;cell communication#GO:0007154;cell adhesion#GO:0007155;cellular process#GO:0009987;protein metabolic process#GO:0019538;phospholipid metabolic process#GO:0006644;protein modification process#GO:0006464;primary metabolic process#GO:0044238;metabolic process#GO:0008152	p53 pathway#P00059>PTEN#G01579;p53 pathway feedback loops 2#P04398>PTEN#G04714;Insulin/IGF pathway-protein kinase B signaling cascade#P00033>PTEN#G04675;Insulin/IGF pathway-protein kinase B signaling cascade#P00033>PTEN#P00905;Inflammation mediated by chemokine and cytokine signaling pathway#P00031>PTEN#P00849;p53 pathway#P00059>PTEN#P01480;Hypoxia response via HIF activation#P00030>PTEN#P00824;PI3 kinase pathway#P00048>PTEN#P01189;p53 pathway feedback loops 2#P04398>PTEN#P04658	-	-	-	endometrium (845 cases),central_nervous_system (560 cases),large_intestine (337 cases),haematopoietic_and_lymphoid_tissue (131 cases),skin (101 cases),breast (99 cases),lung (75 cases),prostate (59 cases),kidney (45 cases),ovary (44 cases),stomach (42 cases),thyroid (28 cases),liver (24 cases),upper_aerodigestive_tract (18 cases),cervix (13 cases),oesophagus (12 cases),soft_tissue (11 cases),urinary_tract (11 cases),vulva (9 cases),pancreas (9 cases),NS (8 cases),biliary_tract (5 cases),eye (4 cases),salivary_gland (3 cases),bone (2 cases),genital_tract (2 cases),meninges (2 cases),autonomic_ganglia (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	G	C/G	single	by-cluster,by-hapmap	0	0	near-gene-5,untranslated-5	1	SingleAlleleFreq	BCM-HGSC-SUB,BL,BUSHMAN,COMPLETE_GENOMICS,CSHL-HAPMAP,ENSEMBL,HUMANGENOME_JCVI,PJP,SC_JCM,SSMP,	1	G,	9.000000,	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	1	0	1961	2.10607	1	1961	99	224	227	COLUMN NOT FOUND	92	1961	1	6	0	0	1.42187	0	-1	54	0.027537	0	2	4	1	0	10	0	0.999490316004077	0.00050968399592255	0.00050968399592255	980.999999999958	chr10.fa:89623901-89623901_G_C	chr10_89623901_89623901		chr10.fa:89623901-89623901_G_C	chr10.fa:89623901-89623901_G_C	N/A					chr10.fa:89623901-89623901_G_C							12	12	2060	0.36	0	G/C	NOBIAS	BIAS	COLUMN NOT FOUND		0.999032	58.5802	0	21.5841	13.7974	58.5788	0	81	20	1	0	1	SBS	0	10	1	0.80198	299.862	1962	1961	0.99949	12.4251	0.352093	0.367324	39.5506	0.215841	0.137974	58.5802	58.5788	0	1.42187	0.0014	1961	2.10607	1	1961	306.579	2323	2321	0.999139	13.4831	0.353066	0.367066	39.5576	0.218852	0.137468	18.1125	18.0851	0	1.43742	0.0274	2320	2.08448	0.999569	2321	0	ENSG00000171862	ENSG00000171862	CCDS31238.1																						
chr7.fa:116411935-116411935_A_C	0	0.855	11966	4546	210	0	0	528	20972	35	40	39.7197	115	146	4713	181	210	0.0445576	SBS	chr7.fa	116411935	116411935	A	C	chr7.fa:116411935-116411935_A_C	ENSG00000105976	MET	NM_001127500	Aga	Cga	992	992	R	R	synonymous_variant	14	COLUMN NOT FOUND	COLUMN NOT FOUND	met proto-oncogene	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr7.fa:116411935-116411935_A_C	chr7:116199171-116199171	chr7:116411935-116411935	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr7.fa:116411935-116411935_A_C		R992T breast (1 cases)	lung (11 cases),large_intestine (1 cases)	large_intestine (89 cases),lung (59 cases),upper_aerodigestive_tract (55 cases),kidney (50 cases),skin (48 cases),liver (23 cases),haematopoietic_and_lymphoid_tissue (19 cases),endometrium (16 cases),stomach (13 cases),central_nervous_system (13 cases),ovary (12 cases),breast (11 cases),urinary_tract (11 cases),oesophagus (6 cases),thyroid (5 cases),pancreas (4 cases),prostate (4 cases),bone (3 cases),autonomic_ganglia (3 cases),NS (2 cases),biliary_tract (2 cases),adrenal_gland (1 cases),testis (1 cases),eye (1 cases)		MET	met proto-oncogene (hepatocyte growth factor receptor)	The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. 	AUTS9;HGFR;RCCP2;c-Met	MET signaling	Over-expression of MET is associated with poor prognosis in many tumor types, including gastric cancer, cholangiocarcinoma, ovarian clear cell carcinoma and glioblastoma	Histol Histopathol. 2011 Sep;26(9):1111-20, Br J Cancer. 2011 Jun 28;105(1):131-8, Mod Pathol. 2011 Aug;24(8):1146-55, J Clin Neurosci. 2011 Jan;18(1):119-2, Expert Opin Investig Drugs. 2011 Sep;20(9):1225-41	S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Prognostic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Prognostic2	Gastric cancer patients with tumors displaying high MET expression have reduced overall survival##MET overexpression is associated with poor prognosis in ovarian clear cell carcinoma patients	Histol Histopathol. 2011 Sep;26(9):1111-20##Mod Pathol. 2011 Aug;24(8):1146-55	A number of MET inhibitors have been developed and have shown promising results in vitro and in clinical trials.  Patients may acquire secondary resistance mutations in this gene during treatment, as seen with NVP-BVU972.  Crizotinib has been successfully used to treat a NSCLC patient with a MET amplification.  Exelixis treatment of human malignant peripheral nerve sheath xenografts expressing MET lead to reduced tumor growth and metastasis in mice.  Knockdown of MET in multiple myeloma cells leads to increased sensitivity to doxorubicin.  The Met inhibitor PF-2341066 demonstrated anti-proliferative efficacy when combined with androgen ablation therapy for advanced prostate cancer in a mouse model, as well as positive results in NSCLC trials and against osteosarcoma in vitro.	Expert Opin Investig Drugs. 2011 Sep;20(9):1225-41, Cancer Res. 2011 Aug 1;71(15):5255-64,J Thorac Oncol. 2011 May;6(5):942-6,Clin Cancer Res. 2011 Jun 15;17(12):3943-55, Mol Med Report. 2011 Mar-Apr;4(2):343-9, BMC Cancer. 2010 Oct 14;10:556	S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Therapeutic2##S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Therapeutic3	Reduced growth of MET expressing xenografts on treatment with Exelixis (XL184)##MET inhibition by PF-2341066 was associated with reduced proliferation of advanced prostate cancer##Dysregulated c-MET pathway in cancer and therapeutic interventions	Clin Cancer Res. 2011 Jun 15;17(12):3943-55##BMC Cancer. 2010 Oct 14;10:556##Expert Opin Investig Drugs. 2011 Sep;20(9):1225-41	MET	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	MET	HUMAN|ENSEMBL=ENSG00000105976|UniProtKB=P08581##HUMAN|ENSEMBL=ENSG00000137776|UniProtKB=Q9NWH9		PTHR24416:SF113##PTHR15683:SF3	TYROSINE-PROTEIN KINASE RECEPTOR##SCAFFOLD ATTACHMENT FACTOR B-RELATED	MACROPHAGE-STIMULATING PROTEIN RECEPTOR##SCAFFOLD ATTACHMENT FACTOR B-RELATED	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672##nucleic acid binding#GO:0003676;RNA binding#GO:0003723;transcription factor activity#GO:0003700;binding#GO:0005488;transcription cofactor activity#GO:0003712;chromatin binding#GO:0003682;DNA binding#GO:0003677;double-stranded DNA binding#GO:0003690;transcription regulator activity#GO:0030528	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152##organelle organization and biogenesis#GO:0006996;regulation of transcription from RNA polymerase II promoter#GO:0006357;nuclear mRNA splicing, via spliceosome#GO:0000398;RNA metabolic process#GO:0016070;mRNA processing#GO:0006397;establishment and/or maintenance of chromatin architecture#GO:0006325;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;transcription#GO:0006350;cellular component organization and biogenesis#GO:0016043;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein kinase receptor#PC00194;protein kinase#PC00193;transferase#PC00220;kinase#PC00137;tyrosine protein kinase receptor#PC00233;receptor#PC00197##DNA binding protein#PC00009;transcription factor#PC00218;chromatin/chromatin-binding protein#PC00077;transcription cofactor#PC00217;RNA binding protein#PC00031;nucleic acid binding#PC00171							chr7.fa:116411935-116411935_A_C	7:116411935	ENSG00000105976	NM_001127500	synonymous_variant	3161	2974	992	1	R	Aga/Cga	2974A>C	%3D)	chr7.fa:116411935-116411935_A_C	ENSG00000105976	ENSG00000105976	NM_001127500	Aga	Cga	992	992	R	R	SYNONYMOUS_CODING	14	PGDX9323P2_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	MET	met proto-oncogene	NM_001127500	chr7.fa:116411935-116411935_A_C	2974A>C	%3D)	14	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.0361648	0.00530615375629631	4756	172	COLUMN NOT FOUND	ENSG00000105976	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672##nucleic acid binding#GO:0003676;RNA binding#GO:0003723;transcription factor activity#GO:0003700;binding#GO:0005488;transcription cofactor activity#GO:0003712;chromatin binding#GO:0003682;DNA binding#GO:0003677;double-stranded DNA binding#GO:0003690;transcription regulator activity#GO:0030528	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152##organelle organization and biogenesis#GO:0006996;regulation of transcription from RNA polymerase II promoter#GO:0006357;nuclear mRNA splicing, via spliceosome#GO:0000398;RNA metabolic process#GO:0016070;mRNA processing#GO:0006397;establishment and/or maintenance of chromatin architecture#GO:0006325;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;transcription#GO:0006350;cellular component organization and biogenesis#GO:0016043;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;metabolic process#GO:0008152	-	-	R992T breast (1 cases)	lung (11 cases),large_intestine (1 cases)	large_intestine (89 cases),lung (59 cases),upper_aerodigestive_tract (55 cases),kidney (50 cases),skin (48 cases),liver (23 cases),haematopoietic_and_lymphoid_tissue (19 cases),endometrium (16 cases),stomach (13 cases),central_nervous_system (13 cases),ovary (12 cases),breast (11 cases),urinary_tract (11 cases),oesophagus (6 cases),thyroid (5 cases),pancreas (4 cases),prostate (4 cases),bone (3 cases),autonomic_ganglia (3 cases),NS (2 cases),biliary_tract (2 cases),adrenal_gland (1 cases),testis (1 cases),eye (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	172	2.26744	0.0361648	4756	99	196	207	COLUMN NOT FOUND	115	210	1	28	0	0	1.85985	0	-1	64	0.304762	2	2	1	0	0	0	0	0.0445576066199873	0.955442393380013	0.0445576066199873	11.2214285714286	chr7.fa:116411935-116411935_A_C	chr7_116411935_116411935			chr7.fa:116411935-116411935_A_C	0.00530615375629631					chr7.fa:116411935-116411935_A_C							7	7	261	0.44	0.0316	A/C	NOBIAS	BIAS	COLUMN NOT FOUND		0.044125	60	0	25.3345	14.4446	60	0	45	56	-101	0	1	SBS	0	0	-101	0.445545	212.574	4713	210	0.0445576	1.7212	0.417341	0.463886	39.7197	0.253345	0.144446	60	60	0	1.85985	0	172	2.26744	0.0361648	4756	155.204	4881	49	0.0100389	1.85714	0.319168	0.415526	39.6735	0.28369	0.160468	41.9407	38.1656	0	2.2449	3.7751	49	2	0.0100389	4881	0	ENSG00000105976	ENSG00000105976	NM_001127500																						
chr1.fa:11184694-11184694_T_A	0	0.359	9350	6	0	0	3931	12	468	34	40	39	0	6	3937	6	6	0.001524	SBS	chr1.fa	11184694	11184694	T	A	chr1.fa:11184694-11184694_T_A	ENSG00000198793	MTOR	CCDS127.1	-				-		intron_variant	46	COLUMN NOT FOUND	COLUMN NOT FOUND	mechanistic target of rapamycin (serine/threonine kinase)	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr1.fa:11184694-11184694_T_A	chr1:11107281-11107281	chr1:11184694-11184694	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr1.fa:11184694-11184694_T_A				large_intestine (97 cases),kidney (68 cases),lung (59 cases),skin (53 cases),endometrium (39 cases),stomach (29 cases),breast (25 cases),haematopoietic_and_lymphoid_tissue (19 cases),urinary_tract (14 cases),liver (13 cases),upper_aerodigestive_tract (13 cases),ovary (11 cases),oesophagus (11 cases),central_nervous_system (10 cases),prostate (5 cases),pancreas (4 cases),genital_tract (2 cases),bone (1 cases),soft_tissue (1 cases),thyroid (1 cases),small_intestine (1 cases),fallopian_tube (1 cases)		MTOR	mechanistic target of rapamycin	The protein encoded by this gene belongs to a family of phosphatidylinositol kinase-related kinases. These kinases mediate cellular responses to stresses such as DNA damage and nutrient deprivation. This protein acts as the target for the cell-cycle arrest and immunosuppressive effects of the FKBP12-rapamycin complex. 	FLJ44809;FRAP;FRAP1;FRAP2;RAFT1;RAPT1	mTOR signaling and cell cycle arrest	High mTOR expression is associated with a higher risk of recurrence in laryngeal carcinoma patients and pMTOR levels correlate with an adverse prognosis in leiomyosarcomas.  MTOR expression is also a poor prognostic factor in NSCLC.	Oral Oncol. 2012 Jan 27, Cancer. 2011 Aug 11, Lung Cancer. 2012 Feb;75(2):217-22	S:\Sample reports\Automated Report Info\Figures for gene slide subset\MTOR_Prognostic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\MTOR_Prognostic2	Disease-free survival in laryngeal cancer patients with differing levels of MTOR expression##Survival of leiomyosarcoma patients with respect to pMTOR expression	Oral Oncol. 2012 Jan 27##Cancer. 2011 Aug 11	There are numerous inhibitors of MTOR.  The first to be developed was rapamycin and in addition to its analogs (everolimus, temsirolimus and ridaforolimus), a new generation of inhibitors that target the mTOR catalytic site are being assessed.  The mTOR inhibitor, ridaforolimus displayed positive results in clinical trials in sarcoma patients.  The combination of the mTOR inhibitor NVP-BEZ235 and sorafenib is effective against renal cell carcinoma in xenograft models.  	Nat Rev Drug Discov. 2011 Oct 31;10(11):868-80, J Clin Oncol. 2012 Jan 1;30(1):78-84, Mol Cancer. 2011 Jul 26;10:90	S:\Sample reports\Automated Report Info\Figures for gene slide subset\MTOR_Therapeutic3##S:\Sample reports\Automated Report Info\Figures for gene slide subset\MTOR_Therapeutic4##S:\Sample reports\Automated Report Info\Figures for gene slide subset\MTOR_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\MTOR_Therapeutic2	Dual mTOR/PI3K inhibitors##Pan mTOR inhibitors##Kaplan-Meier estimates of progression free survival for sarcoma patients treated with ridaforolimus##Treatment of  a renal cell carcinoma mouse model with NVP-BEZ235 and sorafenib inhibits tumor growth	Nat Rev Drug Discov. 2011 Oct 31;10(11):868-80##Nat Rev Drug Discov. 2011 Oct 31;10(11):868-80##J Clin Oncol. 2012 Jan 1;30(1):78-84## Mol Cancer. 2011 Jul 26;10:90	MTOR	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	MTOR	HUMAN|ENSEMBL=ENSG00000198793|UniProtKB=P42345		PTHR11139:SF9	ATAXIA TELANGIECTASIA MUTATED (ATM)-RELATED	FKBP-RAPAMYCIN ASSOCIATED PROTEIN	nucleic acid binding#GO:0003676;transferase activity#GO:0016740;binding#GO:0005488;catalytic activity#GO:0003824;kinase activity#GO:0016301;nucleotide kinase activity#GO:0019201;protein kinase activity#GO:0004672	DNA repair#GO:0006281;induction of apoptosis#GO:0006917;signal transduction#GO:0007165;cell communication#GO:0007154;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cellular component organization and biogenesis#GO:0016043;cellular process#GO:0009987;DNA recombination#GO:0006310;primary metabolic process#GO:0044238;apoptosis#GO:0006915;response to stimulus#GO:0050896;immune system process#GO:0002376;organelle organization and biogenesis#GO:0006996;response to stress#GO:0006950;protein amino acid phosphorylation#GO:0006468;cell cycle#GO:0007049;establishment and/or maintenance of chromatin architecture#GO:0006325;protein metabolic process#GO:0019538;protein modification process#GO:0006464;metabolic process#GO:0008152;DNA metabolic process#GO:0006259		non-receptor serine/threonine protein kinase#PC00167;protein kinase#PC00193;nucleotide kinase#PC00172;transferase#PC00220;kinase#PC00137;nucleic acid binding#PC00171	Hypoxia response via HIF activation#P00030>TOR#P00817;p53 pathway by glucose deprivation#P04397>mTOR#P04638;EGF receptor signaling pathway#P00018>PI3K#P00557;Interleukin signaling pathway#P00036>mTOR#P00966;PDGF signaling pathway#P00047>mTOR#P01144						chr1.fa:11184694-11184694_T_A	1:11184694	ENSG00000198793	CCDS127.1	splice_region_variant,intron_variant	-	-	-	-1	-	-	6527-4A>T	N/A	chr1.fa:11184694-11184694_T_A	ENSG00000198793	ENSG00000198793	CCDS127.1							INTRON		PGDX9323P2_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	MTOR	mechanistic target of rapamycin (serine/threonine kinase)	CCDS127.1	chr1.fa:11184694-11184694_T_A	6527-4A>T	N/A	46	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.001524	0.00121852683050878	3937	6	COLUMN NOT FOUND	ENSG00000198793	nucleic acid binding#GO:0003676;transferase activity#GO:0016740;binding#GO:0005488;catalytic activity#GO:0003824;kinase activity#GO:0016301;nucleotide kinase activity#GO:0019201;protein kinase activity#GO:0004672	DNA repair#GO:0006281;induction of apoptosis#GO:0006917;signal transduction#GO:0007165;cell communication#GO:0007154;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cellular component organization and biogenesis#GO:0016043;cellular process#GO:0009987;DNA recombination#GO:0006310;primary metabolic process#GO:0044238;apoptosis#GO:0006915;response to stimulus#GO:0050896;immune system process#GO:0002376;organelle organization and biogenesis#GO:0006996;response to stress#GO:0006950;protein amino acid phosphorylation#GO:0006468;cell cycle#GO:0007049;establishment and/or maintenance of chromatin architecture#GO:0006325;protein metabolic process#GO:0019538;protein modification process#GO:0006464;metabolic process#GO:0008152;DNA metabolic process#GO:0006259	Hypoxia response via HIF activation#P00030>TOR#P00817;p53 pathway by glucose deprivation#P04397>mTOR#P04638;EGF receptor signaling pathway#P00018>PI3K#P00557;Interleukin signaling pathway#P00036>mTOR#P00966;PDGF signaling pathway#P00047>mTOR#P01144	-	-	-	large_intestine (97 cases),kidney (68 cases),lung (59 cases),skin (53 cases),endometrium (39 cases),stomach (29 cases),breast (25 cases),haematopoietic_and_lymphoid_tissue (19 cases),urinary_tract (14 cases),liver (13 cases),upper_aerodigestive_tract (13 cases),ovary (11 cases),oesophagus (11 cases),central_nervous_system (10 cases),prostate (5 cases),pancreas (4 cases),genital_tract (2 cases),bone (1 cases),soft_tissue (1 cases),thyroid (1 cases),small_intestine (1 cases),fallopian_tube (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	6	2	0.001524	3937	31	18	31	COLUMN NOT FOUND	31	6	1	58	0	0	1.16667	0	-1	0	0	0	1	1	2	0	0	0	0.0015240030480061	0.998475996951994	0.0015240030480061	328.083333333333	chr1.fa:11184694-11184694_T_A	chr1_11184694_11184694			chr1.fa:11184694-11184694_T_A	0.00121852683050878			chr1.fa:11184694-11184694_T_A	SMExclude	chr1.fa:11184694-11184694_T_A							1	1	6	0	0.0156	T/A	BIAS	BIAS	COLUMN NOT FOUND	BIAS	0.00128342	60	0	19.3333	10.8319	60	0	49	52	-101	0	1	SBS	0	0	-101	0.485149	75.8905	3937	6	0.001524	2.44949	0	0.137682	39	0.193333	0.108319	60	60	0	1.16667	0	6	2	0.001524	3937	75.8905	4129	6	0.00145314	2.44949	0	0.137682	39	0.193333	0.108319	41.9931	42	0	1.16667	-0.0069	6	2	0.00145314	4129	0	ENSG00000198793	ENSG00000198793	CCDS127.1																						
chr9.fa:135771988-135771990_GCT_	0	0.105	8960	0	3720	0	0	42	1652	36	40	39.3333	13	8	3729	21	17	0.00455886	DEL	chr9.fa	135771988	135771990	GCT		chr9.fa:135771988-135771990_GCT_	ENSG00000165699	TSC1	CCDS6956.1	AGC	-	1043	1043	S	-	inframe_deletion	21	COLUMN NOT FOUND	COLUMN NOT FOUND	tuberous sclerosis 1	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr9.fa:135771988-135771990_GCT_	chr9:134761809-134761811	chr9:135771988-135771990	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr9.fa:135771988-135771990_GCT_	endometrium (1 cases)		large_intestine (3 cases),lung (1 cases)	large_intestine (51 cases),urinary_tract (25 cases),skin (25 cases),lung (22 cases),stomach (15 cases),endometrium (14 cases),liver (11 cases),kidney (10 cases),breast (9 cases),ovary (6 cases),upper_aerodigestive_tract (5 cases),central_nervous_system (5 cases),haematopoietic_and_lymphoid_tissue (4 cases),bone (2 cases),oesophagus (2 cases),autonomic_ganglia (2 cases),prostate (2 cases),salivary_gland (1 cases),NS (1 cases),soft_tissue (1 cases),pancreas (1 cases)	1	TSC1	tuberous sclerosis 1	This gene encodes a growth inhibitory protein thought to play a role in the stabilization of tuberin. 	KIAA0243;LAM;MGC86987;TSC	mTOR signaling and cell cycle arrest	None described	NA	NA	NA	NA	Renal angiomyolipomas caused by defects in TSC1 display regression on treatment with the mTOR inhibitor, sirolimus (rapamycin).  Everolimus treatment of astrocytomas in patients with germline TSC1 mutations leads to a reduction in tumor size	PLoS One. 2011;6(9):e23379, Clin Cancer Res. 2011 Jun 15;17(12):4071-8,  N Engl J Med. 2010 Nov 4;363(19):1801-11	S:\Sample reports\Automated Report Info\Figures for gene slide subset\TSC2_Therapeutic1	Reduced tumor burden in Tuberous Sclerosis patients treated with sirolimus (rapamycin)	PLoS One. 2011;6(9):e23379	TSC1	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	TSC1	HUMAN|ENSEMBL=ENSG00000165699|UniProtKB=Q92574		PTHR15154:SF2	HAMARTIN	SUBFAMILY NOT NAMED		cell cycle#GO:0007049;cellular process#GO:0009987			Insulin/IGF pathway-protein kinase B signaling cascade#P00033>TSC1#P04495;p53 pathway by glucose deprivation#P04397>TSC1#P04645						chr9.fa:135771988-135771990_GCT_	9:135771988-135771990	ENSG00000165699	CCDS6956.1	inframe_deletion	3127-3129	3127-3129	1043	-1	S/-	AGC/-	3127_3129delAGC	S1043del	chr9.fa:135771988-135771990_GCT_	ENSG00000165699	ENSG00000165699	CCDS6956.1	agc	-	1043	1043	S	-	CODON_DELETION	21	PGDX9323P2_PS_Seq2_BWA	SNP:chr9_135771987_135771987_rs118203743_-_GCTGCT,SNP:chr9_135771987_135771988_rs201192125_G_A,SNP:chr9_135771987_135771990_rs118203719_()1376BPDEL_)LEHPV6731(,SNP:chr9_135771987_135771990_rs118203719_()1376BPDEL_-,SNP:chr9_135771987_135771990_rs2234980_GCTGCTGCTGCTGCTGCT_6)GCT(,SNP:chr9_135771987_135771990_rs2234980_GCTGCTGCTGCTGCTGCT_7,SNP:chr9_135771987_135771990_rs2234980_GCTGCTGCTGCTGCTGCT_8	rs118203743_-_GCT	chr9	135771987	135771987	rs118203743	-	-	-/AGC/AGCAGC	insertion	by-cluster	0	0	cds-indel	1		TSC2DB,	0				clinically-assoc,submitted-by-lsdb		FLAGGED																														COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	TSC1	tuberous sclerosis 1	CCDS6956.1	chr9.fa:135771988-135771990_GCT_	3127_3129delAGC	S1043del	21	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.00240835	0.00157155878668986	3737	9	COLUMN NOT FOUND	ENSG00000165699	-	cell cycle#GO:0007049;cellular process#GO:0009987	Insulin/IGF pathway-protein kinase B signaling cascade#P00033>TSC1#P04495;p53 pathway by glucose deprivation#P04397>TSC1#P04645	endometrium (1 cases)	-	large_intestine (3 cases),lung (1 cases)	large_intestine (51 cases),urinary_tract (25 cases),skin (25 cases),lung (22 cases),stomach (15 cases),endometrium (14 cases),liver (11 cases),kidney (10 cases),breast (9 cases),ovary (6 cases),upper_aerodigestive_tract (5 cases),central_nervous_system (5 cases),haematopoietic_and_lymphoid_tissue (4 cases),bone (2 cases),oesophagus (2 cases),autonomic_ganglia (2 cases),prostate (2 cases),salivary_gland (1 cases),NS (1 cases),soft_tissue (1 cases),pancreas (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-/AGC/AGCAGC	insertion	by-cluster	0	0	cds-indel	1	-	TSC2DB,	0	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	17	1	0	0	17	2	1	9	2.66667	0.00240835	3737	80	96	130	COLUMN NOT FOUND	63	17	1	44	0	0	1	0	-1	0	0	0	1	4	6	20	9						chr9.fa:135771988-135771990_GCT_	chr9_135771988_135771990			chr9.fa:135771988-135771990_GCT_	0.00157155878668986			chr9.fa:135771988-135771990_GCT_	SMExclude	chr9.fa:135771988-135771990_GCT_	chr9.fa:135771988-135771990_GCT_	Keep					10	10	21	0.38	0.1917	GCT/	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.0046875	60	0	31.1429	12.623	60	0	64	37	-1	0	1	DEL	3	9	-1	0.633663	113.688	3729	17	0.00455886	0.981692	0.299157	0.462747	39.3333	0.311429	0.12623	60	60	0	1	0	9	2.66667	0.00240835	3737	119.795	4288	20	0.00466418	0.972203	0.315893	0.466716	39.3478	0.316957	0.121267	41.9842	41.4876	0	1	0.4966	11	2.54545	0.00255993	4297	20	ENSG00000165699	ENSG00000165699	CCDS6956.1																						
chr16.fa:2134994-2134994_C_T	0	0.942	12384	0	2914	0	2493	5702	228698	14	40	39.4443	1130	1719	5397	998	2493	0.461923	SBS	chr16.fa	2134994	2134994	C	T	chr16.fa:2134994-2134994_C_T	ENSG00000103197	TSC2	CCDS10458.1	gaC	gaT	1512	1512	D	D	synonymous_variant	34	COLUMN NOT FOUND	COLUMN NOT FOUND	tuberous sclerosis 2	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr16.fa:2134994-2134994_C_T	chr16:2074995-2074995	chr16:2134994-2134994	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr16.fa:2134994-2134994_C_T			upper_aerodigestive_tract (1 cases),large_intestine (1 cases)	large_intestine (61 cases),lung (44 cases),liver (36 cases),skin (35 cases),kidney (33 cases),stomach (24 cases),endometrium (17 cases),pancreas (15 cases),upper_aerodigestive_tract (14 cases),breast (13 cases),central_nervous_system (11 cases),haematopoietic_and_lymphoid_tissue (8 cases),urinary_tract (7 cases),ovary (6 cases),prostate (6 cases),oesophagus (5 cases),bone (4 cases),NS (2 cases),soft_tissue (2 cases),autonomic_ganglia (2 cases),thyroid (2 cases),parathyroid (1 cases),adrenal_gland (1 cases),cervix (1 cases),biliary_tract (1 cases)		TSC2	tuberous sclerosis 2	This gene product is believed to be a tumor suppressor and is able to stimulate specific GTPases. The protein associates with hamartin in a cytosolic complex, possibly acting as a chaperone for hamartin. 	FLJ43106;LAM;TSC4	mTOR signaling and cell cycle arrest	None described	NA	NA	NA	NA	TSC2 deficient cells are sensitive to anti-EGFR antibodies, Renal angiomyolipomas caused by defects in TSC2 display regression on treatment with the mTOR inhibitor, sirolimus (rapamycin), Everolimus treatment of astrocytomas in patients with germline TSC2 mutations leads to a reduction in tumor size	PLoS One. 2008;3(10):e3558, Clin Cancer Res. 2011 Jun 15;17(12):4071-8, PLoS One. 2011;6(9):e23379, N Engl J Med. 2010 Nov 4;363(19):1801-11	S:\Sample reports\Automated Report Info\Figures for gene slide subset\TSC2_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\TSC2_Therapeutic2, S:\Sample reports\Automated Report Info\Figures for gene slide subset\TSC2_Therapeutic3	Anti-EGFR antibodies reduce proliferation of TSC2 deficient cells##Reduced tumor burden in Tuberous Sclerosis patients treated with sirolimus (rapamycin)##Everolimus treatment of astrocytomas in patients with germline TSC2 mutations leads to a reduction in tumor size 	PLoS One. 2008;3(10):e3558##PLoS One. 2011;6(9):e23379##N Engl J Med. 2010 Nov 4;363(19):1801-11	TSC2	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	TSC2	HUMAN|ENSEMBL=ENSG00000103197|UniProtKB=P49815		PTHR10063:SF1	TUBERIN	TUBERIN	protein binding#GO:0005515;small GTPase regulator activity#GO:0005083;binding#GO:0005488;enzyme regulator activity#GO:0030234	cell cycle#GO:0007049;intracellular protein transport#GO:0006886;vesicle-mediated transport#GO:0016192;cellular process#GO:0009987;protein transport#GO:0015031;endocytosis#GO:0006897;transport#GO:0006810		G-protein modulator#PC00022;enzyme modulator#PC00095	Insulin/IGF pathway-protein kinase B signaling cascade#P00033>TSC2#P04494;p53 pathway by glucose deprivation#P04397>TSC2#P04644;p53 pathway by glucose deprivation#P04397>TSC2#G04706						chr16.fa:2134994-2134994_C_T	16:2134994	ENSG00000103197	CCDS10458.1	synonymous_variant	4536	4536	1512	1	D	gaC/gaT	4536C>T	%3D)	chr16.fa:2134994-2134994_C_T	ENSG00000103197	ENSG00000103197	CCDS10458.1	gaC	gaT	1512	1512	D	D	SYNONYMOUS_CODING	34	PGDX9323P2_PS_Seq2_BWA		rs35986575_C_T	chr16	2134993	2134994	rs35986575	-	C	A/G	single	by-cluster,by-frequency	0.008354	0.064088	coding-synon	1	NonIntegerChromCount	APPLERA_GI,CLINSEQ_SNP,ILLUMINA,KRIBB_YJKIM,NHLBI-ESP,TSC2DB,	2	A,G,	24.958000,5925.040039,	0.004195,0.995805,	clinically-assoc,has-omim-omia,submitted-by-lsdb		FLAGGED																														COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	12	rs35986575	PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	TSC2	tuberous sclerosis 2	CCDS10458.1	chr16.fa:2134994-2134994_C_T	4536C>T	%3D)	34	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.45922	0.013283073045943	5407	2483	COLUMN NOT FOUND	ENSG00000103197	protein binding#GO:0005515;small GTPase regulator activity#GO:0005083;binding#GO:0005488;enzyme regulator activity#GO:0030234	cell cycle#GO:0007049;intracellular protein transport#GO:0006886;vesicle-mediated transport#GO:0016192;cellular process#GO:0009987;protein transport#GO:0015031;endocytosis#GO:0006897;transport#GO:0006810	Insulin/IGF pathway-protein kinase B signaling cascade#P00033>TSC2#P04494;p53 pathway by glucose deprivation#P04397>TSC2#P04644;p53 pathway by glucose deprivation#P04397>TSC2#G04706	-	-	upper_aerodigestive_tract (1 cases),large_intestine (1 cases)	large_intestine (61 cases),lung (44 cases),liver (36 cases),skin (35 cases),kidney (33 cases),stomach (24 cases),endometrium (17 cases),pancreas (15 cases),upper_aerodigestive_tract (14 cases),breast (13 cases),central_nervous_system (11 cases),haematopoietic_and_lymphoid_tissue (8 cases),urinary_tract (7 cases),ovary (6 cases),prostate (6 cases),oesophagus (5 cases),bone (4 cases),NS (2 cases),soft_tissue (2 cases),autonomic_ganglia (2 cases),thyroid (2 cases),parathyroid (1 cases),adrenal_gland (1 cases),cervix (1 cases),biliary_tract (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	C	A/G	single	by-cluster,by-frequency	0.008354	0.064088	coding-synon	1	NonIntegerChromCount	APPLERA_GI,CLINSEQ_SNP,ILLUMINA,KRIBB_YJKIM,NHLBI-ESP,TSC2DB,	2	A,G,	24.958000,5925.040039,	0.004195,0.995805,	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	2483	2.28836	0.45922	5407	98	196	215	COLUMN NOT FOUND	91	2493	1	40	0	0	1.00345	0	-1	31	0.0124348	0	1	2	0	0	0	0	0.461923290717065	0.538076709282935	0.461923290717065	1.08243080625752	chr16.fa:2134994-2134994_C_T	chr16_2134994_2134994		chr16.fa:2134994-2134994_C_T	chr16.fa:2134994-2134994_C_T	0.013283073045943					chr16.fa:2134994-2134994_C_T							13	13	2849	0.4	0	C/T	NOBIAS	BIAS	COLUMN NOT FOUND		0.460433	60	0	26.9151	13.8523	60	0	57	44	-101	0	1	SBS	0	0	-101	0.564356	308.519	5397	2493	0.461923	10.3225	0.389876	0.403385	39.4443	0.269151	0.138523	60	60	0	1.00345	0	2483	2.28836	0.45922	5407	311.599	5887	2706	0.459657	11.0509	0.387298	0.400264	39.425	0.265826	0.138476	41.9798	41.9757	0	1.00354	0.0041	2706	2.25868	0.459657	5887	0	ENSG00000103197	ENSG00000103197	CCDS10458.1	337	2.779e-03	121278	120128	0.062	-9.100e-02	2472584	0.000	85.17	101.13	59.53	0	0.395	224	11.52	0.696	5.35	FS	.	C:0	CG:0	CGA:0
chrX.fa:66766356-66766356_T_C	0	0.08	134	0	14	0	12	28	1082	34	40	38.6429	14	0	66	10	14	0.212121	SBS	chrX.fa	66766356	66766356	T	C	chrX.fa:66766356-66766356_T_C	ENSG00000169083	AR	CCDS14387.1	ggT	ggC	456	456	G	G	synonymous_variant	1	COLUMN NOT FOUND	COLUMN NOT FOUND	androgen receptor	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chrX.fa:66766356-66766356_T_C	chrX:66683081-66683081	chrX:66766356-66766356	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chrX.fa:66766356-66766356_T_C	liver (1 cases)			large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)	1	AR	androgen receptor	The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. 	AIS;DHTR;HUMARA;HYSP1;KD;NR3C4;SBMA;SMAX1;TFM	Hormone activated regulation of transcription	Low AR expression, prior to hormonal therapy, is associated with tumor progression.	Int J Urol. 2002 Oct;9(10):545-53	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Prognostic1	Progression free survival according to AR expression.  Solid line high expression; dotted line low expression	Int J Urol. 2002 Oct;9(10):545-53	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.  Activating mutations in the AR gene lead to endocrine therapy resistance.  Hsp90 inhibitors result in the degradation of AR and inhibit tumor growth in mice.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8, Endocr Relat Cancer. 2005 Jun;12(2):229-44, Semin Oncol. 2003 Oct;30(5):709-16	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Therapeutic1	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8	AR	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	HUMAN|ENSEMBL=ENSG00000169083|UniProtKB=P10275		PTHR24084:SF6	FAMILY NOT NAMED	SUBFAMILY NOT NAMED	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152		transcription factor#PC00218;nuclear hormone receptor#PC00169;receptor#PC00197;nucleic acid binding#PC00171	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774						chrX.fa:66766356-66766356_T_C	X:66766356	ENSG00000169083	CCDS14387.1	synonymous_variant	1368	1368	456	1	G	ggT/ggC	1368T>C	%3D)	chrX.fa:66766356-66766356_T_C	ENSG00000169083	ENSG00000169083	CCDS14387.1	ggT	ggC	456	456	G	G	SYNONYMOUS_CODING	1	PGDX9323P2_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	1	.	PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	androgen receptor	CCDS14387.1	chrX.fa:66766356-66766356_T_C	1368T>C	%3D)	1	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.208955	0.0973522111262755	67	14	COLUMN NOT FOUND	ENSG00000169083	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774	liver (1 cases)	-	-	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	41	3	1	14	2	0.208955	67	11	4	96	COLUMN NOT FOUND	4	14	1	0	0	0	1.35714	0	-1	1	0.0714286	0	1	4	0	102	20	0	0.212121212121212	0.787878787878788	0.212121212121212	2.35714285714286	chrX.fa:66766356-66766356_T_C	chrX_66766356_66766356		chrX.fa:66766356-66766356_T_C	chrX.fa:66766356-66766356_T_C	0.0973522111262755					chrX.fa:66766356-66766356_T_C							19	19	14	0	1e-04	T/C	BIAS	BIAS	COLUMN NOT FOUND	BIAS	0.208955	60	0	4.08333	2.33714	60	0	81	20	18	0	1	SBS	0	20	18	0.80198	104.647	66	14	0.212121	3.74166	0	0.0901339	38.6429	0.0408333	0.0233714	60	60	0	1.35714	0	14	2	0.208955	67	103.68	72	14	0.194444	3.74166	0	0.0901339	38.2857	0.039	0.0201141	41.7981	42	0	1.35714	-0.2019	14	2	0.191781	73	102	ENSG00000169083	ENSG00000169083	CCDS14387.1																						
chr2.fa:16082314-16082314_C_	0	0.07	15074	6277	0	0	0	38	1476	35	40	38.8421	12	7	6286	19	16	0.00254534	DEL	chr2.fa	16082314	16082314	C		chr2.fa:16082314-16082314_C_	ENSG00000134323	MYCN	CCDS1687.1	-		43	43	-		frameshift_variant	1	COLUMN NOT FOUND	COLUMN NOT FOUND	v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr2.fa:16082314-16082314_C_	chr2:15999765-15999765	chr2:16082314-16082314	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr2.fa:16082314-16082314_C_	large_intestine (4 cases),stomach (1 cases)		autonomic_ganglia (4 cases),endometrium (4 cases),large_intestine (3 cases),skin (2 cases),central_nervous_system (2 cases),pancreas (1 cases),stomach (1 cases),kidney (1 cases)	large_intestine (29 cases),skin (22 cases),lung (11 cases),central_nervous_system (7 cases),endometrium (7 cases),urinary_tract (5 cases),autonomic_ganglia (5 cases),stomach (4 cases),kidney (4 cases),liver (3 cases),oesophagus (3 cases),breast (2 cases),NS (2 cases),pancreas (2 cases),prostate (2 cases),salivary_gland (1 cases),ovary (1 cases),bone (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),adrenal_gland (1 cases),upper_aerodigestive_tract (1 cases),biliary_tract (1 cases)	5	MYCN	v-myc myelocytomatosis viral related oncogene, neuroblastoma derived	This gene is a member of the MYC family and encodes a protein with a basic helix-loop-helix (bHLH) domain. This protein is located in the nucleus and must dimerize with another bHLH protein in order to bind DNA. 	MODED;N-myc;NMYC;ODED;bHLHe37	Regulation of transcription	MYCN amplification in neuroblastoma is generally associated with a poor prognosis	Science. 1984 Jun 8;224(4653):1121-4, J Clin Oncol. 2009 Apr 1;27(10):1627-36	S:\Sample reports\Automated Report Info\Figures for gene slide subset\MYCN_Prognostic1	The overall survival of neuroblastoma patients with MYC/MYCN amplifications is reduced compared to those with wild type MYC status	 J Clin Oncol. 2009 Apr 1;27(10):1627-36	None described	NA	NA	NA	NA	MYCN	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	MYCN	HUMAN|ENSEMBL=ENSG00000134323|UniProtKB=P04198		PTHR11514:SF3	MYC	N-MYC PROTO-ONCOGENE PROTEIN	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	apoptosis#GO:0006915;MAPKKK cascade#GO:0000165;induction of apoptosis#GO:0006917;signal transduction#GO:0007165;regulation of transcription from RNA polymerase II promoter#GO:0006357;intracellular signaling cascade#GO:0007242;cell cycle#GO:0007049;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;transcription#GO:0006350;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;metabolic process#GO:0008152		transcription factor#PC00218;nucleic acid binding#PC00171;basic helix-loop-helix transcription factor#PC00055	Wnt signaling pathway#P00057>Wnt Target Genes#G01558						chr2.fa:16082314-16082314_C_	2:16082314	ENSG00000134323	CCDS1687.1	frameshift_variant,feature_truncation	128	128	43	1	-	-	128delC	P45Rfs*86	chr2.fa:16082314-16082314_C_	ENSG00000134323	ENSG00000134323	CCDS1687.1	-	-	43	43	-	-	FRAME_SHIFT	1	PGDX9323P2_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	MYCN	v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog	CCDS1687.1	chr2.fa:16082314-16082314_C_	128delC	P45Rfs*86	1	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.00127105	0.000880234011507511	6294	8	COLUMN NOT FOUND	ENSG00000134323	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	apoptosis#GO:0006915;MAPKKK cascade#GO:0000165;induction of apoptosis#GO:0006917;signal transduction#GO:0007165;regulation of transcription from RNA polymerase II promoter#GO:0006357;intracellular signaling cascade#GO:0007242;cell cycle#GO:0007049;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;transcription#GO:0006350;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;metabolic process#GO:0008152	Wnt signaling pathway#P00057>Wnt Target Genes#G01558	large_intestine (4 cases),stomach (1 cases)	-	autonomic_ganglia (4 cases),endometrium (4 cases),large_intestine (3 cases),skin (2 cases),central_nervous_system (2 cases),pancreas (1 cases),stomach (1 cases),kidney (1 cases)	large_intestine (29 cases),skin (22 cases),lung (11 cases),central_nervous_system (7 cases),endometrium (7 cases),urinary_tract (5 cases),autonomic_ganglia (5 cases),stomach (4 cases),kidney (4 cases),liver (3 cases),oesophagus (3 cases),breast (2 cases),NS (2 cases),pancreas (2 cases),prostate (2 cases),salivary_gland (1 cases),ovary (1 cases),bone (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),adrenal_gland (1 cases),upper_aerodigestive_tract (1 cases),biliary_tract (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	16	1	0	0	17	3	2	8	2.75	0.00127105	6294	78	134	118	COLUMN NOT FOUND	64	16	1	76	0	0	1	0	-1	0	0	0	3	2	7	0	0						chr2.fa:16082314-16082314_C_	chr2_16082314_16082314			chr2.fa:16082314-16082314_C_	0.000880234011507511			chr2.fa:16082314-16082314_C_	SMExclude	chr2.fa:16082314-16082314_C_	chr2.fa:16082314-16082314_C_	Keep					2	2	19	0.37	0.1796	C/	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.0025209	60	0	28.5	11.284	60	0	65	36	-101	0	1	DEL	1	0	-101	0.643564	110.048	6286	16	0.00254534	1.05263	0.284109	0.452734	38.8421	0.285	0.11284	60	60	0	1	0	8	2.75	0.00127105	6294	112.291	7065	17	0.00240623	0.824621	0.318205	0.481795	38.85	0.281364	0.123373	41.9789	42	0	1	-0.0211	10	2.6	0.00141403	7072	0	ENSG00000134323	ENSG00000134323	CCDS1687.1																						
chr17.fa:56435391-56435391_A_T	0	0.134	12656	5465	0	0	6	12	478	39	40	39.8333	6	0	5471	6	6	0.00109669	SBS	chr17.fa	56435391	56435391	A	T	chr17.fa:56435391-56435391_A_T	ENSG00000108375	RNF43	CCDS11607.1	atT	atA	582	582	I	I	synonymous_variant	8	COLUMN NOT FOUND	COLUMN NOT FOUND	ring finger protein 43	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr17.fa:56435391-56435391_A_T	chr17:53790390-53790390	chr17:56435391-56435391	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr17.fa:56435391-56435391_A_T			skin (2 cases),endometrium (1 cases)	large_intestine (101 cases),pancreas (46 cases),stomach (27 cases),skin (22 cases),endometrium (16 cases),lung (15 cases),ovary (13 cases),oesophagus (8 cases),central_nervous_system (7 cases),biliary_tract (7 cases),breast (5 cases),urinary_tract (4 cases),liver (4 cases),prostate (3 cases),haematopoietic_and_lymphoid_tissue (2 cases),kidney (2 cases),autonomic_ganglia (2 cases),bone (1 cases),NS (1 cases),adrenal_gland (1 cases)		RNF43	ring finger protein 43	RNF43 is a HAP95 (AKAP8L; MIM 609475) binding ubiquitin ligase that promotes cell growth and is upregulated in colon cancer	URCC; RNF124	Ubiquitin dependent proteolysis	None described	NA	NA	NA	NA	None described	NA	NA	NA	NA	RNF43	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	RNF43	HUMAN|ENSEMBL=ENSG00000108375|UniProtKB=Q68DV7		PTHR16200:SF0	RING ZINC FINGER	SUBFAMILY NOT NAMED											chr17.fa:56435391-56435391_A_T	17:56435391	ENSG00000108375	CCDS11607.1	synonymous_variant	1746	1746	582	-1	I	atT/atA	1746T>A	%3D)	chr17.fa:56435391-56435391_A_T	ENSG00000108375	ENSG00000108375	CCDS11607.1	atT	atA	582	582	I	I	SYNONYMOUS_CODING	8	PGDX9323P2_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	RNF43	ring finger protein 43	CCDS11607.1	chr17.fa:56435391-56435391_A_T	1746T>A	%3D)	8	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.00109669	0.000877054755150413	5471	6	COLUMN NOT FOUND	ENSG00000108375	-	-	-	-	-	skin (2 cases),endometrium (1 cases)	large_intestine (101 cases),pancreas (46 cases),stomach (27 cases),skin (22 cases),endometrium (16 cases),lung (15 cases),ovary (13 cases),oesophagus (8 cases),central_nervous_system (7 cases),biliary_tract (7 cases),breast (5 cases),urinary_tract (4 cases),liver (4 cases),prostate (3 cases),haematopoietic_and_lymphoid_tissue (2 cases),kidney (2 cases),autonomic_ganglia (2 cases),bone (1 cases),NS (1 cases),adrenal_gland (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	6	2	0.00109669	5471	9	9	48	COLUMN NOT FOUND	9	6	1	40	0	0	1	0	-1	0	0	2	1	1	0	0	0	0	0.00109669164686529	0.998903308353135	0.00109669164686529	455.916666666667	chr17.fa:56435391-56435391_A_T	chr17_56435391_56435391			chr17.fa:56435391-56435391_A_T	0.000877054755150413					chr17.fa:56435391-56435391_A_T							17	17	6	0	0.0156	A/T	BIAS	BIAS	COLUMN NOT FOUND	BIAS	0.000948167	60	0	10.5	2.99939	60	0	64	37	-101	0	1	SBS	0	0	-101	0.633663	77.512	5471	6	0.00109669	2.44949	0	0.137682	39.8333	0.105	0.0299939	60	60	0	1	0	6	2	0.00109669	5471	71.312	6017	5	0.000830979	2.23607	0	0.150823	39.8	0.114	0.0236573	41.983	42	0	1	-0.017	5	2	0.000830979	6017	0	ENSG00000108375	ENSG00000108375	CCDS11607.1																						
chr7.fa:116411994-116411994_A_G	0	0.897	8254	3620	0	176	0	374	14816	34	40	39.615	78	108	3787	165	176	0.0464748	SBS	chr7.fa	116411994	116411994	A	G	chr7.fa:116411994-116411994_A_G	ENSG00000105976	MET	NM_001127500	acA	acG	1011	1011	T	T	synonymous_variant	14	COLUMN NOT FOUND	COLUMN NOT FOUND	met proto-oncogene	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr7.fa:116411994-116411994_A_G	chr7:116199230-116199230	chr7:116411994-116411994	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr7.fa:116411994-116411994_A_G			lung (11 cases),thyroid (4 cases),kidney (3 cases),skin (2 cases),bone (1 cases),large_intestine (1 cases),autonomic_ganglia (1 cases),central_nervous_system (1 cases)	large_intestine (89 cases),lung (59 cases),upper_aerodigestive_tract (55 cases),kidney (50 cases),skin (48 cases),liver (23 cases),haematopoietic_and_lymphoid_tissue (19 cases),endometrium (16 cases),stomach (13 cases),central_nervous_system (13 cases),ovary (12 cases),breast (11 cases),urinary_tract (11 cases),oesophagus (6 cases),thyroid (5 cases),pancreas (4 cases),prostate (4 cases),bone (3 cases),autonomic_ganglia (3 cases),NS (2 cases),biliary_tract (2 cases),adrenal_gland (1 cases),testis (1 cases),eye (1 cases)		MET	met proto-oncogene (hepatocyte growth factor receptor)	The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. 	AUTS9;HGFR;RCCP2;c-Met	MET signaling	Over-expression of MET is associated with poor prognosis in many tumor types, including gastric cancer, cholangiocarcinoma, ovarian clear cell carcinoma and glioblastoma	Histol Histopathol. 2011 Sep;26(9):1111-20, Br J Cancer. 2011 Jun 28;105(1):131-8, Mod Pathol. 2011 Aug;24(8):1146-55, J Clin Neurosci. 2011 Jan;18(1):119-2, Expert Opin Investig Drugs. 2011 Sep;20(9):1225-41	S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Prognostic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Prognostic2	Gastric cancer patients with tumors displaying high MET expression have reduced overall survival##MET overexpression is associated with poor prognosis in ovarian clear cell carcinoma patients	Histol Histopathol. 2011 Sep;26(9):1111-20##Mod Pathol. 2011 Aug;24(8):1146-55	A number of MET inhibitors have been developed and have shown promising results in vitro and in clinical trials.  Patients may acquire secondary resistance mutations in this gene during treatment, as seen with NVP-BVU972.  Crizotinib has been successfully used to treat a NSCLC patient with a MET amplification.  Exelixis treatment of human malignant peripheral nerve sheath xenografts expressing MET lead to reduced tumor growth and metastasis in mice.  Knockdown of MET in multiple myeloma cells leads to increased sensitivity to doxorubicin.  The Met inhibitor PF-2341066 demonstrated anti-proliferative efficacy when combined with androgen ablation therapy for advanced prostate cancer in a mouse model, as well as positive results in NSCLC trials and against osteosarcoma in vitro.	Expert Opin Investig Drugs. 2011 Sep;20(9):1225-41, Cancer Res. 2011 Aug 1;71(15):5255-64,J Thorac Oncol. 2011 May;6(5):942-6,Clin Cancer Res. 2011 Jun 15;17(12):3943-55, Mol Med Report. 2011 Mar-Apr;4(2):343-9, BMC Cancer. 2010 Oct 14;10:556	S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Therapeutic2##S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Therapeutic3	Reduced growth of MET expressing xenografts on treatment with Exelixis (XL184)##MET inhibition by PF-2341066 was associated with reduced proliferation of advanced prostate cancer##Dysregulated c-MET pathway in cancer and therapeutic interventions	Clin Cancer Res. 2011 Jun 15;17(12):3943-55##BMC Cancer. 2010 Oct 14;10:556##Expert Opin Investig Drugs. 2011 Sep;20(9):1225-41	MET	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	MET	HUMAN|ENSEMBL=ENSG00000105976|UniProtKB=P08581##HUMAN|ENSEMBL=ENSG00000137776|UniProtKB=Q9NWH9		PTHR24416:SF113##PTHR15683:SF3	TYROSINE-PROTEIN KINASE RECEPTOR##SCAFFOLD ATTACHMENT FACTOR B-RELATED	MACROPHAGE-STIMULATING PROTEIN RECEPTOR##SCAFFOLD ATTACHMENT FACTOR B-RELATED	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672##nucleic acid binding#GO:0003676;RNA binding#GO:0003723;transcription factor activity#GO:0003700;binding#GO:0005488;transcription cofactor activity#GO:0003712;chromatin binding#GO:0003682;DNA binding#GO:0003677;double-stranded DNA binding#GO:0003690;transcription regulator activity#GO:0030528	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152##organelle organization and biogenesis#GO:0006996;regulation of transcription from RNA polymerase II promoter#GO:0006357;nuclear mRNA splicing, via spliceosome#GO:0000398;RNA metabolic process#GO:0016070;mRNA processing#GO:0006397;establishment and/or maintenance of chromatin architecture#GO:0006325;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;transcription#GO:0006350;cellular component organization and biogenesis#GO:0016043;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein kinase receptor#PC00194;protein kinase#PC00193;transferase#PC00220;kinase#PC00137;tyrosine protein kinase receptor#PC00233;receptor#PC00197##DNA binding protein#PC00009;transcription factor#PC00218;chromatin/chromatin-binding protein#PC00077;transcription cofactor#PC00217;RNA binding protein#PC00031;nucleic acid binding#PC00171							chr7.fa:116411994-116411994_A_G	7:116411994	ENSG00000105976	NM_001127500	synonymous_variant	3220	3033	1011	1	T	acA/acG	3033A>G	%3D)	chr7.fa:116411994-116411994_A_G	ENSG00000105976	ENSG00000105976	NM_001127500	acA	acG	1011	1011	T	T	SYNONYMOUS_CODING	14	PGDX9323P2_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	MET	met proto-oncogene	NM_001127500	chr7.fa:116411994-116411994_A_G	3033A>G	%3D)	14	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.0439937	0.00652406809581872	3796	167	COLUMN NOT FOUND	ENSG00000105976	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672##nucleic acid binding#GO:0003676;RNA binding#GO:0003723;transcription factor activity#GO:0003700;binding#GO:0005488;transcription cofactor activity#GO:0003712;chromatin binding#GO:0003682;DNA binding#GO:0003677;double-stranded DNA binding#GO:0003690;transcription regulator activity#GO:0030528	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152##organelle organization and biogenesis#GO:0006996;regulation of transcription from RNA polymerase II promoter#GO:0006357;nuclear mRNA splicing, via spliceosome#GO:0000398;RNA metabolic process#GO:0016070;mRNA processing#GO:0006397;establishment and/or maintenance of chromatin architecture#GO:0006325;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;transcription#GO:0006350;cellular component organization and biogenesis#GO:0016043;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;metabolic process#GO:0008152	-	-	-	lung (11 cases),thyroid (4 cases),kidney (3 cases),skin (2 cases),bone (1 cases),large_intestine (1 cases),autonomic_ganglia (1 cases),central_nervous_system (1 cases)	large_intestine (89 cases),lung (59 cases),upper_aerodigestive_tract (55 cases),kidney (50 cases),skin (48 cases),liver (23 cases),haematopoietic_and_lymphoid_tissue (19 cases),endometrium (16 cases),stomach (13 cases),central_nervous_system (13 cases),ovary (12 cases),breast (11 cases),urinary_tract (11 cases),oesophagus (6 cases),thyroid (5 cases),pancreas (4 cases),prostate (4 cases),bone (3 cases),autonomic_ganglia (3 cases),NS (2 cases),biliary_tract (2 cases),adrenal_gland (1 cases),testis (1 cases),eye (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	167	2.13174	0.0439937	3796	98	213	172	COLUMN NOT FOUND	91	176	1	30	0	0	1.54545	0	-1	1	0.00568182	0	1	1	1	0	0	0	0.0464747821494587	0.953525217850541	0.0464747821494587	10.7585227272727	chr7.fa:116411994-116411994_A_G	chr7_116411994_116411994			chr7.fa:116411994-116411994_A_G	0.00652406809581872					chr7.fa:116411994-116411994_A_G							8	8	186	0.42	0.0166	A/G	NOBIAS	BIAS	COLUMN NOT FOUND		0.0453114	60	0	24.5662	14.7657	60	0	44	57	-101	0	1	SBS	0	0	-101	0.435644	205.053	3787	176	0.0464748	2.13976	0.393934	0.444776	39.615	0.245662	0.147657	60	60	0	1.54545	0	167	2.13174	0.0439937	3796	190.027	3933	119	0.0302568	3.1887	0.32293	0.384762	39.6923	0.242105	0.149438	41.8978	39.3501	0	1.36923	2.5477	118	2.18644	0.0299949	3934	0	ENSG00000105976	ENSG00000105976	NM_001127500																						
chrX.fa:66765159-66765167_GCAGCAGCA_	0	0.189	2368	0	0	0	946	386	15238	28	40	39.4767	69	124	1075	111	193	0.179535	DEL	chrX.fa	66765159	66765167	GCAGCAGCA		chrX.fa:66765159-66765167_GCAGCAGCA_	ENSG00000169083	AR	CCDS14387.1	ctGCAGCAGCAg	ctg	57	57	LQQQ	L	inframe_deletion	1	COLUMN NOT FOUND	COLUMN NOT FOUND	androgen receptor	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chrX.fa:66765159-66765167_GCAGCAGCA_	chrX:66681884-66681892	chrX:66765159-66765167	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chrX.fa:66765159-66765167_GCAGCAGCA_			large_intestine (25 cases),upper_aerodigestive_tract (19 cases),skin (5 cases),liver (4 cases),kidney (2 cases),central_nervous_system (1 cases),stomach (1 cases),lung (1 cases)	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)		AR	androgen receptor	The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. 	AIS;DHTR;HUMARA;HYSP1;KD;NR3C4;SBMA;SMAX1;TFM	Hormone activated regulation of transcription	Low AR expression, prior to hormonal therapy, is associated with tumor progression.	Int J Urol. 2002 Oct;9(10):545-53	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Prognostic1	Progression free survival according to AR expression.  Solid line high expression; dotted line low expression	Int J Urol. 2002 Oct;9(10):545-53	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.  Activating mutations in the AR gene lead to endocrine therapy resistance.  Hsp90 inhibitors result in the degradation of AR and inhibit tumor growth in mice.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8, Endocr Relat Cancer. 2005 Jun;12(2):229-44, Semin Oncol. 2003 Oct;30(5):709-16	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Therapeutic1	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8	AR	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	HUMAN|ENSEMBL=ENSG00000169083|UniProtKB=P10275		PTHR24084:SF6	FAMILY NOT NAMED	SUBFAMILY NOT NAMED	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152		transcription factor#PC00218;nuclear hormone receptor#PC00169;receptor#PC00197;nucleic acid binding#PC00171	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774						chrX.fa:66765159-66765167_GCAGCAGCA_	X:66765159-66765167	ENSG00000169083	CCDS14387.1	inframe_deletion	171-179	171-179	57-60	1	LQQQ/L	ctGCAGCAGCAg/ctg	171_179delGCAGCAGCA	Q61_Q63del	chrX.fa:66765159-66765167_GCAGCAGCA_	ENSG00000169083	ENSG00000169083	CCDS14387.1	ctgcagcagcag	ctg	57	57	LQQQ	L	CODON_DELETION	1	PGDX9323P2_PS_Seq2_BWA	SNP:chrX_66765159_66765167_rs193922933_CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG_(CAG(10_36)),SNP:chrX_66765159_66765170_rs193922933_CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG_(CAG(10_36)),SNP:chrX_66765160_66765161_rs200185441_A_T,SNP:chrX_66765160_66765167_rs5902610_AGCAGCAGC_-,SNP:chrX_66765160_66765169_rs5902610_AGCAGCAGC_-,SNP:chrX_66765165_66765166_rs137852575_C_T,SNP:chrX_66765166_66765167_rs193922933_CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG_(CAG(10_36)),SNP:chrX_66765166_66765167_rs5902610_AGCAGCAGC_-																																																					COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	androgen receptor	CCDS14387.1	chrX.fa:66765159-66765167_GCAGCAGCA_	171_179delGCAGCAGCA	Q61_Q63del	1	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.105995	0.0177840507336184	1151	122	COLUMN NOT FOUND	ENSG00000169083	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774	-	-	large_intestine (25 cases),upper_aerodigestive_tract (19 cases),skin (5 cases),liver (4 cases),kidney (2 cases),central_nervous_system (1 cases),stomach (1 cases),lung (1 cases)	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	192	0.994819	0	0	205	3	2	122	2	0.105995	1151	73	140	132	COLUMN NOT FOUND	16	193	1	12	0	0	1.00518	0	-1	0	0	0	1	4	7	81	9						chrX.fa:66765159-66765167_GCAGCAGCA_	chrX_66765159_66765167			chrX.fa:66765159-66765167_GCAGCAGCA_	0.0177840507336184			chrX.fa:66765159-66765167_GCAGCAGCA_	SMExclude	chrX.fa:66765159-66765167_GCAGCAGCA_	chrX.fa:66765159-66765170_GCAGCAGCAGCA_,chrX.fa:66765159-66765167_GCAGCAGCA_	Keep					18	18	193	0.36	0	GCAGCAGCA/	NOBIAS	BIAS	COLUMN NOT FOUND		0.163007	60	0	22.6373	3.9475	60	0	71	30	-1	0	1	DEL	9	9	-1	0.70297	207.958	1075	193	0.179535	3.95899	0.333237	0.381789	39.4767	0.226373	0.039475	60	60	0	1.00518	0	122	2	0.105995	1151	212.427	1143	217	0.189851	2.78326	0.382636	0.428424	39.4516	0.227097	0.0388143	41.174	39.5253	0	1.00922	1.6487	147	2	0.12069	1218	81	ENSG00000169083	ENSG00000169083	CCDS14387.1																						
chr10.fa:43604650-43604650_T_A	0	0.08	11998	6	0	0	5106	12	476	39	40	39.6667	0	6	5112	6	6	0.00117371	SBS	chr10.fa	43604650	43604650	T	A	chr10.fa:43604650-43604650_T_A	ENSG00000165731	RET	CCDS7200.1	gTg	gAg	412	412	V	E	missense_variant	6	COLUMN NOT FOUND	COLUMN NOT FOUND	ret proto-oncogene	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr10.fa:43604650-43604650_T_A	chr10:42924656-42924656	chr10:43604650-43604650	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr10.fa:43604650-43604650_T_A			skin (2 cases)	thyroid (372 cases),large_intestine (82 cases),lung (46 cases),skin (45 cases),adrenal_gland (39 cases),stomach (22 cases),endometrium (17 cases),breast (15 cases),urinary_tract (13 cases),haematopoietic_and_lymphoid_tissue (12 cases),oesophagus (10 cases),kidney (9 cases),central_nervous_system (9 cases),ovary (8 cases),pancreas (8 cases),liver (7 cases),upper_aerodigestive_tract (6 cases),prostate (4 cases),bone (2 cases),NS (2 cases),thymus (2 cases),biliary_tract (1 cases)		RET	ret proto-oncogene	This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. 	CDHF12;CDHR16;HSCR1;MEN2A;MEN2B;MTC1;PTC;RET-ELE1;RET51	MAP kinase signaling	Sporadic medullary thyroid cancer patients with RET mutations such as M918T may have a worse prognosis	Curr Opin Oncol. 2009 Jan;21(1):5-10, J Clin Endocrinol Metab. 2008 Mar;93(3):682-7	S:\Sample reports\Automated Report Info\Figures for gene slide subset\RET_Prognostic1	Thyroid cancer patients with sporadic RET mutations have a worse prognosis	 J Clin Endocrinol Metab. 2008 Mar;93(3):682-7	Vandetanib is a small molecule inhibitor of RET that has demonstrated clinical benefits in patients with medullary thyroid cancer and XL184 has shown similar promising results in clinical trials.  Some RET mutations, such as V804M confer resistance to vandetanib treatment	Clin Pharmacol Ther. 2012 Jan;91(1):71-80, J Clin Oncol. 2011 Jul 1;29(19):2660-6, Curr Opin Oncol. 2012 Feb 15, Endocr Relat Cancer. 2010 Nov 30;18(1):1-11	S:\Sample reports\Automated Report Info\Figures for gene slide subset\RET_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\RET_Therapeutic2	Summary of completed studies of vandetanib in thyroid cancer##Clinical trials involving drugs that target RET in thyroid cancer	Clin Pharmacol Ther. 2012 Jan;91(1):71-80##Curr Opin Oncol. 2012 Feb 15	RET	YES	YES	YES	chr10.fa:43604650-43604650_T_A	NM_020630.4_V412E	0.554	0.2423	NA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	RET	HUMAN|ENSEMBL=ENSG00000165731|UniProtKB=P07949		PTHR24416:SF97	TYROSINE-PROTEIN KINASE RECEPTOR	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein kinase receptor#PC00194;protein kinase#PC00193;transferase#PC00220;kinase#PC00137;tyrosine protein kinase receptor#PC00233;receptor#PC00197							chr10.fa:43604650-43604650_T_A	10:43604650	ENSG00000165731	CCDS7200.1	missense_variant	1235	1235	412	1	V/E	gTg/gAg	1235T>A	V412E	chr10.fa:43604650-43604650_T_A	ENSG00000165731	ENSG00000165731	CCDS7200.1	gTg	gAg	412	412	V	E	NON_SYNONYMOUS_CODING	6	PGDX9323P2_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	RET	ret proto-oncogene	CCDS7200.1	chr10.fa:43604650-43604650_T_A	1235T>A	V412E	6	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.00117371	0.000938611420273856	5112	6	COLUMN NOT FOUND	ENSG00000165731	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152	-	-	-	skin (2 cases)	thyroid (372 cases),large_intestine (82 cases),lung (46 cases),skin (45 cases),adrenal_gland (39 cases),stomach (22 cases),endometrium (17 cases),breast (15 cases),urinary_tract (13 cases),haematopoietic_and_lymphoid_tissue (12 cases),oesophagus (10 cases),kidney (9 cases),central_nervous_system (9 cases),ovary (8 cases),pancreas (8 cases),liver (7 cases),upper_aerodigestive_tract (6 cases),prostate (4 cases),bone (2 cases),NS (2 cases),thymus (2 cases),biliary_tract (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	0.554	0.2423	NA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	6	2	0.00117371	5112	9	33	9	COLUMN NOT FOUND	9	6	1	40	0	0	1	0	-1	0	0	0	1	1	0	0	0	0	0.00117370892018779	0.998826291079812	0.00117370892018779	426	chr10.fa:43604650-43604650_T_A	chr10_43604650_43604650			chr10.fa:43604650-43604650_T_A	0.000938611420273856			chr10.fa:43604650-43604650_T_A	SMExclude	chr10.fa:43604650-43604650_T_A							11	11	6	0	0.0156	T/A	BIAS	BIAS	COLUMN NOT FOUND	BIAS	0.00100017	60	0	11	3.07423	60	0	65	36	-101	0	1	SBS	0	0	-101	0.643564	77.1878	5112	6	0.00117371	2.44949	0	0.137682	39.6667	0.11	0.0307423	60	60	0	1	0	6	2	0.00117371	5112	77.1878	5447	6	0.00110152	2.44949	0	0.137682	39.6667	0.11	0.0307423	41.9955	42	0	1	-0.0045	6	2	0.00110152	5447	0	ENSG00000165731	ENSG00000165731	CCDS7200.1																						
Changes Lost (In old file but not in new):
ChangeUID	IndexString	Coverage	ACount	CCount	GCount	TCount	MutCount	SumQualityScore	MinQualityScore	MaxQualityScore	AverageQualityScore	Forward	Reverse	DistinctCoverage	DistinctTags	DistinctPairs	MutPct	MutType	Chrom	Start	End	BaseFrom	BaseTo	LookupKey	ENSG	GeneName	Transcript	TxBaseFRom	TxBaseTo	AminoStart	AminoEnd	AAFrom	AATo	Consequence	Exon Rank	Transcript GeneName	HUGO GeneName	Description	Deleted	SNP	NormalMutCount	NormalRawCoverage	NormalPhredCoverage	NormalEffectiveCoverage	NormalDistinctRawCoverage	NormalDistinctPhredCoverage	NormalDistinctEffectiveCoverage	GermlineNormMutPct	Germline?	TotalNormalMutCount	NormalDistinctMutPairs	ExcludeConsequence?	Silent?	NormMutPct	CosmicGene	CosmicTx	CosmicAAChange	CosmicEffect	CosmicID	DistMutPairsEORA	DistMutPairsEORB	NormalDistMutPairsEORA	NormalDistMutPairsEORB	DistMutPairsEORA+B	EORMutPct	NormalEORMutPct	Ignore	IgnoreB	AddlInfo	LookupKeyB	AAChange	ReportedMutation	ReportedConsequence	PGDX Transcript	PGDX CDS Length	PGDX Protein Length	LiftOver ID	Liftover hg18 Position	LiftOver hg19 position	sameLocation_Lookup	Changes_SameLocation	Changes_Adjacent	polyN:ChangeUID	PolyN_Dust	Sample Name	CDD: #Gene	CDD: Key	CDD: Size Check	CDD: Position of Mutation Within a Protein Domain	CDD: Position of Mutation Near to a Protein Domain	COSMIC: Key	COSMIC: Samples reported with the exact genomic change	COSMIC: Samples reported with a change in the same AA (Missense)	COSMIC: Samples reported with a nearby change	COSMIC: Samples reported with any mutation in this gene	COSMIC: Number of Exact Hits	PGDX Clinical: Gene_symbol	PGDX Clinical: Gene_name	PGDX Clinical: Gene_summary	PGDX Clinical: Gene_aliases	PGDX Clinical: Pathway	PGDX Clinical: Prognostic text	PGDX Clinical: Prognostic ref	PGDX Clinical: Prognostic fig	PGDX Clinical: Prognostic fig legend	PGDX Clinical: Prognostic fig ref	PGDX Clinical: Predictive/Therapeutic text	PGDX Clinical: Predictive/Therapeutic ref	PGDX Clinical: Predictive/Therapeutic fig	PGDX Clinical: Predictive/Therapeutic fig legend	PGDX Clinical: Predictive/Therapeutic fig ref	PGDX: Gene Lookup	PGDX: Biologically significant gene	PGDX: Clinically significant gene	PGDX: Chip Gene	CHASM: MUTID	CHASM: MUT	CHASM: CHASM LUAD	CHASM: PValue LUAD	CHASM: BHFDR LUAD	VEST: MUTID	VEST: MUT	VEST: VEST	VEST: PValue	VEST: BHFDR	PANTHER: Gene Symbol	PANTHER: Gene Identifier	PANTHER: Protein ID	PANTHER: SF ID	PANTHER: Family Name	PANTHER: Subfamily Name	PANTHER: Molecular function	PANTHER: Biological process	PANTHER: Cellular components	PANTHER: Protein class	PANTHER: Pathway	OMIM_gene_symbol	OMIM_status	OMIM_method	OMIM_diseases	OMIM_mim	VEP: ChangeUID	VEP: Position	VEP: Gene	VEP: Transcript	VEP: Consequence	VEP: cDNA Position	VEP: CDS Position	VEP: Protein Position	VEP: Strand	VEP: AAChange	VEP: Codon Change	VEP: HGVS Codon Change	VEP: HGVS AAChange	snpEff360: ChangeUID	snpEff360: GeneID	snpEff360: GeneName	snpEff360: Transcript	snpEff360: CodonFrom	snpEff360: CodonTo	snpEff360: codonStart	snpEff360: codonEnd	snpEff360: AAFrom	snpEff360: AATo	snpEff360: Consequence	snpEff360: Score	dbSNP: Sample	dbSNP: Other dbSNP hits	dbSNP: SNPLookup	dbSNP: Chrom	dbSNP: Start	dbSNP: End	dbSNP: Name	dbSNP: Strand	dbSNP: refUCSC	dbSNP: Observed	dbSNP: Class	dbSNP: Valid	dbSNP: AvHet	dbSNP: AvHetSE	dbSNP: Func	dbSNP: Weight	dbSNP: Exceptions	dbSNP: Submitters	dbSNP: AlleleFreqCount	dbSNP: Alleles	dbSNP: AlleleNs	dbSNP: AlleleFreqs	dbSNP: Bitfields	dbSNP: isCommon	dbSNP: isFlagged	dbSNP: isMultiple	ESP: Chrom	ESP: Start	ESP: End	ESP: ESPKey	ESP: dbsnp hit	ESP: European Allele Count	ESP: African Allele Count	ESP: Total Allele	ESP: MAF	ESP: Observed	ESP: European Genotype Count	ESP: African Genotype Count	ESP: Total Genotype Count	ESP: Average Sample Depth	ESP: GeneList	ESP: scorePhastCons	ESP: consScoreGERP	ESP: chimpAllele	ESP: ClinicalAssociation	ESP: EXOME_CHIP	ESP: GWAS_PUBMED	ESP: Accession	ESP: functionGVS	ESP: aminoAcidChange	ESP: proteinPosition	ESP: cDNAPosition	ESP: granthamScore	ESP: polyPhen	AutoBLATHuman	Seq window	BLAT sequence	BLAT URL	PGDX Norm: Count	PGDX Norm: rs	Report: Sample Name	Report: Alternate ID	Report: Tumor Type	Report: GeneName	Report: Description	Report: Transcript	Report: LookupKey	Report: CodonChange	Report: AAChange	Report: Exon Rank	Report: ReportedMutation	Report: ReportedConsequence	Report: Seq window	Report: SupermutantMutPct	Report: 95% Confidence Interval for % Mutant Reads	Report: SupermutantCov	Report: SupermutantCount	Report: Mutant Molecules per mL	Report: ENSG	Report: Pathway Analysis (GO Molecular Function)	Report: Pathway Analysis (GO Biological Process)	Report: Pathway Analysis (Additional Information)	Report: Samples with the Identical Somatic Mutation	Report: Somatic Mutations in the Same Amino Acid Residue	Report: Somatic Mutations in Nearby Amino Acid Residues	Report: Gene Somatically Mutated in the Following Cancers	Report: Position of Mutation Within a Protein Domain	Report: Position of Mutation Near to a Protein Domain	Report: CHASM Score	Report: PValue	Report: BHFDR	Report: refUCSC	Report: Observed	Report: Class	Report: Valid	Report: AvHet	Report: AvHetSE	Report: Func	Report: Weight	Report: Exceptions	Report: Submitters	Report: AlleleFreqCount	Report: Alleles	Report: AlleleNs	Report: AlleleFreqs	Report: VEST	Report: VEST(PValue)	Report: VEST(BHFDR)	Report: OMIM Diseases	Report: MIM#	Report: PGDX: Chip Gene	CleanDistinctPairs	CleanMutPct	OverlapsTumor	OverlapsNormal	IndelCount	NumAlleles	NumIndelAlleles	Supermutant	SupermutantAvg	SupermutantPct	SupermutantCov	CycleDist	Read1Dist	Read2Dist	MutReadDist	ProperPairs	ProperPairsPct	MMTumor	LQTumor	MMAvg	MutMMAvg	LQAvg	MutLQAvg	MaskedPairs	MaskedMutPct	PolyN	PolyNN	PolyNNN	PolyMut	Dust	RptMask	MutCountCov	SNP_Allele_Fraction_Normal	SNP_Allele_Fraction_Tumor	Ref_Allele_Fraction_Tumor	Observed_MAF	Calculated_MAF_Amplification	dbSNP:ChangeUID	ESPKEY	ESP:ESPLookupID	PGDX Norm: ChangeUID	CI ChangeUID	95% Confidence Interval	CUID	HematopoiesisAssociations	SMChangeUID	SMExcludeCUID	IChangeUID	OlapIndels	ExcludeIndel	HChangeUID	HotList	CHChangeUID	CosmicHotSpot	Row	Row	Total	Strand Bias Percentage (minimum strand)	Strand Bias p-value	BaseFrom/BaseTo	Strand Bias Percentage Result	Strand Bias p-value Result	Strand Bias Mutation Type	OverallStrandBiasResult
chr17.fa:7578496-7578496_A_T	0	91961	7659	2	4	10	92	3828	14	40	36.113209	12	10	10993	16	20	0.001819	SBS	chr17	7578496	7578496	A	T	chr17.fa_7578496-7578496_A_T	ENSG00000141510	TP53	CCDS11118.1	cTg	cAg	145	145	L	Q	missense_variant	4	TP53	TP53	tumor protein p53	0		0	0	0	0.000000	0	0	0.000000	0.000000		0	0	0	0	0						0	0	0	0	0	0.000000	0.000000	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	chr17_7578496-7578496_A_T	145L>Q	Substitution	Nonsynonymous coding	CCDS11118.1	1182	394	chr17.fa:7578496-7578496_A_T	chr17:7519221-7519221	chr17:7578496-7578496	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_novo	TP53	chr17.fa:7578496-7578496_A_T	match	 P53 DNA-binding domain (109-288)	-	chr17.fa:7578496-7578496_A_T	breast (4 cases),pancreas (3 cases),oesophagus (3 cases),ovary (2 cases),lung (2 cases),large_intestine (2 cases),prostate (1 cases),stomach (1 cases),upper_aerodigestive_tract (1 cases)	L145R/LW145RW/L145L/L145P/L145V/L145M large_intestine (6 cases),ovary (5 cases),breast (3 cases),stomach (3 cases),prostate (3 cases),haematopoietic_and_lymphoid_tissue (3 cases),central_nervous_system (3 cases),urinary_tract (2 cases),pancreas (2 cases),skin (1 cases),lung (1 cases),upper_aerodigestive_tract (1 cases),liver (1 cases),oesophagus (1 cases),biliary_tract (1 cases)	large_intestine (76 cases),breast (60 cases),lung (52 cases),upper_aerodigestive_tract (50 cases),haematopoietic_and_lymphoid_tissue (47 cases),oesophagus (47 cases),ovary (43 cases),urinary_tract (28 cases),stomach (26 cases),central_nervous_system (20 cases),skin (18 cases),liver (17 cases),pancreas (16 cases),prostate (11 cases),biliary_tract (8 cases),soft_tissue (7 cases),endometrium (7 cases),vulva (4 cases),adrenal_gland (3 cases),testis (3 cases),salivary_gland (2 cases),bone (2 cases),kidney (2 cases),thyroid (2 cases),pleura (1 cases),NS (1 cases),peritoneum (1 cases),genital_tract (1 cases),cervix (1 cases),eye (1 cases)	large_intestine (2857 cases),lung (1950 cases),breast (1840 cases),upper_aerodigestive_tract (1518 cases),oesophagus (1478 cases),ovary (1326 cases),central_nervous_system (1152 cases),haematopoietic_and_lymphoid_tissue (1148 cases),stomach (938 cases),liver (933 cases),urinary_tract (926 cases),pancreas (594 cases),skin (585 cases),prostate (222 cases),endometrium (215 cases),biliary_tract (207 cases),soft_tissue (177 cases),vulva (110 cases),bone (103 cases),kidney (98 cases),adrenal_gland (63 cases),thyroid (62 cases),cervix (59 cases),small_intestine (43 cases),salivary_gland (38 cases),peritoneum (23 cases),eye (22 cases),pleura (18 cases),thymus (16 cases),genital_tract (15 cases),NS (13 cases),penis (9 cases),testis (6 cases),autonomic_ganglia (5 cases),meninges (3 cases),fallopian_tube (2 cases),pituitary (2 cases),placenta (1 cases),gastrointestinal_tract_(site_indeterminate) (1 cases),vagina (1 cases)	19	TP53	Tumor protein p53	"This gene encodes tumor protein p53, which responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where it's believed to contribute to transformation and malignancy. p53 is a DNA-binding protein containing transcription activation, DNA-binding, and oligomerization domains. It is postulated to bind to a p53-binding site and activate expression of downstream genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. "	FLJ92943;LFS1;P53;TRP53	DNA repair and apoptosis	TP53 mutations are associated with lymphatic invasion in proximal colorectal tumors and poor prognosis in breast cancer and NSCLC	J Clin Oncol.2005 Oct 20;23(30):7518-28; Oncogene. 2007 Apr 2;26(15):2157-65; Clin Cancer Res. 2006 Feb 15;12(4):1157-67; Eur Respir J. 2001 Oct;18(4):705-19; Br J Cancer. 1997;76(1):44-51	S:\Sample reports\Automated Report Info\Figures for gene slide subset\TP53 breast prognosis##S:\Sample reports\Automated Report Info\Figures for gene slide subset\TP53 lung prognosis	"TP53 mutation status is correlated with survival in breast cancer.  Patients without mutation in TP53 and a positive PR status (blue), without mutation in TP53 and negative PR status (red), with mutation in TP53 and positive PR status (green) and with TP53 mutation and negative PR status (black)## Radically resected NSCLC patients with TP53 mutations, especially those in exon 5, have a worse prognosis"	Clin Cancer Res. 2006 Feb 15;12(4):1157-67##Br J Cancer. 1997;76(1):44-51	TP53 mutations confer resistance to the MDM2 inhibitor nutlin-3a in vitro	Nature. 2012 Mar 28;483(7391):570-5	NA	NA	NA	TP53	YES	YES	YES	chr17.fa:7578496-7578496_A_T	NM_001126116.1_L13Q	0.108	0.0002	0.05	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	TP53	HUMAN|ENSEMBL=ENSG00000141510|UniProtKB=P04637		PTHR11447:SF6	CELLULAR TUMOR ANTIGEN P53	CELLULAR TUMOR ANTIGEN P53	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	apoptosis#GO:0006915;DNA repair#GO:0006281;induction of apoptosis#GO:0006917;regulation of transcription from RNA polymerase II promoter#GO:0006357;cell cycle#GO:0007049;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;transcription#GO:0006350;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;DNA metabolic process#GO:0006259;primary metabolic process#GO:0044238;metabolic process#GO:0008152		transcription factor#PC00218	p53 pathway feedback loops 2#P04398>p53#P04668;p53 pathway by glucose deprivation#P04397>p53#P04640;p53 pathway#P00059>p53#P01485;P53 pathway feedback loops 1#P04392>p53#P04539;Apoptosis signaling pathway#P00006>p53#P00273;Huntington disease#P00029>p53#P00797;p53 pathway#P00059>p53#G04702;Wnt signaling pathway#P00057>p53#P01430	TP53	confirmed	REa, A, D	Colorectal cancer;Li-Fraumeni syndrome;Hepatocellular carcinoma;Osteosarcoma;Choroid plexus papilloma;Nasopharyngeal carcinoma;Pancreatic cancer;Adrenal cortical carcinoma;Breast cancer;Basal cell carcinoma 7;Glioma susceptibility 1	114500;151623;114550;259500;260500;607107;260350;202300;114480;614740;137800	chr17.fa:7578496-7578496_A_T	17:7578496	ENSG00000141510	CCDS11118.1	missense_variant	434	434	145	-1	L/Q	cTg/cAg	434T>A	L145Q	chr17.fa:7578496-7578496_A_T	ENSG00000141510	ENSG00000141510	CCDS11118.1	cTg	cAg	145	145	L	Q	NON_SYNONYMOUS_CODING	4	PGDX9323P2_PS_Seq2_novo																																																						OK - 1 hit	CCCACNGCTGC	TGGCCATGGCGCGGACGCGGGTGCCGGGCGGGGGTGTGGAATCAACCCACAGCTGCACAGGGCAGGTCTTGGCCAGTTGGCAAAACATCTTGTTGAGGGCA	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='TGGCCATGGCGCGGACGCGGGTGCCGGGCGGGGGTGTGGAATCAACCCACAGCTGCACAGGGCAGGTCTTGGCCAGTTGGCAAAACATCTTGTTGAGGGCA'&Submit=submit","Run BLAT")			PGDX9323P2_PS_Seq2_novo	COLUMN NOT FOUND	COLUMN NOT FOUND	TP53	tumor protein p53	CCDS11118.1	chr17_7578496-7578496_A_T	434T>A	L145Q	4	Substitution	Nonsynonymous coding	CCCACNGCTGC	0.001042	0.000721931879806351	7675	8	COLUMN NOT FOUND	ENSG00000141510	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	apoptosis#GO:0006915;DNA repair#GO:0006281;induction of apoptosis#GO:0006917;regulation of transcription from RNA polymerase II promoter#GO:0006357;cell cycle#GO:0007049;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;transcription#GO:0006350;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;DNA metabolic process#GO:0006259;primary metabolic process#GO:0044238;metabolic process#GO:0008152	p53 pathway feedback loops 2#P04398>p53#P04668;p53 pathway by glucose deprivation#P04397>p53#P04640;p53 pathway#P00059>p53#P01485;P53 pathway feedback loops 1#P04392>p53#P04539;Apoptosis signaling pathway#P00006>p53#P00273;Huntington disease#P00029>p53#P00797;p53 pathway#P00059>p53#G04702;Wnt signaling pathway#P00057>p53#P01430	breast (4 cases),pancreas (3 cases),oesophagus (3 cases),ovary (2 cases),lung (2 cases),large_intestine (2 cases),prostate (1 cases),stomach (1 cases),upper_aerodigestive_tract (1 cases)	L145R/LW145RW/L145L/L145P/L145V/L145M large_intestine (6 cases),ovary (5 cases),breast (3 cases),stomach (3 cases),prostate (3 cases),haematopoietic_and_lymphoid_tissue (3 cases),central_nervous_system (3 cases),urinary_tract (2 cases),pancreas (2 cases),skin (1 cases),lung (1 cases),upper_aerodigestive_tract (1 cases),liver (1 cases),oesophagus (1 cases),biliary_tract (1 cases)	large_intestine (76 cases),breast (60 cases),lung (52 cases),upper_aerodigestive_tract (50 cases),haematopoietic_and_lymphoid_tissue (47 cases),oesophagus (47 cases),ovary (43 cases),urinary_tract (28 cases),stomach (26 cases),central_nervous_system (20 cases),skin (18 cases),liver (17 cases),pancreas (16 cases),prostate (11 cases),biliary_tract (8 cases),soft_tissue (7 cases),endometrium (7 cases),vulva (4 cases),adrenal_gland (3 cases),testis (3 cases),salivary_gland (2 cases),bone (2 cases),kidney (2 cases),thyroid (2 cases),pleura (1 cases),NS (1 cases),peritoneum (1 cases),genital_tract (1 cases),cervix (1 cases),eye (1 cases)	large_intestine (2857 cases),lung (1950 cases),breast (1840 cases),upper_aerodigestive_tract (1518 cases),oesophagus (1478 cases),ovary (1326 cases),central_nervous_system (1152 cases),haematopoietic_and_lymphoid_tissue (1148 cases),stomach (938 cases),liver (933 cases),urinary_tract (926 cases),pancreas (594 cases),skin (585 cases),prostate (222 cases),endometrium (215 cases),biliary_tract (207 cases),soft_tissue (177 cases),vulva (110 cases),bone (103 cases),kidney (98 cases),adrenal_gland (63 cases),thyroid (62 cases),cervix (59 cases),small_intestine (43 cases),salivary_gland (38 cases),peritoneum (23 cases),eye (22 cases),pleura (18 cases),thymus (16 cases),genital_tract (15 cases),NS (13 cases),penis (9 cases),testis (6 cases),autonomic_ganglia (5 cases),meninges (3 cases),fallopian_tube (2 cases),pituitary (2 cases),placenta (1 cases),gastrointestinal_tract_(site_indeterminate) (1 cases),vagina (1 cases)	 P53 DNA-binding domain (109-288)	-	0.108	0.0002	0.05	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	Colorectal cancer;Li-Fraumeni syndrome;Hepatocellular carcinoma;Osteosarcoma;Choroid plexus papilloma;Nasopharyngeal carcinoma;Pancreatic cancer;Adrenal cortical carcinoma;Breast cancer;Basal cell carcinoma 7;Glioma susceptibility 1	114500;151623;114550;259500;260500;607107;260350;202300;114480;614740;137800	YES	0	0.000000	0	0	0	3	0	8	9.500000	0.001042	7675	91	240	111	68	20	1.000000	12037	0	0.000000	1.094340	0.000000	-1.000000	0	0.000000	0	1	1	0	0	0	0.001000	0.000000	0.000910166560480568	0.999089833439519	0.000910166560480568	549.35	chr17.fa:7578496-7578496_A_T	chr17_7578496_7578496			chr17.fa:7578496-7578496_A_T	0.000721931879806351					chr17.fa:7578496-7578496_A_T							6	6	22	0.45	0.4159	A/T	NOBIAS	NOBIAS	BIAS	NOBIAS
chr7.fa:116411899-116411899_T_A	0	49515	27	2	0	5646	126	5036	16	40	38.738461	10	29	9054	24	39	0.004307	SBS	chr7	116411899	116411899	T	A	chr7.fa_116411899-116411899_T_A	ENSG00000105976	MET	NM_001127500	-				-		splice_acceptor_variant	14	MET	MET	met proto-oncogene	0		0	0	0	0.000000	0	0	0.000000	0.000000		0	0	1	0	0						0	0	0	0	0	0.000000	0.000000	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	chr7_116411899-116411899_T_A	NA	Substitution	Splice site acceptor	NM_001127500	4227	1409	chr7.fa:116411899-116411899_T_A	chr7:116199135-116199135	chr7:116411899-116411899	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_novo						chr7.fa:116411899-116411899_T_A			lung (81  cases), central_nervous_system (3 cases), soft_tissue (3 cases), unknown (6 cases), stomach (2 cases)	large_intestine (89 cases),lung (59 cases),upper_aerodigestive_tract (55 cases),kidney (50 cases),skin (48 cases),liver (23 cases),haematopoietic_and_lymphoid_tissue (19 cases),endometrium (16 cases),stomach (13 cases),central_nervous_system (13 cases),ovary (12 cases),breast (11 cases),urinary_tract (11 cases),oesophagus (6 cases),thyroid (5 cases),pancreas (4 cases),prostate (4 cases),bone (3 cases),autonomic_ganglia (3 cases),NS (2 cases),biliary_tract (2 cases),adrenal_gland (1 cases),testis (1 cases),eye (1 cases)		MET	met proto-oncogene (hepatocyte growth factor receptor)	"The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. "	AUTS9;HGFR;RCCP2;c-Met	MET signaling	"Over-expression of MET is associated with poor prognosis in many tumor types, including gastric cancer, cholangiocarcinoma, ovarian clear cell carcinoma and glioblastoma"	"Histol Histopathol. 2011 Sep;26(9):1111-20, Br J Cancer. 2011 Jun 28;105(1):131-8, Mod Pathol. 2011 Aug;24(8):1146-55, J Clin Neurosci. 2011 Jan;18(1):119-2, Expert Opin Investig Drugs. 2011 Sep;20(9):1225-41"	S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Prognostic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Prognostic2	Gastric cancer patients with tumors displaying high MET expression have reduced overall survival##MET overexpression is associated with poor prognosis in ovarian clear cell carcinoma patients	Histol Histopathol. 2011 Sep;26(9):1111-20##Mod Pathol. 2011 Aug;24(8):1146-55	"A number of MET inhibitors have been developed and have shown promising results in vitro and in clinical trials.  Patients may acquire secondary resistance mutations in this gene during treatment, as seen with NVP-BVU972.  Crizotinib has been successfully used to treat a NSCLC patient with a MET amplification.  Exelixis treatment of human malignant peripheral nerve sheath xenografts expressing MET lead to reduced tumor growth and metastasis in mice.  Knockdown of MET in multiple myeloma cells leads to increased sensitivity to doxorubicin.  The Met inhibitor PF-2341066 demonstrated anti-proliferative efficacy when combined with androgen ablation therapy for advanced prostate cancer in a mouse model, as well as positive results in NSCLC trials and against osteosarcoma in vitro."	"Expert Opin Investig Drugs. 2011 Sep;20(9):1225-41, Cancer Res. 2011 Aug 1;71(15):5255-64,J Thorac Oncol. 2011 May;6(5):942-6,Clin Cancer Res. 2011 Jun 15;17(12):3943-55, Mol Med Report. 2011 Mar-Apr;4(2):343-9, BMC Cancer. 2010 Oct 14;10:556"	S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Therapeutic2##S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Therapeutic3	Reduced growth of MET expressing xenografts on treatment with Exelixis (XL184)##MET inhibition by PF-2341066 was associated with reduced proliferation of advanced prostate cancer##Dysregulated c-MET pathway in cancer and therapeutic interventions	Clin Cancer Res. 2011 Jun 15;17(12):3943-55##BMC Cancer. 2010 Oct 14;10:556##Expert Opin Investig Drugs. 2011 Sep;20(9):1225-41	MET	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	MET	HUMAN|ENSEMBL=ENSG00000105976|UniProtKB=P08581##HUMAN|ENSEMBL=ENSG00000137776|UniProtKB=Q9NWH9		PTHR24416:SF113##PTHR15683:SF3	TYROSINE-PROTEIN KINASE RECEPTOR##SCAFFOLD ATTACHMENT FACTOR B-RELATED	MACROPHAGE-STIMULATING PROTEIN RECEPTOR##SCAFFOLD ATTACHMENT FACTOR B-RELATED	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672##nucleic acid binding#GO:0003676;RNA binding#GO:0003723;transcription factor activity#GO:0003700;binding#GO:0005488;transcription cofactor activity#GO:0003712;chromatin binding#GO:0003682;DNA binding#GO:0003677;double-stranded DNA binding#GO:0003690;transcription regulator activity#GO:0030528	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152##organelle organization and biogenesis#GO:0006996;regulation of transcription from RNA polymerase II promoter#GO:0006357;nuclear mRNA splicing, via spliceosome#GO:0000398;RNA metabolic process#GO:0016070;mRNA processing#GO:0006397;establishment and/or maintenance of chromatin architecture#GO:0006325;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;transcription#GO:0006350;cellular component organization and biogenesis#GO:0016043;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein kinase receptor#PC00194;protein kinase#PC00193;transferase#PC00220;kinase#PC00137;tyrosine protein kinase receptor#PC00233;receptor#PC00197##DNA binding protein#PC00009;transcription factor#PC00218;chromatin/chromatin-binding protein#PC00077;transcription cofactor#PC00217;RNA binding protein#PC00031;nucleic acid binding#PC00171		MET	confirmed	REa, A, F	Renal cell carcinoma, papillary, familial and somatic;Hepatocellular carcinoma, childhood type;Autism suseptibility 9	605074;114550;611015	chr7.fa:116411899-116411899_T_A	7:116411899	ENSG00000105976	NM_001127500	splice_region_variant,intron_variant	-	-	-	1	-	-	2942-4T>A	N/A	chr7.fa:116411899-116411899_T_A	ENSG00000105976	ENSG00000105976	NM_001127500							INTRON		PGDX9323P2_PS_Seq2_novo																																																						OK - 1 hit	TGTTTNAAGAT	CTGGGGCCCATGATAGCCGTCTTTAACAAGCTCTTTCTTTCTCTCTGTTTTAAGATCTGGGCAGTGAATTAGTTCGCTACGATGCAAGAGTACACACTCCT	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='CTGGGGCCCATGATAGCCGTCTTTAACAAGCTCTTTCTTTCTCTCTGTTTTAAGATCTGGGCAGTGAATTAGTTCGCTACGATGCAAGAGTACACACTCCT'&Submit=submit","Run BLAT")			PGDX9323P2_PS_Seq2_novo	COLUMN NOT FOUND	COLUMN NOT FOUND	MET	met proto-oncogene	NM_001127500	chr7_116411899-116411899_T_A	2942-4T>A	N/A	14	Substitution	Splice site acceptor	TGTTTNAAGAT	0.003171	0.00146271668478144	5676	18	COLUMN NOT FOUND	ENSG00000105976	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672##nucleic acid binding#GO:0003676;RNA binding#GO:0003723;transcription factor activity#GO:0003700;binding#GO:0005488;transcription cofactor activity#GO:0003712;chromatin binding#GO:0003682;DNA binding#GO:0003677;double-stranded DNA binding#GO:0003690;transcription regulator activity#GO:0030528	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152##organelle organization and biogenesis#GO:0006996;regulation of transcription from RNA polymerase II promoter#GO:0006357;nuclear mRNA splicing, via spliceosome#GO:0000398;RNA metabolic process#GO:0016070;mRNA processing#GO:0006397;establishment and/or maintenance of chromatin architecture#GO:0006325;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;transcription#GO:0006350;cellular component organization and biogenesis#GO:0016043;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;metabolic process#GO:0008152	-	-	-	lung (81  cases), central_nervous_system (3 cases), soft_tissue (3 cases), unknown (6 cases), stomach (2 cases)	large_intestine (89 cases),lung (59 cases),upper_aerodigestive_tract (55 cases),kidney (50 cases),skin (48 cases),liver (23 cases),haematopoietic_and_lymphoid_tissue (19 cases),endometrium (16 cases),stomach (13 cases),central_nervous_system (13 cases),ovary (12 cases),breast (11 cases),urinary_tract (11 cases),oesophagus (6 cases),thyroid (5 cases),pancreas (4 cases),prostate (4 cases),bone (3 cases),autonomic_ganglia (3 cases),NS (2 cases),biliary_tract (2 cases),adrenal_gland (1 cases),testis (1 cases),eye (1 cases)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	Renal cell carcinoma, papillary, familial and somatic;Hepatocellular carcinoma, childhood type;Autism suseptibility 9	605074;114550;611015	YES	0	0.000000	0	0	1	2	5	18	4.388889	0.003171	5676	99	159	187	2	37	0.948718	6472	0	0.000000	2.784615	0.000000	-1.000000	1	0.025641	4	1	1	2	0	0	0.002545	0.000000	0.00298276623950508	0.997017233760495	0.00298276623950508	167.62962962963	chr7.fa:116411899-116411899_T_A	chr7_116411899_116411899			chr7.fa:116411899-116411899_T_A	0.00146271668478144			COLUMN NOT FOUND	COLUMN NOT FOUND	chr7.fa:116411899-116411899_T_A			COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			39	0.26	0.0017	T/A	NOBIAS	BIAS	BIAS	NOBIAS
chr17.fa:7577124-7577124_C_T	0	60193	9	5656	0	6	33	1547	15	40	32.229168	5	6	8253	11	11	0.001333	SBS	chr17	7577124	7577124	C	T	chr17.fa_7577124-7577124_C_T	ENSG00000141510	TP53	CCDS11118.1	Gtg	Atg	272	272	V	M	missense_variant	7	TP53	TP53	tumor protein p53	0		0	0	0	0.000000	0	0	0.000000	0.000000		0	0	0	0	0						0	0	0	0	0	0.000000	0.000000	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	chr17_7577124-7577124_C_T	272V>M	Substitution	Nonsynonymous coding	CCDS11118.1	1182	394	chr17.fa:7577124-7577124_C_T	chr17:7517849-7517849	chr17:7577124-7577124	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_novo	TP53	chr17.fa:7577124-7577124_C_T	match	 P53 DNA-binding domain (109-288)	-	chr17.fa:7577124-7577124_C_T	large_intestine (16 cases),ovary (14 cases),breast (10 cases),oesophagus (7 cases),stomach (6 cases),lung (6 cases),haematopoietic_and_lymphoid_tissue (5 cases),central_nervous_system (5 cases),pancreas (4 cases),urinary_tract (2 cases),kidney (2 cases),liver (2 cases),upper_aerodigestive_tract (2 cases),vulva (1 cases),bone (1 cases),soft_tissue (1 cases),endometrium (1 cases)	V272L/V272V/V272A/V272K/VR272VS/V272E/V272G large_intestine (9 cases),lung (8 cases),upper_aerodigestive_tract (7 cases),pancreas (4 cases),oesophagus (4 cases),breast (3 cases),haematopoietic_and_lymphoid_tissue (3 cases),stomach (3 cases),ovary (2 cases),skin (2 cases),endometrium (2 cases),soft_tissue (1 cases),urinary_tract (1 cases),liver (1 cases),thyroid (1 cases),central_nervous_system (1 cases),biliary_tract (1 cases)	large_intestine (360 cases),central_nervous_system (271 cases),lung (254 cases),breast (158 cases),ovary (141 cases),oesophagus (131 cases),upper_aerodigestive_tract (127 cases),haematopoietic_and_lymphoid_tissue (111 cases),stomach (106 cases),urinary_tract (92 cases),liver (68 cases),pancreas (63 cases),skin (38 cases),endometrium (28 cases),biliary_tract (22 cases),bone (22 cases),prostate (14 cases),vulva (12 cases),cervix (10 cases),soft_tissue (10 cases),thyroid (6 cases),penis (5 cases),adrenal_gland (4 cases),kidney (4 cases),thymus (4 cases),small_intestine (4 cases),salivary_gland (3 cases),peritoneum (3 cases),genital_tract (3 cases),pleura (2 cases),fallopian_tube (1 cases),NS (1 cases),testis (1 cases),eye (1 cases)	large_intestine (2857 cases),lung (1950 cases),breast (1840 cases),upper_aerodigestive_tract (1518 cases),oesophagus (1478 cases),ovary (1326 cases),central_nervous_system (1152 cases),haematopoietic_and_lymphoid_tissue (1148 cases),stomach (938 cases),liver (933 cases),urinary_tract (926 cases),pancreas (594 cases),skin (585 cases),prostate (222 cases),endometrium (215 cases),biliary_tract (207 cases),soft_tissue (177 cases),vulva (110 cases),bone (103 cases),kidney (98 cases),adrenal_gland (63 cases),thyroid (62 cases),cervix (59 cases),small_intestine (43 cases),salivary_gland (38 cases),peritoneum (23 cases),eye (22 cases),pleura (18 cases),thymus (16 cases),genital_tract (15 cases),NS (13 cases),penis (9 cases),testis (6 cases),autonomic_ganglia (5 cases),meninges (3 cases),fallopian_tube (2 cases),pituitary (2 cases),placenta (1 cases),gastrointestinal_tract_(site_indeterminate) (1 cases),vagina (1 cases)	85	TP53	Tumor protein p53	"This gene encodes tumor protein p53, which responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where it's believed to contribute to transformation and malignancy. p53 is a DNA-binding protein containing transcription activation, DNA-binding, and oligomerization domains. It is postulated to bind to a p53-binding site and activate expression of downstream genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. "	FLJ92943;LFS1;P53;TRP53	DNA repair and apoptosis	TP53 mutations are associated with lymphatic invasion in proximal colorectal tumors and poor prognosis in breast cancer and NSCLC	J Clin Oncol.2005 Oct 20;23(30):7518-28; Oncogene. 2007 Apr 2;26(15):2157-65; Clin Cancer Res. 2006 Feb 15;12(4):1157-67; Eur Respir J. 2001 Oct;18(4):705-19; Br J Cancer. 1997;76(1):44-51	S:\Sample reports\Automated Report Info\Figures for gene slide subset\TP53 breast prognosis##S:\Sample reports\Automated Report Info\Figures for gene slide subset\TP53 lung prognosis	"TP53 mutation status is correlated with survival in breast cancer.  Patients without mutation in TP53 and a positive PR status (blue), without mutation in TP53 and negative PR status (red), with mutation in TP53 and positive PR status (green) and with TP53 mutation and negative PR status (black)## Radically resected NSCLC patients with TP53 mutations, especially those in exon 5, have a worse prognosis"	Clin Cancer Res. 2006 Feb 15;12(4):1157-67##Br J Cancer. 1997;76(1):44-51	TP53 mutations confer resistance to the MDM2 inhibitor nutlin-3a in vitro	Nature. 2012 Mar 28;483(7391):570-5	NA	NA	NA	TP53	YES	YES	YES	chr17.fa:7577124-7577124_C_T	NM_001276698.1_V113M	0.146	0.0006	0.05	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	TP53	HUMAN|ENSEMBL=ENSG00000141510|UniProtKB=P04637		PTHR11447:SF6	CELLULAR TUMOR ANTIGEN P53	CELLULAR TUMOR ANTIGEN P53	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	apoptosis#GO:0006915;DNA repair#GO:0006281;induction of apoptosis#GO:0006917;regulation of transcription from RNA polymerase II promoter#GO:0006357;cell cycle#GO:0007049;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;transcription#GO:0006350;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;DNA metabolic process#GO:0006259;primary metabolic process#GO:0044238;metabolic process#GO:0008152		transcription factor#PC00218	p53 pathway feedback loops 2#P04398>p53#P04668;p53 pathway by glucose deprivation#P04397>p53#P04640;p53 pathway#P00059>p53#P01485;P53 pathway feedback loops 1#P04392>p53#P04539;Apoptosis signaling pathway#P00006>p53#P00273;Huntington disease#P00029>p53#P00797;p53 pathway#P00059>p53#G04702;Wnt signaling pathway#P00057>p53#P01430	TP53	confirmed	REa, A, D	Colorectal cancer;Li-Fraumeni syndrome;Hepatocellular carcinoma;Osteosarcoma;Choroid plexus papilloma;Nasopharyngeal carcinoma;Pancreatic cancer;Adrenal cortical carcinoma;Breast cancer;Basal cell carcinoma 7;Glioma susceptibility 1	114500;151623;114550;259500;260500;607107;260350;202300;114480;614740;137800	chr17.fa:7577124-7577124_C_T	17:7577124	ENSG00000141510	CCDS11118.1	missense_variant	814	814	272	-1	V/M	Gtg/Atg	814G>A	V272M	chr17.fa:7577124-7577124_C_T	ENSG00000141510	ENSG00000141510	CCDS11118.1	Gtg	Atg	272	272	V	M	NON_SYNONYMOUS_CODING	7	PGDX9323P2_PS_Seq2_novo	SNP:chr17_7577123_7577124_rs121912657_C_A																																																					OK - 1 hit	ACGCANCTCAA	ATTCTCTTCCTCTGTGCGCCGGTCTCTCCCAGGACAGGCACAAACACGCACCTCAAAGCTGTTCCGTCCCAGTAGATTACCACTACTCAGGATAGGAAAAG	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='ATTCTCTTCCTCTGTGCGCCGGTCTCTCCCAGGACAGGCACAAACACGCACCTCAAAGCTGTTCCGTCCCAGTAGATTACCACTACTCAGGATAGGAAAAG'&Submit=submit","Run BLAT")			PGDX9323P2_PS_Seq2_novo	COLUMN NOT FOUND	COLUMN NOT FOUND	TP53	tumor protein p53	CCDS11118.1	chr17_7577124-7577124_C_T	814G>A	V272M	7	Substitution	Nonsynonymous coding	ACGCANCTCAA	0.000529	0.000598469674131121	5671	3	COLUMN NOT FOUND	ENSG00000141510	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	apoptosis#GO:0006915;DNA repair#GO:0006281;induction of apoptosis#GO:0006917;regulation of transcription from RNA polymerase II promoter#GO:0006357;cell cycle#GO:0007049;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;transcription#GO:0006350;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;DNA metabolic process#GO:0006259;primary metabolic process#GO:0044238;metabolic process#GO:0008152	p53 pathway feedback loops 2#P04398>p53#P04668;p53 pathway by glucose deprivation#P04397>p53#P04640;p53 pathway#P00059>p53#P01485;P53 pathway feedback loops 1#P04392>p53#P04539;Apoptosis signaling pathway#P00006>p53#P00273;Huntington disease#P00029>p53#P00797;p53 pathway#P00059>p53#G04702;Wnt signaling pathway#P00057>p53#P01430	large_intestine (16 cases),ovary (14 cases),breast (10 cases),oesophagus (7 cases),stomach (6 cases),lung (6 cases),haematopoietic_and_lymphoid_tissue (5 cases),central_nervous_system (5 cases),pancreas (4 cases),urinary_tract (2 cases),kidney (2 cases),liver (2 cases),upper_aerodigestive_tract (2 cases),vulva (1 cases),bone (1 cases),soft_tissue (1 cases),endometrium (1 cases)	V272L/V272V/V272A/V272K/VR272VS/V272E/V272G large_intestine (9 cases),lung (8 cases),upper_aerodigestive_tract (7 cases),pancreas (4 cases),oesophagus (4 cases),breast (3 cases),haematopoietic_and_lymphoid_tissue (3 cases),stomach (3 cases),ovary (2 cases),skin (2 cases),endometrium (2 cases),soft_tissue (1 cases),urinary_tract (1 cases),liver (1 cases),thyroid (1 cases),central_nervous_system (1 cases),biliary_tract (1 cases)	large_intestine (360 cases),central_nervous_system (271 cases),lung (254 cases),breast (158 cases),ovary (141 cases),oesophagus (131 cases),upper_aerodigestive_tract (127 cases),haematopoietic_and_lymphoid_tissue (111 cases),stomach (106 cases),urinary_tract (92 cases),liver (68 cases),pancreas (63 cases),skin (38 cases),endometrium (28 cases),biliary_tract (22 cases),bone (22 cases),prostate (14 cases),vulva (12 cases),cervix (10 cases),soft_tissue (10 cases),thyroid (6 cases),penis (5 cases),adrenal_gland (4 cases),kidney (4 cases),thymus (4 cases),small_intestine (4 cases),salivary_gland (3 cases),peritoneum (3 cases),genital_tract (3 cases),pleura (2 cases),fallopian_tube (1 cases),NS (1 cases),testis (1 cases),eye (1 cases)	large_intestine (2857 cases),lung (1950 cases),breast (1840 cases),upper_aerodigestive_tract (1518 cases),oesophagus (1478 cases),ovary (1326 cases),central_nervous_system (1152 cases),haematopoietic_and_lymphoid_tissue (1148 cases),stomach (938 cases),liver (933 cases),urinary_tract (926 cases),pancreas (594 cases),skin (585 cases),prostate (222 cases),endometrium (215 cases),biliary_tract (207 cases),soft_tissue (177 cases),vulva (110 cases),bone (103 cases),kidney (98 cases),adrenal_gland (63 cases),thyroid (62 cases),cervix (59 cases),small_intestine (43 cases),salivary_gland (38 cases),peritoneum (23 cases),eye (22 cases),pleura (18 cases),thymus (16 cases),genital_tract (15 cases),NS (13 cases),penis (9 cases),testis (6 cases),autonomic_ganglia (5 cases),meninges (3 cases),fallopian_tube (2 cases),pituitary (2 cases),placenta (1 cases),gastrointestinal_tract_(site_indeterminate) (1 cases),vagina (1 cases)	 P53 DNA-binding domain (109-288)	-	0.146	0.0006	0.05	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	Colorectal cancer;Li-Fraumeni syndrome;Hepatocellular carcinoma;Osteosarcoma;Choroid plexus papilloma;Nasopharyngeal carcinoma;Pancreatic cancer;Adrenal cortical carcinoma;Breast cancer;Basal cell carcinoma 7;Glioma susceptibility 1	114500;151623;114550;259500;260500;607107;260350;202300;114480;614740;137800	YES	0	0.000000	0	0	0	3	0	3	7.000000	0.000529	5671	91	148	43	21	11	1.000000	6256	0	0.000000	1.062500	0.000000	-1.000000	1	0.090909	2	1	1	0	0	0	0.000548	0.000000	0.000727802037845706	0.999272197962154	0.000727802037845706	687	chr17.fa:7577124-7577124_C_T	chr17_7577124_7577124			chr17.fa:7577124-7577124_C_T	0.000598469674131121					chr17.fa:7577124-7577124_C_T					chr17.fa:7577124-7577124_C_T	Yes	3	3	11	0.45	0.5	C/T	NOBIAS	NOBIAS	BIAS	NOBIAS
chr10.fa:43615012-43615012_A_T	0	28419	3386	0	3	8	65	2682	14	40	36.739727	10	2	5893	11	10	0.001697	SBS	chr10	43615012	43615012	A	T	chr10.fa_43615012-43615012_A_T	ENSG00000165731	RET	CCDS7200.1	tAc	tTc	809	809	Y	F	missense_variant	14	RET	RET	ret proto-oncogene	0		0	0	0	0.000000	0	0	0.000000	0.000000		0	0	0	0	0						0	0	0	0	0	0.000000	0.000000	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	chr10_43615012-43615012_A_T	809Y>F	Substitution	Nonsynonymous coding	CCDS7200.1	3345	1115	chr10.fa:43615012-43615012_A_T	chr10:42935018-42935018	chr10:43615012-43615012	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_novo	RET	chr10.fa:43615012-43615012_A_T	match	 Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein (723-1012); Protein tyrosine kinase (724-1005)	-	chr10.fa:43615012-43615012_A_T			large_intestine (1 cases)	thyroid (372 cases),large_intestine (82 cases),lung (46 cases),skin (45 cases),adrenal_gland (39 cases),stomach (22 cases),endometrium (17 cases),breast (15 cases),urinary_tract (13 cases),haematopoietic_and_lymphoid_tissue (12 cases),oesophagus (10 cases),kidney (9 cases),central_nervous_system (9 cases),ovary (8 cases),pancreas (8 cases),liver (7 cases),upper_aerodigestive_tract (6 cases),prostate (4 cases),bone (2 cases),NS (2 cases),thymus (2 cases),biliary_tract (1 cases)		RET	ret proto-oncogene	"This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. "	CDHF12;CDHR16;HSCR1;MEN2A;MEN2B;MTC1;PTC;RET-ELE1;RET51	MAP kinase signaling	Sporadic medullary thyroid cancer patients with RET mutations such as M918T may have a worse prognosis	"Curr Opin Oncol. 2009 Jan;21(1):5-10, J Clin Endocrinol Metab. 2008 Mar;93(3):682-7"	S:\Sample reports\Automated Report Info\Figures for gene slide subset\RET_Prognostic1	Thyroid cancer patients with sporadic RET mutations have a worse prognosis	 J Clin Endocrinol Metab. 2008 Mar;93(3):682-7	"Vandetanib is a small molecule inhibitor of RET that has demonstrated clinical benefits in patients with medullary thyroid cancer and XL184 has shown similar promising results in clinical trials.  Some RET mutations, such as V804M confer resistance to vandetanib treatment"	"Clin Pharmacol Ther. 2012 Jan;91(1):71-80, J Clin Oncol. 2011 Jul 1;29(19):2660-6, Curr Opin Oncol. 2012 Feb 15, Endocr Relat Cancer. 2010 Nov 30;18(1):1-11"	S:\Sample reports\Automated Report Info\Figures for gene slide subset\RET_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\RET_Therapeutic2	Summary of completed studies of vandetanib in thyroid cancer##Clinical trials involving drugs that target RET in thyroid cancer	Clin Pharmacol Ther. 2012 Jan;91(1):71-80##Curr Opin Oncol. 2012 Feb 15	RET	YES	YES	YES	chr10.fa:43615012-43615012_A_T	NM_020630.4_Y809F	0.248	0.0103	0.05	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	RET	HUMAN|ENSEMBL=ENSG00000165731|UniProtKB=P07949		PTHR24416:SF97	TYROSINE-PROTEIN KINASE RECEPTOR	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein kinase receptor#PC00194;protein kinase#PC00193;transferase#PC00220;kinase#PC00137;tyrosine protein kinase receptor#PC00233;receptor#PC00197		RET	confirmed	A, REn, Fd, Ch, D	Multiple endocrine neoplasia IIA;Medullary thyroidcarcinoma;Multiple endocrine neoplasia IIB;Central hypoventilation syndrome, congenital;Pheochromocytoma;Renal agenesis;Hirschsprung disease, susceptibility to, 1	171400;155240;162300;209880;171300;191830;142623	chr10.fa:43615012-43615012_A_T	10:43615012	ENSG00000165731	CCDS7200.1	missense_variant	2426	2426	809	1	Y/F	tAc/tTc	2426A>T	Y809F	chr10.fa:43615012-43615012_A_T	ENSG00000165731	ENSG00000165731	CCDS7200.1	tAc	tTc	809	809	Y	F	NON_SYNONYMOUS_CODING	14	PGDX9323P2_PS_Seq2_novo																																																						OK - 1 hit	CAAATNCGGCT	CCTCTCTCCGCCCCCAGGCCCGCTCCTCCTCATCGTGGAGTACGCCAAATACGGCTCCCTGCGGGGCTTCCTCCGCGAGAGCCGCAAAGTGGGGCCTGGCT	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='CCTCTCTCCGCCCCCAGGCCCGCTCCTCCTCATCGTGGAGTACGCCAAATACGGCTCCCTGCGGGGCTTCCTCCGCGAGAGCCGCAAAGTGGGGCCTGGCT'&Submit=submit","Run BLAT")			PGDX9323P2_PS_Seq2_novo	COLUMN NOT FOUND	COLUMN NOT FOUND	RET	ret proto-oncogene	CCDS7200.1	chr10_43615012-43615012_A_T	2426A>T	Y809F	14	Substitution	Nonsynonymous coding	CAAATNCGGCT	0.002061	0.0015249711238482	3397	7	COLUMN NOT FOUND	ENSG00000165731	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152	-	-	-	large_intestine (1 cases)	thyroid (372 cases),large_intestine (82 cases),lung (46 cases),skin (45 cases),adrenal_gland (39 cases),stomach (22 cases),endometrium (17 cases),breast (15 cases),urinary_tract (13 cases),haematopoietic_and_lymphoid_tissue (12 cases),oesophagus (10 cases),kidney (9 cases),central_nervous_system (9 cases),ovary (8 cases),pancreas (8 cases),liver (7 cases),upper_aerodigestive_tract (6 cases),prostate (4 cases),bone (2 cases),NS (2 cases),thymus (2 cases),biliary_tract (1 cases)	 Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein (723-1012); Protein tyrosine kinase (724-1005)	-	0.248	0.0103	0.05	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	Multiple endocrine neoplasia IIA;Medullary thyroidcarcinoma;Multiple endocrine neoplasia IIB;Central hypoventilation syndrome, congenital;Pheochromocytoma;Renal agenesis;Hirschsprung disease, susceptibility to, 1	171400;155240;162300;209880;171300;191830;142623	YES	0	0.000000	0	0	0	3	0	7	8.142858	0.002061	3397	91	30	223	30	10	1.000000	2775	0	0.000000	1.178082	0.000000	-1.000000	0	0.000000	0	1	1	0	0	0	0.002287	0.000000	0.00135823429541596	0.998641765704584	0.00135823429541596	368.125	chr10.fa:43615012-43615012_A_T	chr10_43615012_43615012			chr10.fa:43615012-43615012_A_T	0.0015249711238482					chr10.fa:43615012-43615012_A_T							1	1	12	0.17	0.0193	A/T	BIAS	BIAS	BIAS	BIAS
chr7.fa:116411874-116411899_ACAAGCTCTTTCTTTCTCTCTGTTTT_	0	43481	5028	0	1	2	1162	116200	100	100	100.000000	173	185	8181	260	346	0.042293118200709	DEL	chr7	116411874	116411899	ACAAGCTCTTTCTTTCTCTCTGTTTT		chr7.fa_116411874-116411899_ACAAGCTCTTTCTTTCTCTCTGTTTT_	ENSG00000105976	MET	NM_001127500	-				-		splice_acceptor_variant	14	MET	MET	met proto-oncogene	0		0	0	0	0.000000	0	0	0.000000	0.000000		0	0	1	0	0						0	0	0	0	0	0.000000	0.000000	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	chr7_116411874-116411899_ACAAGCTCTTTCTTTCTCTCTGTTTT_	NA	Deletion	Splice site acceptor	NM_001127500	4227	1409	chr7.fa:116411874-116411899_ACAAGCTCTTTCTTTCTCTCTGTTTT_	chr7:116199110-116199135	chr7:116411874-116411899	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_novo						chr7.fa:116411874-116411899_ACAAGCTCTTTCTTTCTCTCTGTTTT_			lung (81  cases), central_nervous_system (3 cases), soft_tissue (3 cases), unknown (6 cases), stomach (2 cases)	large_intestine (89 cases),lung (59 cases),upper_aerodigestive_tract (55 cases),kidney (50 cases),skin (48 cases),liver (23 cases),haematopoietic_and_lymphoid_tissue (19 cases),endometrium (16 cases),stomach (13 cases),central_nervous_system (13 cases),ovary (12 cases),breast (11 cases),urinary_tract (11 cases),oesophagus (6 cases),thyroid (5 cases),pancreas (4 cases),prostate (4 cases),bone (3 cases),autonomic_ganglia (3 cases),NS (2 cases),biliary_tract (2 cases),adrenal_gland (1 cases),testis (1 cases),eye (1 cases)		MET	met proto-oncogene (hepatocyte growth factor receptor)	"The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. "	AUTS9;HGFR;RCCP2;c-Met	MET signaling	"Over-expression of MET is associated with poor prognosis in many tumor types, including gastric cancer, cholangiocarcinoma, ovarian clear cell carcinoma and glioblastoma"	"Histol Histopathol. 2011 Sep;26(9):1111-20, Br J Cancer. 2011 Jun 28;105(1):131-8, Mod Pathol. 2011 Aug;24(8):1146-55, J Clin Neurosci. 2011 Jan;18(1):119-2, Expert Opin Investig Drugs. 2011 Sep;20(9):1225-41"	S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Prognostic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Prognostic2	Gastric cancer patients with tumors displaying high MET expression have reduced overall survival##MET overexpression is associated with poor prognosis in ovarian clear cell carcinoma patients	Histol Histopathol. 2011 Sep;26(9):1111-20##Mod Pathol. 2011 Aug;24(8):1146-55	"A number of MET inhibitors have been developed and have shown promising results in vitro and in clinical trials.  Patients may acquire secondary resistance mutations in this gene during treatment, as seen with NVP-BVU972.  Crizotinib has been successfully used to treat a NSCLC patient with a MET amplification.  Exelixis treatment of human malignant peripheral nerve sheath xenografts expressing MET lead to reduced tumor growth and metastasis in mice.  Knockdown of MET in multiple myeloma cells leads to increased sensitivity to doxorubicin.  The Met inhibitor PF-2341066 demonstrated anti-proliferative efficacy when combined with androgen ablation therapy for advanced prostate cancer in a mouse model, as well as positive results in NSCLC trials and against osteosarcoma in vitro."	"Expert Opin Investig Drugs. 2011 Sep;20(9):1225-41, Cancer Res. 2011 Aug 1;71(15):5255-64,J Thorac Oncol. 2011 May;6(5):942-6,Clin Cancer Res. 2011 Jun 15;17(12):3943-55, Mol Med Report. 2011 Mar-Apr;4(2):343-9, BMC Cancer. 2010 Oct 14;10:556"	S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Therapeutic2##S:\Sample reports\Automated Report Info\Figures for gene slide subset\MET_Therapeutic3	Reduced growth of MET expressing xenografts on treatment with Exelixis (XL184)##MET inhibition by PF-2341066 was associated with reduced proliferation of advanced prostate cancer##Dysregulated c-MET pathway in cancer and therapeutic interventions	Clin Cancer Res. 2011 Jun 15;17(12):3943-55##BMC Cancer. 2010 Oct 14;10:556##Expert Opin Investig Drugs. 2011 Sep;20(9):1225-41	MET	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	MET	HUMAN|ENSEMBL=ENSG00000105976|UniProtKB=P08581##HUMAN|ENSEMBL=ENSG00000137776|UniProtKB=Q9NWH9		PTHR24416:SF113##PTHR15683:SF3	TYROSINE-PROTEIN KINASE RECEPTOR##SCAFFOLD ATTACHMENT FACTOR B-RELATED	MACROPHAGE-STIMULATING PROTEIN RECEPTOR##SCAFFOLD ATTACHMENT FACTOR B-RELATED	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672##nucleic acid binding#GO:0003676;RNA binding#GO:0003723;transcription factor activity#GO:0003700;binding#GO:0005488;transcription cofactor activity#GO:0003712;chromatin binding#GO:0003682;DNA binding#GO:0003677;double-stranded DNA binding#GO:0003690;transcription regulator activity#GO:0030528	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152##organelle organization and biogenesis#GO:0006996;regulation of transcription from RNA polymerase II promoter#GO:0006357;nuclear mRNA splicing, via spliceosome#GO:0000398;RNA metabolic process#GO:0016070;mRNA processing#GO:0006397;establishment and/or maintenance of chromatin architecture#GO:0006325;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;transcription#GO:0006350;cellular component organization and biogenesis#GO:0016043;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein kinase receptor#PC00194;protein kinase#PC00193;transferase#PC00220;kinase#PC00137;tyrosine protein kinase receptor#PC00233;receptor#PC00197##DNA binding protein#PC00009;transcription factor#PC00218;chromatin/chromatin-binding protein#PC00077;transcription cofactor#PC00217;RNA binding protein#PC00031;nucleic acid binding#PC00171		MET	confirmed	REa, A, F	Renal cell carcinoma, papillary, familial and somatic;Hepatocellular carcinoma, childhood type;Autism suseptibility 9	605074;114550;611015	chr7.fa:116411874-116411899_ACAAGCTCTTTCTTTCTCTCTGTTTT_	7:116411874-116411899	ENSG00000105976	NM_001127500	splice_region_variant,intron_variant,feature_truncation	-		-	1	-	-	2942-29_2942-4delACAAGCTCTTTCTTTCTCTCTGTTTT	N/A	chr7.fa:116411874-116411899_ACAAGCTCTTTCTTTCTCTCTGTTTT_	ENSG00000105976	ENSG00000105976	NM_001127500							INTRON		PGDX9323P2_PS_Seq2_novo																																																						OK - 1 hit	CTTTANCAAGC	GTTCTGGGCACTGGGTCAAAGTCTCCTGGGGCCCATGATAGCCGTCTTTAACAAGCTCTTTCTTTCTCTCTGTTTTAAGATCTGGGCAGTGAATTAGTTCG	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='GTTCTGGGCACTGGGTCAAAGTCTCCTGGGGCCCATGATAGCCGTCTTTAACAAGCTCTTTCTTTCTCTCTGTTTTAAGATCTGGGCAGTGAATTAGTTCG'&Submit=submit","Run BLAT")			PGDX9323P2_PS_Seq2_novo	COLUMN NOT FOUND	COLUMN NOT FOUND	MET	met proto-oncogene	NM_001127500	chr7_116411874-116411899_ACAAGCTCTTTCTTTCTCTCTGTTTT_	2942-29_2942-4delACAAGCTCTTTCTTTCTCTCTGTTTT	N/A	14	Deletion	Splice site acceptor	CTTTANCAAGC	0.025406	0.00426262462930729	5235	133	COLUMN NOT FOUND	ENSG00000105976	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672##nucleic acid binding#GO:0003676;RNA binding#GO:0003723;transcription factor activity#GO:0003700;binding#GO:0005488;transcription cofactor activity#GO:0003712;chromatin binding#GO:0003682;DNA binding#GO:0003677;double-stranded DNA binding#GO:0003690;transcription regulator activity#GO:0030528	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152##organelle organization and biogenesis#GO:0006996;regulation of transcription from RNA polymerase II promoter#GO:0006357;nuclear mRNA splicing, via spliceosome#GO:0000398;RNA metabolic process#GO:0016070;mRNA processing#GO:0006397;establishment and/or maintenance of chromatin architecture#GO:0006325;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;transcription#GO:0006350;cellular component organization and biogenesis#GO:0016043;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;metabolic process#GO:0008152	-	-	-	lung (81  cases), central_nervous_system (3 cases), soft_tissue (3 cases), unknown (6 cases), stomach (2 cases)	large_intestine (89 cases),lung (59 cases),upper_aerodigestive_tract (55 cases),kidney (50 cases),skin (48 cases),liver (23 cases),haematopoietic_and_lymphoid_tissue (19 cases),endometrium (16 cases),stomach (13 cases),central_nervous_system (13 cases),ovary (12 cases),breast (11 cases),urinary_tract (11 cases),oesophagus (6 cases),thyroid (5 cases),pancreas (4 cases),prostate (4 cases),bone (3 cases),autonomic_ganglia (3 cases),NS (2 cases),biliary_tract (2 cases),adrenal_gland (1 cases),testis (1 cases),eye (1 cases)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	Renal cell carcinoma, papillary, familial and somatic;Hepatocellular carcinoma, childhood type;Autism suseptibility 9	605074;114550;611015	YES	0	0.000000	0	0	204	2	6	133	5.233083	0.025406	5235	46	384	242	45	343	0.991329	4392	0	0.000000	1.819277	0.000000	-1.000000	2	0.005780	2	1	1	1	0	0	0.026691						chr7.fa:116411874-116411899_ACAAGCTCTTTCTTTCTCTCTGTTTT_	chr7_116411874_116411899			chr7.fa:116411874-116411899_ACAAGCTCTTTCTTTCTCTCTGTTTT_	0.00426262462930729			COLUMN NOT FOUND	COLUMN NOT FOUND	chr7.fa:116411874-116411899_ACAAGCTCTTTCTTTCTCTCTGTTTT_	chr7.fa:116411874-116411899_ACAAGCTCTTTCTTTCTCTCTGTTTT_,chr7.fa:116411875-116411875__AGATCTGGGCAGTGAATT,chr7.fa:116411875-116411875__AGATCTGGG	Keep	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			358	0.48	0.2805	ACAAGCTCTTTCTTTCTCTCTGTTTT/	NOBIAS	NOBIAS	NOBIAS - Indel	NOBIAS
chr16.fa:2115578-2115578_A_T	0	49354	5136	1	2	9	45	1889	2	40	34.981480	13	0	8260	11	13	0.001574	SBS	chr16	2115578	2115578	A	T	chr16.fa_2115578-2115578_A_T	ENSG00000103197	TSC2	CCDS10458.1	tAc	tTc	553	553	Y	F	missense_variant	15	TSC2	TSC2	tuberous sclerosis 2	0		0	0	0	0.000000	0	0	0.000000	0.000000		0	0	0	0	0						0	0	0	0	0	0.000000	0.000000	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	chr16_2115578-2115578_A_T	553Y>F	Substitution	Nonsynonymous coding	CCDS10458.1	5424	1808	chr16.fa:2115578-2115578_A_T	chr16:2055579-2055579	chr16:2115578-2115578	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			PGDX9323P2_PS_Seq2_novo	TSC2	chr16.fa:2115578-2115578_A_T	match	-	 Tuberin (557-904)	chr16.fa:2115578-2115578_A_T		Y553S/Y553Y haematopoietic_and_lymphoid_tissue (1 cases),kidney (1 cases)	liver (2 cases),large_intestine (2 cases),central_nervous_system (1 cases)	large_intestine (61 cases),lung (44 cases),liver (36 cases),skin (35 cases),kidney (33 cases),stomach (24 cases),endometrium (17 cases),pancreas (15 cases),upper_aerodigestive_tract (14 cases),breast (13 cases),central_nervous_system (11 cases),haematopoietic_and_lymphoid_tissue (8 cases),urinary_tract (7 cases),ovary (6 cases),prostate (6 cases),oesophagus (5 cases),bone (4 cases),NS (2 cases),soft_tissue (2 cases),autonomic_ganglia (2 cases),thyroid (2 cases),parathyroid (1 cases),adrenal_gland (1 cases),cervix (1 cases),biliary_tract (1 cases)		TSC2	tuberous sclerosis 2	"This gene product is believed to be a tumor suppressor and is able to stimulate specific GTPases. The protein associates with hamartin in a cytosolic complex, possibly acting as a chaperone for hamartin. "	FLJ43106;LAM;TSC4	mTOR signaling and cell cycle arrest	None described	NA	NA	NA	NA	"TSC2 deficient cells are sensitive to anti-EGFR antibodies, Renal angiomyolipomas caused by defects in TSC2 display regression on treatment with the mTOR inhibitor, sirolimus (rapamycin), Everolimus treatment of astrocytomas in patients with germline TSC2 mutations leads to a reduction in tumor size"	"PLoS One. 2008;3(10):e3558, Clin Cancer Res. 2011 Jun 15;17(12):4071-8, PLoS One. 2011;6(9):e23379, N Engl J Med. 2010 Nov 4;363(19):1801-11"	"S:\Sample reports\Automated Report Info\Figures for gene slide subset\TSC2_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\TSC2_Therapeutic2, S:\Sample reports\Automated Report Info\Figures for gene slide subset\TSC2_Therapeutic3"	Anti-EGFR antibodies reduce proliferation of TSC2 deficient cells##Reduced tumor burden in Tuberous Sclerosis patients treated with sirolimus (rapamycin)##Everolimus treatment of astrocytomas in patients with germline TSC2 mutations leads to a reduction in tumor size 	PLoS One. 2008;3(10):e3558##PLoS One. 2011;6(9):e23379##N Engl J Med. 2010 Nov 4;363(19):1801-11	TSC2	YES	YES	YES	chr16.fa:2115578-2115578_A_T	NM_001077183.1_Y553F	0.694	0.5252	0.60	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	TSC2	HUMAN|ENSEMBL=ENSG00000103197|UniProtKB=P49815		PTHR10063:SF1	TUBERIN	TUBERIN	protein binding#GO:0005515;small GTPase regulator activity#GO:0005083;binding#GO:0005488;enzyme regulator activity#GO:0030234	cell cycle#GO:0007049;intracellular protein transport#GO:0006886;vesicle-mediated transport#GO:0016192;cellular process#GO:0009987;protein transport#GO:0015031;endocytosis#GO:0006897;transport#GO:0006810		G-protein modulator#PC00022;enzyme modulator#PC00095	Insulin/IGF pathway-protein kinase B signaling cascade#P00033>TSC2#P04494;p53 pathway by glucose deprivation#P04397>TSC2#P04644;p53 pathway by glucose deprivation#P04397>TSC2#G04706	TSC2	confirmed	Fd, Ch, D, REn	Tuberous sclerosis-2;Lymphangioleiomyomatosis,somatic	613254;606690	chr16.fa:2115578-2115578_A_T	16:2115578	ENSG00000103197	CCDS10458.1	missense_variant	1658	1658	553	1	Y/F	tAc/tTc	1658A>T	Y553F	chr16.fa:2115578-2115578_A_T	ENSG00000103197	ENSG00000103197	CCDS10458.1	tAc	tTc	553	553	Y	F	NON_SYNONYMOUS_CODING	15	PGDX9323P2_PS_Seq2_novo	SNP:chr16_2115577_2115578_rs137854114_(8871BPDEL)_-,SNP:chr16_2115577_2115578_rs137854159_GTGATGGCCCGCTCCCTCTCCCCACCCCCGGAGCTGGAAGAAAGGGATGTGGCCGCATACTCGGCCTCCTTGGAGGATGTGAAGACAGCCGTCCTGGGGCTTCTGGTCATCCTTCAG_lengthTooLong																																																					OK - 1 hit	CGCATNCTCGG	CCGCTCCCTCTCCCCACCCCCGGAGCTGGAAGAAAGGGATGTGGCCGCATACTCGGCCTCCTTGGAGGATGTGAAGACAGCCGTCCTGGGGCTTCTGGTCA	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='CCGCTCCCTCTCCCCACCCCCGGAGCTGGAAGAAAGGGATGTGGCCGCATACTCGGCCTCCTTGGAGGATGTGAAGACAGCCGTCCTGGGGCTTCTGGTCA'&Submit=submit","Run BLAT")			PGDX9323P2_PS_Seq2_novo	COLUMN NOT FOUND	COLUMN NOT FOUND	TSC2	tuberous sclerosis 2	CCDS10458.1	chr16_2115578-2115578_A_T	1658A>T	Y553F	15	Substitution	Nonsynonymous coding	CGCATNCTCGG	0.001166	0.000932051533544476	5148	6	COLUMN NOT FOUND	ENSG00000103197	protein binding#GO:0005515;small GTPase regulator activity#GO:0005083;binding#GO:0005488;enzyme regulator activity#GO:0030234	cell cycle#GO:0007049;intracellular protein transport#GO:0006886;vesicle-mediated transport#GO:0016192;cellular process#GO:0009987;protein transport#GO:0015031;endocytosis#GO:0006897;transport#GO:0006810	Insulin/IGF pathway-protein kinase B signaling cascade#P00033>TSC2#P04494;p53 pathway by glucose deprivation#P04397>TSC2#P04644;p53 pathway by glucose deprivation#P04397>TSC2#G04706	-	Y553S/Y553Y haematopoietic_and_lymphoid_tissue (1 cases),kidney (1 cases)	liver (2 cases),large_intestine (2 cases),central_nervous_system (1 cases)	large_intestine (61 cases),lung (44 cases),liver (36 cases),skin (35 cases),kidney (33 cases),stomach (24 cases),endometrium (17 cases),pancreas (15 cases),upper_aerodigestive_tract (14 cases),breast (13 cases),central_nervous_system (11 cases),haematopoietic_and_lymphoid_tissue (8 cases),urinary_tract (7 cases),ovary (6 cases),prostate (6 cases),oesophagus (5 cases),bone (4 cases),NS (2 cases),soft_tissue (2 cases),autonomic_ganglia (2 cases),thyroid (2 cases),parathyroid (1 cases),adrenal_gland (1 cases),cervix (1 cases),biliary_tract (1 cases)	-	 Tuberin (557-904)	0.694	0.5252	0.60	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	Tuberous sclerosis-2;Lymphangioleiomyomatosis,somatic	613254;606690	YES	0	0.000000	0	0	0	2	0	6	4.666667	0.001166	5148	89	33	183	33	13	1.000000	5063	0	0.000000	1.055556	0.000000	-1.000000	0	0.000000	0	1	1	0	0	0	0.000912	0.000000	0.00108998425578297	0.998910015744217	0.00108998425578297	458.722222222222	chr16.fa:2115578-2115578_A_T	chr16_2115578_2115578			chr16.fa:2115578-2115578_A_T	0.000932051533544476					chr16.fa:2115578-2115578_A_T							2	2	13	0	1e-04	A/T	BIAS	BIAS	BIAS	BIAS
